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Abstract 
The use of nanomaterials in consumer products and medical research continues to 
increase.  This trend is concerning, especially for orally consumed products, since 
studies on the effects of oral exposure to nanomaterials remain inconclusive.  The 
limited availability of appropriate in vitro models impedes research, even though 
questions arising from the increasing prevalence of chronic inflammatory conditions of 
the intestine need to be addressed urgently.  
This project aimed to develop an in vitro co-culture model of Caco-2 and PMA-
differentiated THP-1 cells to mimic the human intestine in both homeostatic and 
controlled inflamed states.  The two co-culture models were characterised for cytotoxic 
(barrier integrity, membrane integrity, and metabolic activity) and inflammatory 
parameters (cytokines, nitric oxide).  After establishing the co-culture protocols, the 
models were used to study the cytotoxic and inflammatory effects of different 
nanomaterials (silver and copper oxide nanoparticles) in relation to the health status at 
the time of exposure.  Additionally, the co-cultures were applied to investigate the 
barrier crossing of radio-labelled gold nanoparticles. 
Especially for silver nanoparticles strikingly different effects were noted between the 
two conditions.  Overall, the effects were more pronounced in the inflamed co-culture 
supporting the hypothesis of increased susceptibility to nanomaterials in subjects with 
impaired health.  
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1. Introduction 
The use of nanotechnology in the manufacture of consumer goods and medical products 
remains, financially and technologically, one of the most promising advancements of 
the 21
st
 century (Kaur et al., 2014).  Prognoses concerning the two key areas of 
nanotechnology, nanomedicine and the agribusiness sector, estimated a market value of 
$81 billion and $1 trillion between 2020 and 2030, respectively (Kaur et al., 2014; 
Sabourin and Ayande, 2015).  Nanotechnology is expected to revolutionise various 
areas of life, including the production and processing of food, technological 
innovations, and medical advancements.   
Since years, the use of nanomaterials (NMs) in consumer products increases 
continuously.  In 2016, the ‘Nanotechnology Consumer Products Inventory’, the largest 
database for NM-containing consumer products, lists more than 1,800 products 
claiming to contain NMs (Consumer Products Inventory, 2016).  In parallel, the 
production volume of NMs increases, currently reaching between 550 to 5,500 tons / 
year for the three most synthesised materials, titanium dioxide (TiO2), silicium dioxide 
(SiO2), and zinc oxide (ZnO) (Bondarenko et al., 2013).  At the same time, the number 
of studies investigating the safety of NMs increased exponentially over the last 15 years 
(Krug, 2014).  Albeit relentless efforts of countless research groups hardly any 
unequivocal conclusions regarding the potential impacts of NMs on human health and 
the environment could be drawn to date.   
The increasing presence of NMs in products for oral consumption, including food, 
beverages, and nanomedical products, is concerning since it affects a vast number of 
individuals on a regular and long-term basis.  The intestine is the largest interface 
between the exogenous and endogenous environment and the main side for the 
digestion, uptake of nutrients, and water regulation (Kvietys and Granger, 2010).  Under 
homeostatic conditions the intestinal barrier provides a ‘gate’ function that, in co-
operation with constituents of the innate immune system, keeps exogenous antigens 
from entering the organism.  In conditions affecting intestinal health, e.g. acute and 
chronic inflammation, these functions are impaired, which can have far-reaching 
implications for the whole organism (Levine and Burakoff, 2011). 
Recently, the efforts to investigate the uptake, fate, and effects of orally ingested NMs 
have increased.  The impact of pre-existing health conditions on NM-induced effects 
remain, however, neglected (Fröhlich and Roblegg, 2012; Lefebvre et al., 2015).  
2 
Extensive research on the effects of air pollution demonstrated an increased 
vulnerability in susceptible groups, e.g. patients with chronic obstructive pulmonary 
disorder (Sunyer et al., 2000; Löndahl et al., 2012).  In this context, the increasing 
prevalence and incidences of inflammatory bowel diseases (IBD) (a summarising term 
for chronic inflammatory conditions characterised by alternating active and remission 
periods) raises concerns (Ponder and Long, 2013).  Similar to subjects with chronic 
pulmonary disorders, IBD patients might face greater risks arising from the oral 
exposure to NMs than the average population.  One of the main challenges in 
addressing these questions is the limited availability of appropriate in vitro models 
(Lefebvre et al., 2015).  
 
1.1 Anatomy and functions of the gastrointestinal tract 
The human gastrointestinal (GI)-tract is a continuous luminal space framed by mucosal 
epithelia ranging from the oral cavity over the stomach and intestine to the anus.  The 
functional differences of the subunits are reflected in phenotypical distinctions on 
morphological and biochemical level.  As a whole, the GI-tract is responsible for the 
mechanical and biochemical digestion of food components from macromolecular to 
absorbable micromolecular size.  The digestive process begins in the oral cavity with 
the physical impact of the teeth and initial enzymatic breakdown of dietary starch and 
fats.  Apart from the allocation of digestive enzymes the secreted saliva supports the 
formation of a food bolus and allows it to pass from the oral cavity to the stomach via 
the oesophagus.  Whereas important steps of degradation of proteins are completed in 
the stomach, the enzymatic digestion and absorption of carbohydrates, fats and proteins 
happens in the small intestine.   
With a length of ~6 m the small intestine is the largest part of the GI-tract (Whitney and 
Rady Rolfes, 2008).  To fulfil the task of nutrient absorption with the highest efficacy 
the small intestine has developed a uniquely specialized surface structure.  Its mucosa is 
pleated in large folds, which in turn have smaller elevations – so-called villi.  The great 
majority of the villous surface is lined with a single-cell layer of absorptive, 
functionally and morphologically polarised epithelial cells (‘intestinal epithelial cells’ 
(IECs)).  Together with the underlying lamina propria and a layer a smooth muscle cells 
the epithelium forms the intestinal mucosa.   
3 
A schematic overview of the most important IECs and leukocytes is given in Figure 
1.1A. 
 
1.1.1 Enterocytes 
Enterocytes are the most abundant epithelial cell type in the small intestine and line the 
majority of its villous surface (Barker, 2014).  To maximizing the contact area between 
the epithelium and chime (i.e. the bolus of partly digested food) enterocytes express 
micro-villi on their luminal surface forming the so-called ‘brush-border’ (Shiner and 
Birbeck, 1961).  This anatomy increases the surface area to roughly 300 m².  The 
expression of micro-villi and brush border hydrolases, including alkaline phosphatase 
and sucrose isomaltase, render small intestinal enterocytes unequivocally 
distinguishable from the other epithelial cell types of the GI-tract (Ranaldi et al., 2003).   
The small intestine is one of the fastest renewing tissues in the human body.  All 
enterocytes originate from intestinal stem cells (iSC) located in the crypts surrounding 
the villi (Figure 1.1A) (Barker, 2014), and subsequently migrate to the tip of the villi 
within 3-5 days.  Throughout this process the cells’ anchorage gradually loosens until 
they are eventually shed at the tip.  The loss of cell anchorage induces a specific type of 
apoptotic cell death termed ‘anoikis’ (Grossmann et al., 2001). 
The enterocyte layer forms the major physical barrier between the exogenous and 
endogenous environment in the gut.  This barrier is, however, selectively permeable via 
transcellular and paracellular pathways: The transcellular uptake is mainly associated 
with the absorption of dietary compounds, e.g. monosaccharides, amino acids, and fatty 
acids (Suzuki, 2013), whereas the paracellular permeability is controlled by a junctional 
complex composed of adherence junctions (AD) and tight junctions (TJ) (Figure 1.1B) 
(further discussed in Section 1.2.1) (Assimakopoulos et al., 2011).   
 
1.1.2 Non-enterocytic epithelial cells 
Apart from the enterocytes, 4 additional epithelial cell types can be distinguished in the 
small intestine: goblet, endocrine, Paneth and Microfold (M)-cells (Menard et al. 2010).  
Like enterocytes, all other IECs originate from iSC (Barker, 2014).  Whereas 
enterocytes, goblet, endocrine, and M-cells move towards the tip of the villi, the Paneth 
cells remain at the base of the crypt (van Es et al., 2005).  Paneth cells are mainly 
4 
responsible for the synthesis and secretion of anti-microbial peptides (AMP), which act 
strongly against both Gram-positive and Gram-negative bacteria (Muniz et al., 2012).  
A high concentration of AMP is secreted directly into the crypt lumen (Bevins and 
Salzman, 2011) to prevent bacterial invasion of this otherwise vulnerable space 
(Johansson et al., 2013).  Additionally, the AMP disperse in the mucous layer that 
sheathes the epithelium (Bevins and Salzman, 2011).   
The mucus is secreted by goblet cells, which are scattered over the whole epithelium.  It 
is now understood that the mucus lining is more than a static physical barrier to protect 
the host from luminal antigens.  It is a dynamic hurdle that adapts to environmental 
factors, e.g. the composition of the intestinal microbiota (Deplancke and Gaskins, 
2001).  In the small intestine, the mucus layer is discontinuous and does not cover the 
surfaces of M-cells (Deplancke and Gaskins, 2001). 
M-cells make up for around 10 % of the follicle-associated epithelium, which covers 
aggregated lymphoid follicles located in the lamina propria – the so-called Peyer’s 
patches (Mabbott et al., 2013; Jung et al., 2010).  Using phagocytotic and transcytotic 
mechanisms, M-cells enable the translocation of intact macromolecules, e.g. proteins, 
bacteria, and viruses, from the gut lumen to the underlying Peyer’s patches (Neutra et 
al., 1987; Mabbott et al., 2013). 
5 
 
Figure 1.1 Schematic overview of (A) intestinal epithelial cells and the gut-associated lymphoid tissue, and (B) the intestinal TJs 
(iMΦ: intestinal macrophages, AMP: anti-microbial peptides, iSC: intestinal stem cells, (F)DCs: (follicular) dendritic cell, MLS: mesenteric lymph node, ZO: Zonula Occludens, 
JAM: Junctional Adhesion Molecules) 
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1.1.3 Gut-associated lymphoid tissue  
The intestine forms the largest interface between the environment and the human 
organism.  As such, it is in constant contact with a variety of exogenous components, 
e.g. food-derived macromolecules, and microbial structures of both commensal and 
pathogenic bacteria that require differential feedback.  This feedback can range from 
tolerance to active immune response (Muniz et al., 2012).  The intestine’s functions are 
a tightrope walk between the uptake of nutrients across the intestinal barrier and 
preventing the intrusion of harmful antigens (Clayburgh et al., 2004).  To fulfil this 
ambivalent role, IECs and the gut-associated lymphoid tissue (GALT) have established 
a finely-tuned cohabitation.  The GALT is composed of aggregated lymphoid tissue (the 
Peyer’s patches and mesenteric lymph nodes (MLN)), as well as individually operating 
leukocytes (Lorenz and Newberry, 2004).  After crossing the follicle-associated 
epithelium and entering the sub-epithelial dome, luminal macromolecules are 
phagocytised, presented to and analysed by various types of immune cells, including B-
cells, T-cells, dendritic cells (DCs) and macrophages (MΦ) (Rios et al., 2016; Mabbott 
et al., 2013).  DCs travel continuously between compartments of the organised 
lymphoid tissue to transport antigens from the Peyer’s patches to the MLN where they 
are presented and further immune reactions are decided (Macpherson and Smith, 2006).  
Outside of the organised lymphoid tissue individual leukocytes, such as T-cells, MΦ, 
DCs, and natural killer cells, roam the lamina propria to phagocytise, present, and / or 
analyse randomly encountered antigens (Coombes and Powrie, 2008; Smythies et al., 
2005; Guo et al., 2008).  In addition to the uptake of lumenal macromolecules via M-
cells, DCs can penetrate the TJs between IECs and sample directly from the intestinal 
lumen.  By expressing several TJ proteins, including occludin, claudin 1, and JAM-A, 
their interference with the junctions does not cause a disruption of the barrier integrity 
(Rescigno et al., 2001; Chiba et al., 2008).  
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1.2 The intestine in healthy and diseased states 
The following sub-titles will focus on the major measurable differences between the 
healthy and diseased intestine and summarise the hallmarks of intestinal inflammation. 
 
1.2.1 Cytokines and chemokines 
‘Cytokine’ is a broad term summarising several groups of small effector proteins that 
can be released by various cell types, including epithelial cells and leukocytes (Haller et 
al., 2000; Neurath, 2014).  Cytokines are crucial messenger molecules that affect the 
behaviour of and the communication between cells.  They can act in an autocrine, 
paracrine, and even endocrine manner on the cells that release them, neighbouring cells, 
and distant cells, respectively (Zhang and An, 2007).  Typically, the same cytokine can 
be secreted by different cell types, and a specific cytokine can act on more than one cell 
type (Zhang and An, 2007). 
Cytokines are commonly distinguished as pro-inflammatory, anti-inflammatory, or 
chemotactic (chemokines) according to three fields of responsibility, i.e. the induction / 
maintenance of inflammation, the termination of inflammation, and the recruitment of 
target cells (Zhang and An, 2007).  However, several if not most cytokines can have 
more than one task depending on additional environmental factors (Müzes et al., 2012; 
Scheller et al., 2011).  Pro-inflammatory cytokines are predominantly synthesised by 
activated macrophages.  Several of these cytokines, e.g. interleukin (IL)-1β, tumour 
necrosis factor (TNF)-α, and interferon (IFN)-γ, are crucial for the initiation and 
mediation of inflammatory responses (Zhang and An, 2007).  Normally, an infection or 
damage of the IEC barrier induces a short-term, local acute inflammation under 
generation of high concentrations of pro-inflammatory cytokines and chemokines, 
which is followed by a complete recovery of the intestinal wall and its functions 
(Bamias et al., 2014).  However, in some cases, and for reasons that are not yet fully 
understood, the inflammatory response is not resolved but rather sustained in a chronic 
manner.  The blocking of single cytokines, e.g. TNF-α, has been shown to greatly 
alleviate the condition of IBD patients (Altwegg and Vincent, 2014).  In contrast, the 
exclusion of others, e.g. IL-1β, rather worsened the condition, which suggests an 
involvement in the initiation and facilitation of anti-inflammatory and recovery 
processes like the limitation of leukocyte infiltration (Bamias et al., 2014). 
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Other cytokines have been shown to be of importance for the preservation and / or 
recovery of intestinal homeostasis.  The chemokines IL-8 and transforming growth 
factor (TGF)-β, facilitate the recruitment and differentiation of blood monocytes to the 
lamina propria (Smythies et al., 2006).  IL-8 is furthermore involved in the recruitment 
of neutrophils as first-responders during intestinal inflammation (Fournier and Parkos, 
2012).  Others, like IL-22, have been attributed a protective role based on the 
observations that significantly lower levels are recovered in subjects with ongoing 
inflammatory conditions compared to healthy controls (Bamias et al., 2014).   
 
1.2.2 Nitric oxide  
Nitric oxide (NO) can be an important physiological messenger molecule or an indicator 
for pathophysiological processes depending on the stimulus of its synthesis, its source, 
as well as the duration and quantity of its release (Forstermann and Sessa, 2012).  Under 
physiological conditions, the generation of nanomolar concentrations of NO by 
constitutively expressed endothelial and neuronal NOS (eNOS and nNOS, respectively) 
is meticulously regulated (Kolios et al., 2004).  In these cases, NO can be involved in 
the regulation of blood pressure (Huang et al., 1995), neuronal functions (Prast and 
Philippu, 2001), and the maintenance of intestinal barrier integrity (Kolios et al., 2004).  
NO derived from eNOS and nNOS acts as anti-inflammatory mediator by reducing the 
chemotactic potential of several chemokines and modulation of macrophage-cytokine 
release towards an anti-inflammatory composition (Kolios et al., 2004).  In contrast, the 
activation of inducible NOS (iNOS) causes the persistent release of micromolar 
concentrations of NO (Kolios et al., 2004).  The ability to release large quantities of NO 
has been demonstrated to be an important feature of an organism’s innate immune 
response to pathogens (MacMicking et al., 1995; Zeidler et al., 2004).  The prolonged 
and uncontrolled release of NO, however, is suspected to play a role in IBD (Singer et 
al., 1996) and to contribute to a very early onset of IBD (Dhillon et al., 2014).  NO can 
react further with O2 or O2ˉ and subsequently impose oxidative or nitrosative stress, 
which can induce DNA damage and enzyme inhibition (Grisham et al., 1999).  
Furthermore, the excessive generation of NO and the formation of its stable metabolite 
nitrate (NO3ˉ) likely accelerates the growth of less beneficial intestinal bacterial strains, 
thereby, displacing more favourable ones (Winter et al., 2013).  
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1.2.3 Intestinal barrier integrity 
The integrity of the IEC barrier is essentially controlled by the presence and intactness 
of TJs sealing the paracellular space between epithelial cells (Figure 1.1B).  Whereas 
the initiation and stabilisation of cell-to-cell contacts is mainly related to the formation 
of AJ with proteins of the cadherin and catenin families at the core (Hartsock and 
Nelson, 2008), the TJs determine the selective paracellular permeability to ions, solutes, 
and water (Suzuki, 2013).  At the same time, TJs restrict the passage of any kind of 
potentially noxious antigens from the lumenal to the serosal side (Edelblum and Turner, 
2009).  The TJs form the most apical of the junctional structures of adjacent cells and 
reduce the width between enterocytes to 8-12 and 2-2.5 Å in the jejunum and colon 
respectively (Bolger et al., 2006).  In addition to the charge and size selective ‘gate’ 
function (Chiba et al., 2008), TJs hold a ‘fence’ function, preventing the mixing of 
apical (AP) and basolateral (BL) membrane proteins and lipids (Hartsock and Nelson, 
2008).  The integrity of the TJ network and paracellular permeability is often studied by 
measurement of the transepithelial electrical resistance (TEER) or the translocation of 
small molecules across the epithelial barrier (Suzuki, 2013).   
 
1.2.3.1 TJ proteins 
To date, more than 40 proteins have been identified that are involved in the construction 
of the TJs (Anderson and Van Itallie, 2009).  They can roughly be divided into two 
types of proteins: (1) transmembrane proteins forming intercellular adhesion structures 
and (2) intracellular proteins connecting the transmembrane proteins with the actin 
cytoskeleton (McNeil et al., 2006).  Four main transmembrane proteins can be 
distinguished, namely occludin, claudins, junctional adhesion molecules (JAMs), and 
tricellulin (Chiba et al., 2008).  Occludin has been shown to be dispensable for TJ 
assembly and the development of a polarised epithelium.  However, more detailed 
analysis revealed histological and functional abnormalities, including inflammation and 
hyperplasia in the stomach, in occludin knock-out mice suggesting a more complex role 
of occludin than just involvement in TJs (Saitou et al., 2000).  In contrast, proteins of 
the claudin family are critical for both TJ morphology and function (Van Itallie and 
Anderson, 2014).  Claudins form the structural base of the TJ strands and are, therefore, 
seen as the backbone of the TJ (Chiba et al., 2008).  Whereas some proteins of the 
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claudin family are involved in the development and maintenance of the barrier, others, 
e.g. Claudin-2, are essential for the formation of paracellular pores (Yu et al., 2009).   
Zonula occludens (ZO) proteins – the main group of intracellular proteins – were the 
first identified proteins of the TJ and remain one of the best studied group of TJ proteins 
(Van Itallie and Anderson, 2014).  With binding to ZO-1 the transmembrane protein 
claudin is connected to the actin cytoskeleton (Fannings et al., 1998).  For many of their 
tasks, the members of the ZO-protein family seem to be functionally interchangeable.  
For instance, the individual depletion of either ZO-1 or ZO-2 only caused mild 
structural and functional effects on developing epithelia (Umeda et al., 2004).  When 
both proteins were suppressed in parallel the TJ-assembly failed (Umeda et al., 2006).  
Apart from its involvement in the epithelial barrier integrity ZO-1 actively controls cell 
proliferation through binding to the ZO-1-associated Y-box (ZONAB) transcription 
factor (Gottardi et al., 1996; McNeil et al., 2006).  
 
1.2.3.2 Regulation of TJ integrity 
The regulation of the TJs has not been fully elucidated to date.  Even though one of 
their main functions is to keep noxious substances from entering the organism, the 
paracellular permeability can be regulated by a multitude of physiological and 
pathophysiological stimuli.  The main stimuli known to affect the TJ integrity are 
pathogenic bacteria, cytokines, oxidative stress, and growth factors.  These will be 
presented in more detail under the following sub-headings. 
Several different factors that influence the TJ integrity are known to date, including 
interactions between transmembrane proteins and the actomyosin ring of the 
cytoskeleton, the phosphorylation of TJ proteins, and the up- or downregulation of TJ 
proteins (Ulluwishewa et al., 2011; Shen, 2012).  The interaction between TJ proteins 
and the actomyosin ring can be determined by different signalling proteins depending 
on the type of stimulus.  For instance the stimulation of TLR2 activates protein kinase c, 
which in turn induces a re-distribution of ZO-1 (Cario et al., 2004).  In contrast, 
mitogen-activated protein kinases (MAPK) is mobilised by growth factors (Howe et al., 
2005) (Section 1.2.3.2.4).  The probably best studied mechanism of TJ regulation, 
however, involves the phosphorylation of myosin light chain (MLC) through MLC 
kinase (MLCK), which induces the contraction of the actomyosin ring (Shen, 2012).   
11 
A distorted paracellular permeability can affect the gate function of the epithelial barrier 
and lead to an increased influx of lumenal antigens.  Increased intestinal permeability is 
strongly associated with both acute, e.g. in response to a bacterial infection (Section 
1.2.3.2.1), and chronic inflammatory conditions of the intestine.  Decreased barrier 
integrity has been demonstrated in Crohn’s disease and ulcerative colitis patients, as 
well as the patients’ first grade relatives (Katz et al., 1989; Gerova et al., 2011), but also 
in individuals with coeliac disease and diabetes Type 1 (van Elburg et al., 1993; Visser 
et al., 2010).  The mechanisms behind the reduction in barrier integrity are best 
understood for IBD.  Biopsy samples from IBD patients showed a significant 
downregulation of occludin, ZO-1, and claudin-5 and 8, as well as an increase in 
claudin-2 (Gassler et al., 2001; Zeissig et al., 2007; Weber et al., 2008).  It remains 
unclear, whether the impaired epithelial barrier is the primary cause or a secondary 
consequence of the disorder.  
 
1.2.3.2.1 Pathogenic bacteria 
Various pathogenic bacterial strains target the TJ network to enter the organism 
(Guttman and Finlay, 2009).  In mice, the infection with enterohemorrhagic E. coli 
(EHEC) induced intestinal barrier disruption as measured by reduction in TEER and 
increase in the mucosal permeability for FITC-labelled dextran.  In response to the 
EHEC infection the distribution and transcription profiles of several TJ proteins were 
altered (Roxas et al., 2010).  Interestingly, whereas EHEC caused an increase in 
claudin-2 in vivo, a significant reduction in claudin-2 expression was reported in vitro in 
a colonic epithelial cell line (T84) (Howe et al., 2005).  Another enteroinvasive 
pathogen – Shigella – caused dislocation of ZO-1, occludin, and claudin-1 from the cell 
boundaries.  The disengagement of occludin has been shown to be caused by 
phosphorylation of the protein.  The effects on the TJ network resulted in a significant 
reduction in barrier integrity, as well as an increase in paracellular flux of molecules as 
large as 66 kDa (Fiorentino et al., 2014).  Direct interactions with TJ proteins have been 
reported in infections involving the bacterium Clostridium perfringens.  Shortly after 
the infection, Clostridium perfringens enterotoxin bound to selective proteins of the 
claudin family and induced a rapid disintegration of the TJ strands, which was reflected 
in reduced TEER and increased flux of dextran (4-10 kDa) (Sonoda et al., 1999).  
Whether bacterial endotoxin can affect the barrier integrity is not clear yet as studies 
have generated contradictive results (Guo et al., 2013; Van De Walle et al., 2010). 
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1.2.3.2.2 Pro-inflammatory cytokines 
Various pro-inflammatory cytokines have been shown to affect the TJ network and 
paracellular permeability.  Interestingly, many of the cytokines seem to induce 
individual pathways ultimately leading to the barrier disruption.  In the presence of both 
TNF-α and IFN-γ the observed reduction in barrier integrity is associated with increased 
phosphorylation of MLC.  Whereas the phosphorylation of MLC in the presence of 
IFN-γ is linked to the enhanced expression of Rho associated kinase (ROCK), an 
increase in MLCK was found in the case of TNF-α exposure (Capaldo and Nusrat, 
2009; Wang et al., 2005).  For both cytokines, studies reported reduced protein levels of 
ZO-1 and re-localisation of transmembrane proteins via endocytosis (Bruewer et al., 
2003; Marchiando et al., 2010).  The disruptive effect was, however, maximised when 
both cytokines were present in parallel indicating a strong synergistic effect (Wang et 
al., 2005).   
Furthermore, several interleukins (ILs) have been shown to influence the barrier 
integrity of epithelial cells.  In the case of IL-1β exposure, a reduction in occludin on 
both protein and mRNA level was reported, as well as an up-regulation of MLCK 
(Capaldo and Nusrat, 2009; Al-Sadi et al., 2010).  In contrast to this, the barrier 
disruption induced by IL-6 was demonstrated to be caused by the activation c-jun N-
terminal kinase (JNK) pathway and the subsequent up-regulation of claudin-2 (Al-Sadi 
et al., 2014).   
The reduction in barrier integrity often causes an increased permeability for ions or 
molecules.  However, the individual cytokines seem to affect the permeability 
differently.  The increase in permeability caused by IL-6 was limited to small molecules 
(<4 Å) but not non-ionic macromolecules (Al-Sadi et al., 2014; Suzuki et al., 2011).  On 
the other hand, IL-1β caused a similar reduction in TEER as IL-6, but allowed an 
increased flux of molecules as large as 15 Å (Al-Sadi and Ma, 2007).  In the presence of 
either IFN-γ or TNF-α alone, no increased flux of larger molecules (3 kDa dextran) was 
detected.  When epithelial cells were co-exposed to both cytokines, a large increase in 
permeability was observed for 3 kDa dextran (Wang et al., 2005). 
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1.2.3.2.3 Reactive oxygen and nitrogen species (ROS/RNS) 
In contrast to many pro-inflammatory cytokines, H2O2 did not affect the total protein 
levels of TJ proteins, but causes the increased phosphorylation of ZO-1 and occludin 
(Basuroy et al., 2006).  NO on the other hand, induced delocalisation of ZO-1 and 
occludin (Cuzzocrea et al., 2000).  Several reported observations suggest that NO not 
only induces intestinal barrier disruption itself but also at least partially mediates the 
barrier disruption caused by pro-inflammatory cytokines (Xu et al., 2002; Unno et al., 
1995). 
 
1.2.3.2.4 Growth Factors 
Some have been shown to be able to induce both an increase and decrease in barrier 
permeability depending on the cell environment (Capaldo and Nusrat, 2009).  Whereas 
TGF-β caused a reduction in TEER in murine uterine epithelial cells (Grant-Tschudy 
and Wira, 2005), a significant increase in barrier integrity was reported in intestinal 
epithelial cells (Howe et al., 2005).  Furthermore, growth factors appear to have TJ-
related protective effects.  In Caco-2 cells, the treatment with epithelial growth factor 
inhibited H2O2-associated disruption of the TJs by preventing the dissociation of ZO-1 
and occludin from the cytoskeleton (Basuroy et al., 2006).  In the cell line T84, TGF-β 
not only increased the TEER through upregulation of claudin-1, but also protected the 
epithelial cell layer from EHEC-induced TJ-disruption (Howe et al., 2005). 
 
1.2.4 Macrophage populations  
In the homeostatic intestine, different types of leukocytes make up the first line defence 
of the innate immune system, including DCs and MΦ.  These cells are involved in the 
unspecific protection of the intestinal barrier from harmful antigens and the overall 
immune regulation in the intestine.  Cells of the innate immune system bind 
encountered antigens through pattern recognitions receptors.  Subsequently, the antigen 
is phagocytised, digested, and parts of its proteins presented via the major 
histocompatibility complex (MHC), while the cell migrates to the lymph node.  There, 
the antigen is presented to T-cells, which together with B-cells are the main effector 
cells of the adaptive immune system.  The antigen-presentation together with the 
initiated cytokine release by the innate immune response triggers the T-cell activation 
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and, thereby, starts the targeted antigen-elimination through the adaptive immune 
response (Medzhitov, 2007).  The different types of leukocytes are distributed over the 
GALT, the intestinal epithelium, as well as the lamina propria (Habtezion et al., 2016).  
Within this project, the focus was put on the role of macrophages on intestinal 
homeostasis and inflammation. 
 
1.2.4.1 Macrophage populations in the homeostatic intestine 
Intestinal macrophages (iMΦ) form the largest pool of tissue macrophages within the 
human body (Smythies et al., 2006).  The tissue-resident MΦ are mainly present in the 
lamina propria, the core of the mucosa, but can also be found to a lesser extent in deeper 
layers of the intestine – the submucosa and muscularis mucosae (Mowat and Bain, 
2011).  To sustain the pool, circulating blood monocytes are recruited by IEC-released 
TGF-β and IL-8 (Smythies et al., 2006; Bain and Mowat, 2014).   
Human monocytes are commonly grouped into ‘classical’, ‘non-classical’, and 
‘intermediate’ monocytes according to their expression of CD14 and CD16 (Shi and 
Pamer, 2011):   
 Classical: CD14++CD16ˉ 
 Non-classical: CD14+CD16++ 
 Intermediate: CD14++CD16+. 
 
Generally, a ‘classical’ pro-inflammatory (M1) and an ‘alternative’ anti-inflammatory 
(M2)-type differentiation are distinguished (Wang et al., 2014).  However, monocytes 
are known to be able to adapt their phenotype to the environmental circumstances.  It 
was demonstrated in mice that the pool of intestinal tissue macrophages is replenished 
by recruited classical-type monocytes, which, subsequently, mature into iMΦ (Bain et 
al., 2014).  Functionally, iMΦ are closely related but not identical to anti-inflammatory 
M2 MΦ (Smith et al., 2011).  They are characterised by a systematic inflammatory 
anergy, which describes the lack of pro-inflammatory reactions towards the encounter 
of non-self antigens (Smythies et al., 2005).  This anergy is characterised by a strict 
down-regulation of the synthesis of TLR-mediated cytokines like IL-1, IL-6, and TNF-
α, but not of the phagocytising and bactericidal activity are down-regulated in iMΦ 
(Smythies et al., 2005).  The exact reason for the inflammatory anergy is not clear yet.  
15 
iMΦ express Toll-like receptors (TLRs) like TLR2 and 4, which are necessary for the 
recognition of pathogen-associated molecular patterns (PAMPs) (Mowat und Bain 
2014).  It was suggested, that the adequate response to stressors is impaired due to a 
lack or the insufficient expression of other proteins necessary for the recognitions of 
LPS or the subsequent signal transduction, e.g. CD14 and MyD88 (Smythies et al., 
2010; Smith et al., 2011).  Yoshioka et al. (2009) found minimal expression of CD14 on 
the membrane of iMΦ, which the group suggested might be caused by an impaired 
transport of CD14 from the endoplasmic reticulum to the Golgi apparatus.  
In contrast to DCs, iMΦ do not commonly enter the lymphoid tissue.  Nevertheless, 
they can present processed antigens through MHC II to lamina propria T-cells (Mann 
and Li, 2014; Bain and Mowat, 2014).  Altogether, their role can be described as 
bacterial waste disposal of the innate immune system, which does not rush to action 
itself but forwards the information (Mowat and Bain, 2011).   
 
1.2.4.2 Macrophage populations in the inflamed intestine 
Intestinal inflammation is associated with a significant infiltration of classical 
monocytes into the lamina propria (Kühl et al., 2015).  In the homeostatic intestine, the 
vast majority of iMΦ lacks the LPS-receptor CD14.  However, a small fraction could be 
identified bearing both macrophage (CD14
+
/CD68
+
) and DC (CD205
+
/CD209
+
) 
receptors,
, 
which strongly increases in numbers during intestinal inflammation (Kamada 
et al., 2008).  In contrast to CD14ˉ iMΦ, newly recruited CD14+ macrophages release 
high concentrations of pro-inflammatory cytokines, including IL-6, TNF-α, IL-1β, and 
IFN-γ, as well as chemokines to attract additional monocytes (Kamada et al., 2008; 
Kühl et al., 2015).  IL-8, monocyte chemoattractant protein (MCP)-1, and macrophage 
inflammatory protein (MIP)-1α are the three most abundant chemokines that are 
involved in the recruitment of blood monocytes to the site of inflammation (Smith et al., 
2011; Shi and Pamer, 2011; Banks et al., 2003).  For the recruitment of monocytes in 
both health and disease, MCP-1 seems to be especially important.  Whereas the absence 
of either MCP-1 or its associated receptor causes a significant reduction in the iMΦ 
pool under homeostatic conditions (Bain et al., 2014), a lack of MCP-1 throughout an 
infection reduces the monocyte recruitment by up to 50 % (Shi and Pamer, 2011).  
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1.3 Available approaches for research of the intestine 
To study the intestine and its functions various in vivo, ex vivo, and in vitro models are 
available that differ in applicability and validity.  The use of computer-based modelling 
(so-called in silico research) will not be discussed within this project.  A non-exhaustive 
summary of the advantages and disadvantages regarding in vivo, ex vivo, and in vitro-
based research models is presented in Table 1.1. 
 
1.3.1 In vivo 
The physiology and integrity of the intestine is regulated by the complex interplay of 
different epithelial and mononuclear cell types, but also the microbiome.  Data derived 
from in vivo models offer the great advantage of reflecting the processes within a 
complete organism rather than a snapshot based on isolated cell types.  These results are 
regarded as the most applicable, especially concerning the integrity and bioavailability 
of compounds throughout the GI-passage, even though this view is increasingly 
challenged (Musther et al., 2014).  Animal models helped to expand the knowledge 
regarding digestive processes, absorption, and immune regulation in the intestine under 
homeostatic conditions.  In addition, several models mimicking acute and chronic 
inflammation are available of which rodent-based models using mice and rats are the 
most commonly applied (Jiminez et al., 2015).  These models are either based on 
transgenic animal strains or rely on a chemically induced intestinal inflammation 
(Prattis and Jurjus, 2015; Wirtz et al., 2007).  However, results generated using animal 
studies can only be extrapolated to humans to a limited extent (Musther et al., 2014).  
Physiological and pathological processes in humans can be tremendously different from 
those of the experimental species, and the generated results and subsequently drawn 
conclusions are highly susceptible to flaws and / or biases in the study design 
(Cerquetella, 2010; Ioannidis, 2012).  Furthermore, in vivo research is confronted with a 
generally negative public opinion and demand for the development and use of 
alternative animal-free methods by the European legislator (Ioannidis, 2012). 
 
1.3.2 Ex vivo 
An alternative between in vivo and in vitro approaches is the use of ex vivo cell cultures, 
which can be divided into biopsy- and stem cell-based approaches.  The use of intestinal 
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biopsy samples has generated numerous insights regarding the intestinal barrier function 
in health and disease (Piche et al., 2009), the interaction of IECs with enteropathogenic 
bacteria (Schüller et al., 2009), and material transport across the intestinal barrier 
(Schmidt et al., 2013).  Biopsies-based ex vivo research offers the great advantage of 
providing a short-term organ culture featuring all epithelial cell types (He et al., 2013).  
This heterogeneous structure of multiple cell types can also present a disadvantage, as it 
complicates the study of cell type-specific effects (Turner et al., 1997).  Furthermore, 
inter-individual differences between the donors, including variations in genetics, overall 
health status, or life style choices (e.g. diet, physical activity, consumption of alcohol, 
caffeine, and nicotine), can cause significant deviations in the outcomes.  The main 
limitation of biopsy sample cultures is the narrow longevity of isolated IECs ex vivo 
(Grossmann et al., 1998).  Therefore, efforts were focused on the isolation and 
maintenance of iSC.  For these experiments, intestinal crypts were separated from the 
intestinal barrier and subsequently grown into three-dimensional organotypic structures 
in presence of appropriate growth factors (Grabinger et al., 2014).  These cultures were 
found to correlate significantly better with cytotoxicity results generated in vivo than 
cell line-based in vitro cultures (Grabinger et al., 2014).  Even though stem cell-derived 
cultures have a significantly increased life span compared to isolated IECs their very 
limited availability remains a great disadvantage for both approaches.  For this project, 
ex vivo cultures were not accessible.  
 
1.3.3 In vitro 
In vitro research comprises the use of isolated primary cells and immortalised cell lines 
to study one or more defined endpoints.  For decades, in vitro models of the intestinal 
barrier have been used to study the pharmacological and toxicological effects, as well as 
the bio-availability of molecules (Sambruy et al., 2001) and particles (Desai et al., 
1997).  Although the development of primary (Castellanos-Gonzalez et al., 2013) and 
stem cell-derived (Chopra et al., 2010) intestinal cultures has advanced recently, the 
application of immortalised cell lines remains favoured due to their easy accessibility, 
handling, and maintenance.  However, the numerous cell types and complex structure 
defining the small intestine are difficult to mimic in vitro.  A monoculture of 
differentiated (D)Caco-2 cells showed limited correlation to ex vivo permeability of other 
species (canine, rodent, and non-human primates) for various compounds (e.g. D-
glucose, mannitol, progesterone), but promising parallels to human in vivo data (Rubas 
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et al., 1993).  Whereas cell monocultures are valuable to study a specific endpoint, e. g. 
cytotoxicity, their ability to predict downstream impacts in relation to biokinetics and 
metabolism is limited (Duell et al., 2011; Lilienblum et al., 2008).   
Therefore, efforts have focused on the development of more sophisticated intestinal 
models combining at least two different cell types.  Depending on the desired 
application, developments have aimed for an improved representation of the intestinal 
barrier (Wikman-Larhed and Artursson, 1995; Hilgendorf et al., 2000; Chen et al., 
2010; Schimpel et al., 2014) or the integration of immune cells (Leonard et al., 2010; 
Susewind et al., 2016).  Several groups studied immune responses involving leukocytes 
with the help of primary cells (Bisping et al., 2001; Leonard et al., 2010; Parlesak et al., 
2004).  Nevertheless, acquiring and maintaining primary cells is significantly more 
expensive than the use of cell lines.  Furthermore, their accessibility and donor-
variability can be problematic in particular regarding the inter-laboratory comparability 
(Corazza and Wade, 2010).  
Additionally to the application of co-cultures, groups recently started to improve the 
physiological representation of intestinal tissue by culturing cells on three-dimensional 
scaffolds mimicking the villous structure of the intestine (Chen et al., 2015b; Kim et al., 
2014).  The newest advancements are so-called ‘gut-on-a-chip’ developments, which 
can combine different cell types and representative strains from the microbiome, but 
also account for the physiological structure, peristaltic and sheer stress of the intestinal 
environment (Lee et al., 2016; Kim et al., 2012a). 
The application of these increasingly complex cell models helped generate new insights 
regarding the regulation of intestinal homeostasis (Parlesak et al., 2004; Nathens et al., 
1995), as well as the influence of immune cells on IEC responsiveness to stressors 
(Wottrich et al., 2004; Susewind et al., 2016) and particles (Moyes et al., 2010).  Even 
though various models involving immune cells are available, none was directly 
applicable to our interests. Either the models were established using primary cells 
(Leonard et al., 2010; Bisping et al., 2001) or cell lines of non-human origin (Tanoue et 
al., 2008).  Others were characterised by a spontaneous disruption of the IEC barrier 
induced by an uncontrolled inflammation-like reaction (Watanabe et al., 2004; Moyes et 
al., 2010; Kanzato et al., 2001; Satsu et al., 2006).  In the most recently presented model 
by Susewind et al. (2016) the immune cells are embedded in a collagen layer, which can 
render the application costly.  Furthermore, the introduction of a collagen layer might 
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hinder the accurate detection of messenger molecules, as well as the quantification of 
NM translocation.   
In contrast, the aim of this project was to establish a non-contacting – paracrine – co-
culture.  For reasons of practicality and accessibility the model was to be based on cell 
lines rather than primary cells.  To maximise the model’s applicability to a human 
exposure scenario cell lines of human origin were favoured.   
 
1.4 Cell lines 
1.4.1 Enterocytic cell lines 
Over the last 40 years numerous enterocytic cell lines have been established that mainly 
originated from colon carcinomas (Chantret et al., 1988).  One of the most extensively 
used and best characterised models is the human colon carcinoma cell line Caco-2.  
Originally isolated from colonic tissue, the cells differentiate spontaneously without 
external stimulus to enterocyte-like cells once the cells reach confluence (Pinto et al., 
1983; Chantret et al., 1988).  This differentiation is reflected in the development of a 
microvillous apical membrane, indicating structural polarisation of the Caco-2 barrier, 
and the increase in brush border-associated hydrolases (Chantret et al., 1988; Hilgers et 
al., 1990).  Caco-2 cell cultures offer similar transport and permeability characteristics 
as human intestinal tissue (Lennernas et al., 1996; Rubas et al., 1993).  With a size 
between 4.3-4.6 Å (Watson et al., 2001; Knipp et al., 1997) the TJ pore radius in intact 
Caco-2 cell layers is slightly larger than in the colon, but only around half the size of the 
small intestinal TJ radius (Bolger et al., 2006).  Even though the cell line does not offer 
a perfect representation, e.g. concerning drug permeability (Yamaura et al., 2016), it 
shares a significant amount of proteins and characteristics with human enterocytes and 
the intestinal barrier (Lenaerts et al., 2007).   
 
1.4.2 Monocyte / macrophage cell lines 
In contrast to IECs, the number of available human monocytic or macrophage cell lines 
is very limited.  The THP-1 cell line is one of the most widely used human monocytic 
cell lines and has been extensively characterised, morphologically and functionally, 
against peripheral blood mononuclear cells (PBMCs) and PMBC-derived MΦ 
(Daigneault et al., 2010).  The monoblast-like cells can be differentiated into a 
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macrophage-like phenotype using various stimuli, including phorbol 12-myristate 13-
acetate (PMA) and 1α, 25-dihydroxy vitamin D3 (Tsuchiya, 1980; Tsuchiya et al., 
1982).  From the basic (M0) macrophage phenotype the cells can be further polarized 
towards a M1 or M2 phenotype using LPS and IFN-γ or IL-4 and IL-13, respectively 
(Genin et al., 2015).  THP-1 cells have a wide application range as they can be 
differentiated towards a macrophage-like, as well as a DC-like phenotype (Berges et al., 
2005).   
Several other groups showed that THP-1 cells are suitable candidates to be introduced 
in cell line-based co-cultures models of the lung (Kasper et al., 2015) and the intestine 
(Susewind et al., 2016).  It has furthermore been demonstrated that the presence of 
THP-1 cells can alter the response of a co-culture model towards the exposure to 
particulate matter compared to monocultures (Alfaro-Moreno et al., 2008; Klein et al., 
2013). 
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Table 1.1 Summary of the general advantages (+) and disadvantages (-) of in vivo-, ex vivo-, and in vitro-based research models 
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1.5 Nanomaterials 
As early as 1959, Richard Feynman raised the idea to manipulate matter on the atomic 
scale, which he presented in his famous ‘There’s plenty of Room at the Bottom’ speech. 
Even though not manageable back then, it created a vision and encouraged an entirely 
new field of research, which today is commonly known as ‘nanotechnology’.  
Nanotechnology concerns itself with the atomic, molecular, and supramolecular levels 
of elements and thereof resulting materials to understand and exploit their size-
dependent change in behaviour (Boland, 2006).  These materials – summarised in the 
term ‘nanomaterials’ (NMs) – are characterised by a size of less than 100 nm in at least 
one dimension (Handy and Shaw, 2007).  A more detailed definition, which is used in 
this project, has recently been recommended by the European Commission (2011) for 
regulatory purposes clarifying NMs to be any 
 “[…] natural, incidental or manufactured material containing particles, 
 in an unbound state or as an aggregate or as an agglomerate and where, 
 for 50 % or more of the particles in the number size distribution, one or more 
external dimensions is in the size range of 1 nm – 100 nm.” 
 
Usually three major exposure routes are distinguished: inhalation (which to date is seen 
to be the most likely route of exposure for incidentally generated NPs), dermal uptake 
through the skin, and absorption of ingested NMs in the GI-tract (Elsaesser and 
Howard, 2012).  Considering the use of NMs in medical products or therapeutics, the 
direct intravenous and intramuscular exposure to nano-sized objects has to be taken into 
account additionally (Farokhzad and Langer, 2006).  This project will focus on the 
interactions of NMs with the intestinal barrier and underlying immune cells. 
 
1.5.1 Oral exposure to NMs 
NMs are increasingly used in both consumer and industrial products with numerous 
applications in the food sector.  They can be intentionally introduced into food products 
and beverages or accidentally present as contaminants, e.g. resulting from dissolution 
and migration from packaging material (Bergin and Witzmann, 2013).  The increased 
incorporation of NMs in a variety of products could cause problems of environmental 
contamination and, eventually, accumulation of NMs in water and animal products 
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(Conway et al., 2014; Lu et al., 2016).  In a wider context, oral exposure also include 
the ingestion of inhaled particles after mucocilliary clearance from the respiratory tract 
(Arora et al., 2012), as well as the ingestion of medical products containing nano-sized 
components (Bergin and Witzmann, 2013).   
Evaluating the average oral uptake of NMs is challenging, as it greatly depends on the 
diet, the status of processed foods within a diet, as well as the portion size (Lomer et al., 
2000).  An average daily intake of 10
12
 to 10
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micro-and nano-sized particles was 
estimated with SiO2 and TiO2 accounting for the major share (Lomer et al., 2002).  For 
nano-sized SiO2 particles the daily intake was estimated with 1.8 mg / kg bodyweight, 
whereas for TiO2 NPs an oral uptake of roughly 0.07 mg / kg was proposed (Dekkers et 
al., 2011; Lomer et al., 2000).  Concerning Ag, the mean uptake of dietary Ag (i.e. 
elemental, ionic, and nanoparticulate) was compiled for the French population resulting 
in the estimation of 1.29-2.65 µg / kg bodyweight (ANSES, 2011).  For other NMs, like 
copper oxide (CuO) no estimations on the oral uptake are available to date.  Due to its 
bactericidal activity, however, CuO is expected to be increasingly used in the future to 
replace Ag species.  To date, the antibacterial properties of CuO only account for a 
minimal amount of its applications (Bondarenko et al., 2013). 
In the food industry, TiO2 NPs are commonly used as whitening pigment (Weir et al., 
2012).  SiO2 NPs are applied as anti-caking agent, and used for the clearance of beer 
and wine (Yang et al., 2016; Dekkers et al., 2011).  Furthermore, the application of 
NMs offers possibilities to improve the structure of food products, e.g. by increasing the 
stability of foams and emulsions (Dickinson, 2010) or preserving vulnerable compounds 
(Freiberger et al., 2015).  NMs cam also be used to enhance the nutritional value of food 
products and nutraceuticals, as well as food supplements (Moncada et al., 2015; Luo et 
al., 2012; Santos et al., 2013).   
Other materials are incorporated into food packaging and food contact materials from 
which they might – purposely or accidently – be released into the product.  The use of 
nanotechnology in the manufacture of food containers or food contact surfaces 
generally aims to increase the quality and safety of the product (Silvestre et al., 2011).  
The applied materials include bactericidal agents like Zn NPs and AgNPs, which serve 
as shelf life extenders (Perez Espitia et al., 2012; Griffiths, 2015; von Goetz et al., 2013) 
and antibacterial compounds in water purification systems (Phong et al., 2009).  
Another aspect to improve food safety is the use of nanotechnology-based ‘intelligent 
labels’ capable of monitoring the condition of the packaged product and its 
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environment, e.g. pH, oxygen, CO2, or pathogens (Kuswandi et al., 2011).  Other 
applications are aimed at improving specific characteristics of the packaging material.  
The most commonly addressed points are the flexibility of a material, as well as the 
improvement of its barrier function to enhance the gas barrier properties, e.g. in plastic 
bottles, and atmospheric stability (Silvestre et al., 2011).  Carbon- and silicon based 
NMs are main components in the sensor development for intelligent food packaging 
(Vanderroost et al., 2014), whereas polymer-nano-composites (featuring filler materials 
like nano-clay and SiO2) enabled major advancements in the improvement of packaging 
materials (Duncan, 2011).  Several studies have demonstrated that NMs used in 
packaging can migrate from the material into the food product or beverage in the 
container and might, subsequently, be ingested (von Goetz et al., 2013).  Detailed 
indications regarding their share on the total exposure of consumers are not known. 
 
1.5.2 Fate of orally ingested NMs 
The incorporation of NMs as components in a food product or packaging containers 
makes an oral uptake highly likely.  In this context, Ag, metal oxides and metalloids 
(e.g. SiO2, ZnO, and TiO2), as well as gold (Au) if nanomedical applications are taken 
into account (Fröhlich and Roblegg, 2012), are the materials of main concern.   
Nanoparticulate matter can reach the GI-tract via two pathways: directly through oral 
uptake of nano-sized ingredients or contaminants in food products, beverages, and 
medical products, or indirectly after mucocilliary clearance from the respiratory tract 
(Arora et al., 2012).  Since the incidental exposure to NMs after clearance from the 
respiratory tract is difficult to estimate normally only the direct dietary intake is 
considered in exposure assessments.  Even though the exposure likelihood is high and 
the possibility of particle translocation from the intestinal lumen is recognised since 90 
years (Hoet et al., 2004), studies on the uptake of NPs and associated risks have 
generated few definite answers to date.   
 
1.5.2.1 Overcoming the mucus barrier of the GI-tract 
Before overcoming the epithelial monolayer, NMs encounter the mucous lining of the 
mucosa, which presents an important barrier in the GI-tract.  As a visco-adhesive 
hydrogel, mucus can entrap particles, e.g. through electrostatic interactions, van der 
25 
Waals forces, and chain entanglement (Liu et al., 2015).  The health condition of the 
intestinal tissue strongly influences the mucus generation and composition.  Both in 
vitro and in vivo models of the intestine showed an increased synthesis of mucus in 
inflamed conditions (Lamprecht et al., 2001; Leonard et al., 2010).  Furthermore, an 
enhanced accumulation of nano-and micro-sized particles was noted at inflamed areas, 
which was suggested to be related to the mucus generation and composition (Leonard et 
al., 2010; Maisel et al., 2015).  On one side, this knowledge can be used to develop new 
therapies for the treatment of IBD (Lamprecht et al., 2001; Ali et al., 2013).  On the 
other side, individuals with chronic inflammatory conditions are likely to face different 
biological responses to NMs compared to healthy subjects (Leonard et al., 2010; 
Schmidt et al., 2013).   
 
1.5.2.2 Overcoming the intestinal epithelial barrier 
Four different pathways have been suggested for the uptake of NMs across the intestinal 
barrier: 
1) Transcellular through enterocytes 
2) Transcellular through M-cells 
3) Paracellular (Fröhlich and Roblegg, 2012) 
4) Persorption through single degrading enterocytes (Hillyer and Albrecht, 2001; 
Martirosyan et al., 2012). 
Whereas the significance of uptake via paracellular processes and persorption remains 
questionable the transcellular passage of NMs through enterocytes and M-cells is 
widely acknowledged (Fröhlich and Roblegg, 2012).  It has been demonstrated that 
NMs can enter systemic distribution after the uptake across the gut wall (Florence, 
2005; Powell et al., 2010).   
Due to the diversity of study outcomes, no broad consensus exists on how NMs interact 
with the GI-tract and what exactly determines their ability to reach systemic 
distribution.  Several pathways that facilitate the internalisation of NPs into epithelial 
cells have been identified, including clathrin- and caveolin-mediated endocytosis, 
clathrin/caveolin-independent endocytosis, pinocytosis, and macropinocytosis (Oh and 
Park, 2014).  Which mechanism is employed for the uptake of a NM appears to 
critically depend on the particle characteristics, such as size (of primary the particle and 
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potential aggregates/agglomerates), hydrophobicity, surface modification, and shape 
(Desai et al., 1997; Win and Feng, 2005; Florence, 2005).  Whereas large vesicles of up 
to 5 µm are formed during macropinocytosis (Oh and Park, 2014) the size of caveolin-
mediated caveolae usually ranges between 50 and 80 nm (Iversen et al., 2011).  Apart 
from the size, the particle charge and geometry were shown to influence the uptake 
mechanisms.  Bannunah et al. (2014) observed that the uptake of positively charged 
particles was mainly facilitated through clathrin-mediated endocytosis, as well as 
macropinocytosis, whereas the majority of negatively charged particles was internalised 
via a lipid raft-associated pathway.  Alemdaroglu et al. (2008) noted a significantly 
higher uptake of rod-shaped compared to spherical copolymer micelles in Caco-2 cells. 
However, the endocytosis rate of NMs does not necessarily equal their exocytosis, and 
hence, cannot be applied as a measure for entrance into systemic distribution.  For 
instance Jani et al. (1990) noted size-dependent differences in the uptake of polystyrene 
particles in the GI-tract of rats.  For particles up to 100 nm, higher concentrations of 50 
than 100 nm were taken up and systemically distributed.  Particles larger than 300 nm 
were taken up into the intestinal wall but trapped within the Peyer’s patches (Jani et al., 
1990). 
Next to the characteristics of NMs, the diet itself and the physiology of the individual 
subject, including mucus secretion, pH, and GI-transit time greatly influence the uptake 
of NMs (Fröhlich and Roblegg, 2012). 
 
1.5.3 Risks and benefits of oral exposure to NMs 
The following paragraphs will summarise the potential risks and benefits of orally 
ingested NMs from a general perspective.  More detailed discussions of AgNPs, CuO 
NPs, and AuNPs will follow in Chapters 4-6. 
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In vitro studies are widely available in the scientific literature, as both cell lines and 
commercial NMs are easily accessible and maintainable at comparably low costs.  
However, the general lack of guidelines and protocols for the design and execution of 
studies resulted in a multitude of combinations regarding the investigated cell type and 
chosen cell line and 
 cell differentiation 
 the NM and its characteristics, e.g. size, geometry, surface modifications, 
surface charge 
 exposure conditions, e.g. time and concentration 
 endpoints studied including the choice of assay. 
Therefore, it can be difficult to compare across different studies, which can complicate 
the detection of similarities and differences in the effects and pathways between 
different NMs and characteristics of NMs.  
For several NMs, e.g. SiO2, ZnO, and TiO2, the use of moderate exposure 
concentrations often did not result in measurable adverse effects in short-term exposure 
studies (McCracken et al., 2013).  Some NMs, including TiO2 NPs, AuNPs, and nano-
diamonds, are reported to exhibit very low to no toxicity.  No adverse effects on cell 
viability and gene expression were observed in Caco-2 cells after exposure to 10 µg / 
mL TiO2 NPs for up to 72h (Fisichella et al., 2012).  The exposure to nano-diamonds 
(up to 250 µg / mL) induced neither cytotoxicity nor genotoxicity in 6 cell lines or 
potential target organs, including an intestinal, a kidney, and two liver cell lines (Paget 
et al., 2014).  In contrast, AgNPs were found to significantly reduce cell viability and 
proliferation in undifferentiated (UD)Caco-2 cells at very low exposure concentrations of 
1.25 µg / mL (McCracken et al., 2015).   
It has been shown in vivo that NMs, albeit in a very small fraction, can be absorbed 
from the GI-tract and systemically distributed (Schleh et al., 2012).  The potential 
effects of orally ingested NMs likely depend on their bioavailability, which can vary 
significantly between materials.  In a 90-day oral exposure study in rats Cho et al. 
(2013b) observed significant differences in the uptake of ZnO and TiO2 NPs.  Whereas 
90 nm ZnO NPs were absorbed and systemically distributed, considerably smaller 26 
nm TiO2 NPs were not (Cho et al., 2013b).  In contrast, Nogueira et al. (2012) observed 
a potential pro-inflammatory effect of sub-chronic exposure to 100 mg / kg bodyweight 
TiO2 NPs and MPs in mice.  The group noted an increased presence of CD4
+
 T-cells, as 
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well as increased levels of pro-inflammatory cytokines like TNF-α, IFN-γ, and IL-12 
(Nogueira et al., 2012).  Several studies reported indications for the induction of organ-
specific toxicity, for instance in response to AgNPs (Kim et al., 2008) or ZnO NPs 
(Sharma et al., 2012).  Most of the available studies used acute or sub-chronic exposure 
scenarios.  Only very few information are available on a potential bio-accumulation of 
NMs and the induction of chronic toxicity (van der Zande et al., 2012).  Furthermore, it 
remains questionable how these findings translate to a human exposure situation.  
To what extend the intestinal physiology can influence the effects of NMs is still 
unclear.  Several in vivo studies and one study in human volunteers have shown 
increased attachment and accumulation of NMs at the site of inflammation within the 
intestine (Schleh et al., 2012; Schmidt et al., 2013).  On the one hand, this might cause 
an increased uptake of NMs across the intestinal barrier and subsequent systemic 
distribution.  On the other hand, dietary NPs have been suggested to play a role in the 
induction of intestinal inflammation and even the deterioration of IBD (Martirosyan et 
al., 2012; Lomer et al., 2002).   
Focusing on the benefits of NMs it appears that the great majority are primarily 
favourable for the manufacturers.  The introduction of nano-sized materials to food 
products is more efficient and effective than the use of the bulk counterpart (Kasaai, 
2015).  However, both manufacturers and consumers can profit from the use of 
nanotechnological approaches to improve food safety and quality as mentioned before 
(Section 1.5.1).  One of the most promising developments expected to benefit a wider 
range of individuals is the use of NMs in medical products and pharmaceuticals.  
Especially the formulation of drug delivery vehicles to improve targeting, 
bioavailability, or circulation time of an active substance is a promising application field 
(de Jong and Borm, 2008). 
 
1.5.4 Unknowns concerning the oral exposure to NMs 
The hereinafter presented challenges should be understood as examples and is by no 
means an exhaustive list.  
One of the biggest question marks concerning the oral exposure to NMs is the actual 
exposure concentration an individual faces.  For some NMs average exposure 
estimations are available (Section 1.5.1), but for most no sound assessment has been 
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performed.  The knowledge of exposure concentrations is of great interest to design 
studies using realistic exposure scenarios.  To date, most studies apply nonsensically 
high concentrations applied as a single dose / one-time exposure.  The results of many 
in vivo studies suggest, though, that the occurrence of chronic toxic effects is 
substantially more likely than the induction of acute toxicity (Pettibone et al., 2009).  In 
a study by van der Zande et al. (2012), the results showed a low but detectable 
accumulation of AgNPs in the brain and testes after a 28-day oral exposure study in 
rats.  The detected concentrations were far lower than in the liver or spleen, however, 
hardly any elimination occurred over a period of 2 months after the last exposure (van 
der Zande et al., 2012).  Results like these strongly call for long-term and repeated-
exposure studies to address potential bioaccumulation of NMs and, thereby, induced 
chronic toxicity. 
A topic currently receiving increased interest is the effect of NM-exposure on the 
intestinal flora.  Whereas several studies could show a negative impact of NM-exposure 
on the composition of the microbiome in vivo (Tyagi et al., 2016) and in vitro (Taylor et 
al., 2015) others did not find any significant effects (Wilding et al., 2016).  Over the last 
years, however, the diversity of tasks and importance of the microbiome for the 
organism, e.g. mental health and weight control (Foster and McVey Neufeld, 2013; 
Sweeney and Morton, 2013), have become increasingly evident.  Hence, reliable and 
consistent statements are required. 
Whereas hardly any effects are known with certainty in the healthy organism even less 
is known regarding the impact of NM-exposure in the diseased intestine.  So far, most 
exposure experiments are performed in healthy animals and cell cultures mimicking 
intact tissue, even though the effects of exposure are likely different in individuals with 
impaired health (de Jong and Borm, 2008).  Also concerning the oral uptake of NPs and 
MPs studies have shown specific effects in IBD patients.  For instance Lomer et al. 
(2002) reported a significant impact of the dietary particle content on the disease 
activity index of Crohn’s disease patients.  Furthermore, several studies have observed 
differences in the adherence and uptake of NMs between healthy and inflamed intestinal 
tissue (Section 1.5.2.1).  However, only few insights have been gained concerning a 
potentially changed toxicity of NMs in impaired tissue.  In this regard, a major 
limitation is the scarce availability of well-designed and -defined in vitro disease 
models (Lefebvre et al., 2015). 
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1.6 Aims, objectives, and general hypotheses of the project 
The human intestine is constantly in contact with nano-sized objects, including dietary 
proteins and micelles.  Taking into account that both epithelial and immune cells must 
frequently encounter them, NMs are unlikely to present a danger to human health per se.  
However, the number of engineered NMs incorporated in food products and packaging 
material rises continuously.  The safety of these materials has been demonstrated using 
their bulk products, but has generally not taken into account the change in physico-
chemical properties when reducing their size to the nanoscale.  It is, therefore, unclear 
how the oral exposure to these NMs affects the human organism compared to their 
larger-sized counterparts.  Even less is known regarding the effects of orally ingested 
NMs in the diseased compared to the healthy intestine.  However, both acute and 
chronic inflammatory conditions of the intestine present challenges world-wide.  
Whereas improvements in hygiene and food safety practices slowly reduce the 
occurrence of foodborne illnesses the prevalence of IBD is rising.  In this context, the 
exposure to NMs must not necessarily mean a hazard, but can also include innovative 
nanomedical approaches for the treatment of IBD.  
The overarching goal of this project was identified to be the development and 
characterisation of an in vitro co-culture model of the human small intestine to progress 
in vitro-based intestinal research models for nanosafety applications.  To achieve this 
goal the following aims (roman numbers) and corresponding objectives (small letters) 
were defined: 
 
I. Development of an in vitro cell line-based co-culture model combining 
enterocytes and macrophages representing the human small intestine in 
homeostatic state. 
I.a THP-1 differentiation protocol and seeding density will be adapted so 
that no disruption of the Caco2 barrier occurs throughout the co-culture.   
I.b To assure that THP-1 and Caco-2 cells do not negatively affect each 
other, the following endpoints will be measured at least once over a time 
course of 48h: TEER, release of pro-inflammatory cytokines, LDH as 
marker for necrotic cell death, and NO2ˉ. 
I.c The endpoints will be compared to a Caco-2 monoculture control. 
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II. Advancement of the homeostatic intestinal model to mimic the diseased 
intestine by displaying a controlled inflamed state in response to the exposure to 
a pathophysiological stressor.   
II.a The homeostatic co-culture will be triggered to display hallmarks of 
intestinal inflammation – reduction in barrier integrity, pro-inflammatory 
cytokine release, LDH release, and NO2ˉ synthesis – using a 
pathophysiological stressor. 
II.b The inflammation-like reaction will be induced without altering the 
previously adapted details, i.e. THP-1 differentiation and seeding 
density.  
II.c The inflammation-like reaction will be assessed regarding the TEER, 
pro-inflammatory cytokine release, LDH release, and NO2ˉ synthesis 
over a time course of 48h against a Caco-2 monoculture control and the 
homeostatic co-culture. 
 
III. Application of the two established co-culture models to study the cytotoxic and 
(pro-)inflammatory effects of NMs in context of the model’s health status at the 
time of exposure. 
III.a Both developed co-culture models will be exposed to non-toxic 
concentrations of NMs that are likely to be orally ingested.  
III.b The cytotoxic potential of the NMs will be studied in the cell 
monocultures prior to the exposure of co-cultures.  
III.c In both co-culture conditions the cytotoxic and inflammatory effects of 
the NMs will be assessed by monitoring TEER, pro-inflammatory 
cytokine release, LDH release, and NO2ˉ synthesis. 
III.d All results will be compared to an unexposed Caco-2 monoculture, as 
well as a corresponding unexposed co-culture control. 
 
IV. Application of the two established co-culture conditions to investigate the effect 
of the model’s health status on the paracellular passage of NMs across the IEC 
barrier.   
IV.a Both developed co-culture models will be exposed to different sizes of 
radio-labelled AuNPs. 
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IV.b The effect of the co-culture and the exposure to AuNPs will be 
monitored by means of TEER and compared to an unexposed Caco-2 
monoculture control. 
IV.c The activity of the radio-label will be measured in the AP and BL 
supernatants, as well as in both cell lines. 
IV.d The activity distribution in the co-culture models will be compared to an 
exposed Caco-2 monoculture control and against each other.  
 
The project is based on the hypotheses that 
1. Caco-2 and THP-1 cells can cohabit in a paracrine co-culture system to mimic 
the intestine in homeostatic state. 
2. An inflammation-like response displaying hallmarks of intestinal inflammation 
can be induced in the homeostatic co-culture through the stimulation of the 
THP-1 cells. 
3. The two co-culture models are suitable to study the effects of NMs in relation to 
the health status of the in vitro co-culture at the time of exposure.  
The specific hypotheses will be elaborated in the introductory paragraphs of the 
experimental Chapters 2-6. 
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2 Development of a co-culture model to mimic the healthy and 
inflamed human intestine 
This chapter will describe the development of the two conditions of the envisaged co-
culture model: 
1. A homeostatic co-culture of Caco-2 and THP-1 cells to mimic the healthy 
human intestine (Aim I). 
2. An in vitro inflammation-like response in a co-culture of Caco-2 and THP-1 
cells to resemble the diseased human intestine (Aim II). 
The induction of an inflammation-like response should result in the manifestation of the 
hallmarks of intestinal inflammation – disruption of barrier integrity, cytotoxicity, and 
release of pro-inflammatory molecules, e.g. cytokines and NO.  To obtain highly 
comparable results from the individual co-culture models the differences between the 
two set-ups will have to be kept to an absolute minimum. 
The development of the co-culture models was based on the following hypotheses: 
 THP-1 and Caco-2 cells can cohabit and, therefore, can be used to develop a 
homeostatic co-culture model. 
 The homeostatic co-culture can be disrupted by stimulation of the THP-1 cells 
with a physiologically relevant stressor. 
 The stimulation of THP-1 cells with a stressor causes a significant reduction in 
barrier integrity compared to the homeostatic co-culture.  
 
2.1 Materials & Methods 
2.1.1 Chemicals 
Phosphate Buffered Saline (PBS) (20012-019), Minimum Essential Medium (MEM) 
(31095), Roswell Park Memorial Institute medium (RPMI) (52400), sodium pyruvate 
(11360), Penicillin / Streptomycin (Pen/Strep) (15150), 2-mercaptoethanol (31350), 
Trypsin / EDTA (25300-054), and L-Glutamine (35050) were purchased from Thermo 
Fisher Scientific.  D-Glucose (G8769), TritonX-100 (93443), PMA (P1585), 
formaldehyde (254-9), lipopolysaccharides (LPS) (L4391), Lucifer Yellow (LY) 
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(L0259), Accutase (A6964), and bovine serum albumin (BSA) (A2153) were obtained 
from Sigma-Aldrich.  
 
2.1.2 Cell culture 
NB: The details concerning the co-culture development will be covered in the results, 
Sections 2.2.3 and 2.2.4. 
Caco-2 cells (DSMZ, ACC169; a kind gift from Dr. Roel Schins) were culture in MEM-
based cell culture medium (CCM) substituted with 20 % FBS (Thermo Fisher Scientifc, 
26140079), and 1 % Pen/Strep at standard culture conditions (37°C, 5 % CO2).  The 
cells were sub-cultured at 3x10
5
 cells / 25cm² flask when cell layers reached ~80 % 
confluence.  For co-culture experiments, cells were seeded at a density of 1.8x10
5
 cells / 
cm² on transparent PET transwell inserts (1 µm pore size; Falcon 353103) and 
maintained for 18-21 days to allow for barrier formation and differentiation of the cells.  
Transparent filters were chosen to facilitate the analysis of the cells with light and 
fluorescence microscopy.  Since the model shall eventually be used to study barrier 
crossing of NMs, filter inserts with a pore-size <1 µm and collagen coating of the filters 
were avoided, as both might hinder particles to pass into the BL compartment after 
crossing the Caco-2 cell layer.  Apically, cells were maintained in MEM-based CCM, 
whereas the medium on the BL side was gradually (Table 2.1) changed to RPMI-based 
THP-1 medium (composition below) without mercaptoethanol.  The barrier formation 
was monitored by regular measurements of TEER every 2 to 3 days of culture (Section 
2.1.4), assessment of the translocation of LY across the cell barrier (Section 2.1.5), and 
immunohistochemical staining of F-actin (cytoskeleton) and the TJ-associated protein 
ZO-1 (Section 2.1.6). 
The early monocytic cell line THP-1 (ATCC, TIB-202) was cultured in RPMI-based 
CCM substituted with 10 % FBS (Thermo Fisher Scientifc, 10099), 1 % Pen/Strep, 1 % 
L-Glutamine, 1 nM sodium pyruvate, 0.7 % D-Glucose, and 0.05 mM mercaptoethanol 
at standard culture conditions.  The cells were sub-cultured when reaching a cell density 
of 8-10x10
5
 cells / mL.  For co-culture experiments, the cells were seeded in 25 cm² 
culture flasks at a density of 3x10
6
 cells / 6 mL CCM and differentiated with 100 nM 
PMA (60 μL of a 10 μM stock in PBS).  The differentiation with PMA will be discussed 
in more detail in Section 2.2.2.1.  After differentiation, the cells were detached with 
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Accutase and plated at a density of 1.8x10
5
 cells / well on transwell-suitable 12-well 
plates. 
Table 2.1 Medium composition in the basolateral compartment over 21 days of Caco-2 culture 
 
 
Both cell lines were tested for their genetic integrity (performed by DSMZ, 
Braunschweig, Germany).  The Caco-2 cell line was confirmed to fully match the 
testing institute’s STR profile.  The THP-1 cells were attested a slight deviation from 
the DSMZ profiles, but fully matched the STR information of the original supplier 
(ATCC).  Both cell lines were negative for contamination with foreign mitochondrial 
DNA sequences (DSMZ, Braunschweig) and mycoplasma (Minerva Analytix, Berlin).   
 
2.1.3 Adjustments for the inflamed co-culture 
To establish the inflamed co-culture several adjustments to the stable co-culture set-up 
were investigated.   
 
2.1.3.1 LPS-stimulation of THP-1 cells 
To induce the release of pro-inflammatory cytokines, 10 ng / mL LPS were added to the 
BL compartment at the start of the co-culture (T0) to activate the PMA-differentiated 
THP-1 cells.   
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2.1.3.2 Pre-stimulation of THP-1 cells  
To allow for an unrestricted activation, the THP-1 cells were exposed before the start of 
the co-culture.  After PMA-differentiation, the cells were plated onto transwell-suitable 
12 well plates.  The cells were left to re-attach for 1.5h after which the medium was 
discarded and exchanged for 1.5 mL fresh medium.  Subsequently, 10 ng / mL LPS or a 
combination of LPS and IFN-γ (10 ng / mL each) was added to the well and the cells 
incubated for 4h at standard culture conditions.  After 4h, the co-culture was started by 
placing the filter inserts with Caco-2 cells on the THP-1-containing wells.  
 
2.1.3.3 IFN-γ priming of Caco-2 cells  
To increase their sensitivity to the presence of TNF-α, Caco-2 barriers were primed with 
IFN-γ as described by Wang et al. (2005).  18-24h before the start of the co-culture, 
Caco-2 cells were exposed to 10 ng / mL IFN-γ in the BL compartment of the transwell 
system.  Two hours before the start of the co-culture, the exposed cells were washed 2x 
with 1 mL PBS on the BL side and 1.5 mL fresh CCM were added.  The co-culture was 
initiated as before by placing the primed filters onto transwell-suitable 12 well plates 
containing PMA-differentiated THP-1 cells. 
 
2.1.4 Monitoring of barrier integrity by TEER 
The TEER was measured using an Ohm-meter (Millicell, ERS-2) to monitor the barrier 
development of the Caco-2 cell layer, as well as to assess the barrier integrity 
throughout the co-culture with THP-1 cells.  To monitor the barrier development, the 
TEER was measured every 2-3 days from day 2 to 21 post-seeding.  For studying the 
effect of co-culturing Caco-2 and THP-1 cells the TEER was measured just before the 
co-culture and after 4, 24, and 48h.  If applicable, the TEER was also measured after 
18h of co-culture.  Before measurements were taken, the electrode was sterilised for 15 
min in 70 % Ethanol and neutralised in pre-warmed PBS and MEM.  The results were 
corrected for the blank value and multiplied by the filter size to obtain the final results 
in Ohm per cm
2
 (Ω·cm2).   
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2.1.5 Barrier permeability assay and calculation of the apparent 
permeability coefficient  
To monitor the Caco-2 barrier development the flux of LY from the AP to the BL 
compartment was measured at day 2, 4, 6, 12, and 21 post-seeding.  The supernatant 
was removed and the cells washed twice on both AP and BL side with Hank’s Balanced 
Salt Solution containing magnesium and calcium (HBSS
+/+
). Subsequently, 1.6 mL 
HBSS
+/+
 were added to the BL side and 0.6 mL of 5 mg / mL LY dissolved in HBSS
+/+
 
to the AP side.  The cells were incubated for 4h at standard culture conditions.  From 
both sides, 100 μL samples were taken immediately after addition of LY and after 4h.  
The sample volumes were not replaced in the wells.  The fluorescence was measured 
spectrophotometrically (Perkin Elmer, Enspire) at an excitation wavelength of 485 nm 
and emission wavelength of 530 nm.   
To calculate the apparent permeability coefficient (Papp) from samples taken after 4h the 
following equation (2.1) was applied:  
𝑃𝑎𝑝𝑝 =  
𝑑𝑄/𝑑𝑡
𝐶0 ∗ 𝐴
 
(2.1) 
With dQ/dt being the permeability rate in μM / s, C0 the initial concentration of LY in 
the AP compartment (5 μM), and A the filter surface are in cm2 (0.9).  The result is 
expressed as cm / s. 
 
2.1.6 Immunocytochemcial staining and analysis 
Target proteins of both Caco-2 and THP-1 cells were stained using specific primary 
antibodies (Abs) coupled with fluorophore-conjugated secondary Abs and imaged with 
the Zeiss Axiovert 200M in Apotome mode.  In Caco-2 cells the development of the 
(microvillous) cytoskeleton (F-actin, villin) and the TJ network (here ZO-1) were 
monitored.  For THP-1 cells, the influence of PMA exposure on the cytoskeletal 
structure, as well as the expression of cell surface receptors (CD14 and CD68) were 
analysed.  For immunocytochemical staining the cells were fixed in 3.7 % 
formaldehyde for 13 min.  Subsequently, they were permeabilised with 1 % (Caco-2) or 
0.1 % (THP-1) TritonX-100 in PBS for 5 min and blocked against unspecific binding 
with 3 % BSA in PBS at room temperature (RT).  The cells were incubated with the 
primary Ab (ZO-1: 5 µg / mL [Thermo Fisher, 61-7300]; villin [Sigma, SAB5500190]: 
38 
1:100; CD14 [Sigma, C7673] and CD68 [abcam, ab955]: 5 µL / 1x10
6
 cells) for 1.5h at 
RT.  After washing with PBS, the cells were incubated with a mix of AlexaFluor546 
(Caco-2 1:300, THP-1 1:2,000), Phalloidin-AlexaFluor488 conjugate (1:40) and DAPI 
(1:4,000) in PBS for 45 min at 37°C.  For analysis using the Zeiss Axiovert microscope 
the filters were cut out and mounted cells facing up on standard microscopy glass slides.  
The slides were stored protected from light at 4°C. 
A black & white AxioCam MRm (Carl Zeiss; Jena, Germany) was used and 
pseudocolours were applied after image acquisition.  The exposure times for all three 
channels were set using stained control cells and subsequently applied in the image 
acquisition of all conditions.  The channel focus was adjusted manually for each 
position.  If applicable, the acquired images were analysed using the software ImageJ.  
All images were treated with the same background subtraction.  In case the signal 
intensity was increased a linear enhancement was applied to the whole file.  All 
corresponding images were treated identically.  Further details on the image analysis are 
given in the individual sections. 
 
2.1.7 Flow cytometry 
Flow cytometry was used to study the expression of two cell surface receptors – CD14 
and CD68 – on THP-1 cells.  The cells were fixed in 3.7 % formaldehyde as 
undifferentiated control or after differentiation with PMA.  For each condition a 
minimum of 1x10
6
 cells was prepared.  The cells were used as unstained control, 
stained with the primary Ab (CD14 or CD68 as above), stained with the secondary Ab 
(AlexaFluor 546 at a concentration of 1:100), or stained with both Abs.  Since both 
primary Abs were generated in mice, the receptor stainings had to be performed 
separately.  The unstained and stained cell samples were analysed with flow cytometry 
(Partec CyFlow Space), kindly performed by Blanka Halamoda-Kenzaoui from the 
‘Interaction with Biological Systems’ (IBS) Competence Group (CG) of the 
Nanobiosciences (NBS) Unit at the Joint Research Centre (JRC) (Italy).  The results are 
presented as % of gated cells. 
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2.1.8 Cytokine quantification using Enzyme-Linked Immuno-Sorbent Assay 
(ELISA) 
The release of IL-1β, IL-8, and TNF-α was quantified by a sandwich ELISA using cell-
free supernatant collected after 4h exposure to LPS or LPS and IFN-γ, or after 4h of co-
culture.  The ELISA was run as described by Kinsner et al. (2006).  Briefly, the primary 
Ab (R&D, DY210/201/208) was incubated overnight in coating buffer (0.1 M NaHCO3 
in MilliQ H2O) on high protein-binding 96-well plates (Nunc MaxiSorp).  After 
washing (0.05 % TWEEN20 in PBS) and blocking (3 % BSA / PBS) the supernatant 
samples were added pure or if necessary diluted (1:2-1:10 in 1 % BSA / PBS) and 
incubated for 2h.  After thorough washing, the secondary Ab was added and incubated 
for 1.5h at 37°C.  After incubation (30 min) with peroxidase (Bio Trend, S207), 100 µL 
3,3′,5,5′-Tetramethylbenzidine (Sigma, T0440) were added and the reaction stopped 
with sulphuric acid (1M) after 10-15 minutes.  The absorbance was read 
spectrophotometrically at 450 nm.  In every analysis, a calibration curve and blank was 
included for each cytokine.  The calibration curve was plotted as 4-parameter logfit. 
  
Table 2.2 ELISA upper and lower detection limit according to the manufacturer  
 
 
2.1.9 Statistical Analysis 
Throughout the entire project, the data analysis was performed with Microsoft Excel 
and the results were illustrated using GraphPad Prism 6.  Variations between results are 
expressed as standard deviation (StDev). The statistical analysis was done by one-way 
ANOVA and Dunnett’s test, or if applicable unpaired T-test, using Minitab.  A value of 
p≤0.05 was accepted as statistically significant.  In graphs, no symbolic distinction is 
made between p≤0.05, ≤0.01, ≤0.005, and ≤0.001. 
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2.2 Results / Protocols 
2.2.1 Caco-2 monoculture 
2.2.1.1 Barrier formation and TJ development  
The barrier formation was monitored by regular measurements of TEER.  The 
maximum TEER of 510±38 Ω•cm² was reached approximately 12 days post-seeding 
(Figure 2.1).  Subsequently, the barrier resistance decreased again to around 400 Ω•cm².  
Hereinafter, the TEER results of co-culture and barrier exposure experiments are 
expressed as percentage of the unexposed Caco-2 monoculture control.  
In correspondence to this, the imaging of Caco-2 cells after different culture periods 
(Figure 2.2) show a clear increase in cell number over 21 days.  After 24h of culture 
(Figure 2.2A) the cells attached and small colonies were formed.  The large surrounding 
F-actin rings suggest a high cellular volume and ample cytosolic space.  The TJ-
associated protein ZO-1 is exclusively expressed between adjacent cells.  On cell 
membranes facing unoccupied space no ZO-1 expression was observed.  After 12 days 
of culture (Figure 2.2B), two observations were striking.  Firstly, the intracellular area 
was clearly reduced compared to after 24h of culture.  Secondly, the cells formed large 
dome-like structures.  The severity of these domes reduced again and was observed 
infrequently in fully differentiated Caco-2 barriers.  After 21 days of culture (Figure 
2.2C), a tightly packed cell layer featuring a continuous cytoskeleton and TJ network 
was formed. 
 
 
Figure 2.1 Caco-2 barrier development and TJ formation measured as TEER over 21 days of 
culture  
(Day 2-9: Average of N=2; Day 12-21: Average of N≥3 ± StDev)  
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Figure 2.2 Caco-2 barrier development  
Imaging of nuclei (blue), F-actin (green), and ZO-1 (red) after (A) 1 day, (B) 12 days, and (C) 21 days of culture (imaged with 40x magnification in Apotome mode, scale bar:20 µm, 
applies to all images) 
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Apart from the measurement of TEER, the Caco-2 barrier development was monitored 
by quantifying the paracellular passage of LY (molecular weight = 521.57) at different 
time points post-seeding.  With increasing formation of the TJ network the translocation 
of LY across the barrier was expected to be inhibited.  The results of LY passage are 
summarised in Figure 2.3.  Over the culture period of 21 days, the Papp of LY gradually 
decreased.  The small discrepancy in LY passage between day 4 and 6 is likely related 
to variations between cultures.  Between 6 and 12 days of culture, the Caco-2 barrier 
becomes almost impermeable to LY and the Papp, henceforth, remains low.  After 21 
days of culture, the translocation of LY from AP to BL compartment was below 1 % 
over an incubation time of 4h. 
 
Figure 2.3 LY barrier passage across Caco-2 cells after 2, 4, 6, 12, and 21 days of culture  
Results are presented as Papp after 4h incubation (Average of N≥2 ± StDev) 
 
2.2.1.2 Caco-2 differentiation 
Known as actin-binding / -bundling protein, villin is expected to co-localise to a high 
extend with F-actin of the cellular cytoskeleton.  As shown in Figure 2.4, the fluorescent 
signal of villin (red) greatly overlays the green signal corresponding to phalloidin-
stained F-actin.  With increasing culture time the villin-associated fluorescent signal 
clearly intensifies, confirming an increase in protein expression over time.   
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Figure 2.4 Caco-2 villin expression after (A) 2, (B) 5, (C) 13, and (D) 21 days of culture  
Fluorescence microscopy analysis in Apoptome mode, 40x magnification, scale bar:20 µm, applies to all images  
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For the quantitative analysis, the fluorescence intensity (FI) was first normalised to the 
number of cells and subsequently to the FI measured after 2 days of culture.  The results 
are expressed as fold-increase compared to 2 Days of co-culture (Figure 2.5).  Over a 
period of 21 days of culture, the villin expression of Caco-2 cells increased steadily.  At 
21 days post-seeding, the FI was ~2.3 times enhanced compared to day 2 (Figure 2.5). 
 
Figure 2.5 Villin expression in Caco-2 cells over 21 days of culture  
Measured as increase in villin-associated fluorescence signal normalised to FI after 2 days of culture and 
cell number (Average of n=2 of one experiment ± StDev) 
 
2.2.2 THP-1 
2.2.2.1 PMA-differentiation of THP-1 cells 
The monocyte-like THP-1 cells require an external differentiation stimulus, e.g. PMA, 
to develop macrophage-like characteristics (Tsuchiya et al., 1982).  The suspension cells 
responded to the PMA-treatment by adhering to the plastic surfaces of flasks and well 
plates.  During this process, they underwent a striking morphological change: from 
compact-spherical (Figure 2.6A&C) to an amoeboid shape forming pseudopodia-like 
extensions (Figure 2.6B&D).  As was observed by optical microscopy, approximately 
80-90 % of the cells were firmly attached and the cells’ proliferation had ceased after 
24h of exposure to PMA.  
 
With flow cytometry and immunohistochemistry the effect of PMA exposure on the 
expression of two cell surface receptors – CD68 and CD14 – was analysed.  The 
45 
analysis of undifferentiated THP-1 cells with flow cytometry showed that most cells 
expressed both surface markers: 85 ± 9 % CD14, 90 ± 0.36 % CD68 (data not shown).  
Interestingly, after PMA-treatment CD14 was only detected in 70 ± 14 % of the cells, 
whereas the expression of CD68 was not affected (96 ± 1.3 %) (data not shown). 
 
A 
 
B 
 
C 
 
D 
 
Figure 2.6 Morphology of undifferentiated (A&C) PMA-differentiated (B&D) THP-1 cells 
Light microscope 20x magnification; fluorescence microscope (Apotome mode) 40x magnification; blue: 
DAPI (nuclei), green: Phalloidin AlexaFluor488 conjugated (F-actin); scale bar light microscope: 40 
µm; scale bar fluorescence microscope: 20 µm. 
 
To confirm the results obtained with flow cytometry, undifferentiated and PMA-
differentiated THP-1 cells were stained, fluorophore-labelled and analysed 
microscopically (Figure 2.7).  For the quantitative analysis, the FI was background-
corrected and normalised to the measured area using ImageJ.  The results are expressed 
as FI, which is the intensity per pixel of the measured area.  On undifferentiated and 
PMA-differentiated THP-1 cells CD68 was expressed similarly (FI 19.8 ± 7.3 vs. 15.1 ± 
5.6).  In line with the flow cytometry outcome the CD14-associated FI was reduced by 
~36 % in PMA-treated compared to undifferentiated cells (FI 14.3 ± 5.6 vs. 22.4 ± 7).  
Since only a very limited number of cells were assessed these results are not 
representative. 
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Figure 2.7 Expression of CD68 (A&B) and CD14 (C&D) in undifferentiated (A&C) and PMA-differentiated (B&D) THP-1 cells  
Images were acquired in Apotome mode at 40x magnification, scale bar: 20 µm, applies to all images (NB: For differentiation THP-1 cells were exposed to 100 nM PMA for 48h. 
PMA-treated THP-1 cells were enzymatically detached before fixation. Therefore, the cells do not show the typical amoeboid phenotype associated with PMA-differentiation.)
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2.2.2.2 LPS-induced release of pro-inflammatory cytokines  
The functionality of the CD14 receptor was confirmed by studying the release of IL-1β, 
IL-8, and TNF-α from PMA-treated THP-1 cells without stimulation (hereinafter 
‘unstimulated’) and after 4h stimulation with 10 ng / mL LPS.   
As shown in Figure 2.8 and Figure 2.9 below, the LPS-induced cytokine release 
strongly depends on the differentiation status of THP-1 cells.  Without stimulation, 
undifferentiated THP-1 cells released low to undetectable concentrations of pro-
inflammatory cytokines (Figure 2.8, black bars).  When exposed to LPS, the release of 
IL-8 (24 vs. 347 pg / mL) and TNF-α (18 vs. 308 pg / mL) increased significantly.  The 
concentration of IL-1β was minimally affected (8 vs. 14 pg / mL) (Figure 2.8, white 
bars).   
 
 
Figure 2.8 Cytokine release of undifferentiated THP-1 cells after 4h exposure to 10 ng/mL LPS  
(IL-1ß and TNF-α: Average of N≥3 ± StDev, IL-8: Average of n=3 of one experiment ± StDev) 
 
For initial studies, THP-1 cells were differentiated by exposing the cells to PMA for 24h 
and subsequent resting for 24h in PMA-free CCM (hereinafter ‘48h-differentiated’).  
When differentiated according to the 48h protocol, THP-1 cells readily released 
considerable concentrations of cytokines without prior LPS stimulation.  Especially IL-
8 was present at remarkable levels with >3,600 pg / mL (Figure 2.9A, black bars).  Both 
IL-1β and TNF-α were expressed at lower but detectable concentrations (Figure 2.9A, 
black bars).  The exposure to LPS strongly enhanced the release of IL-1β, IL-8, and 
TNF-α to ~221, 11,328, and 1,037 pg / mL, respectively (Figure 2.9A, white bars).   
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Figure 2.9 Cytokine release of unstimulated and 4h LPS (10 ng / mL) stimulated PMA-
differentiated THP-1 cells  
(A) 48h PMA-differentiated THP-1 cells; B) 24h PMA-differentiated THP-1 cells (Average of N≥3 ± 
StDev; *p≤0.05 compared to cytokine release of unstimulated cells, #p≤0.05 cytokine release of 24h-
differentiated compared to 48h-differentiated cells) 
 
The high background cytokine release of unstimulated THP-1 cells was problematic, 
since it might negatively affect the Caco-2 barrier integrity.  Simplifying the 
differentiation protocol to a 24h PMA-treatment without subsequent resting (hereinafter 
‘24h-differentiated’) significantly decreased the release of IL-1β and IL-8 from 
unstimulated THP-1 cells by 85 (p=0.04) and 88 % (p≤0.001) to 8.7 and 615 pg / mL, 
respectively (Figure 2.9B, black bars).  The release of TNF-α was completely inhibited.  
However, the shortened PMA treatment also affected the cells’ cytokine response to 
stimulation with LPS.  Significantly lower amounts of IL-8 and TNF-α were released 
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after 24h-differentiation (Figure 2.9B, white bars) compared to 48h-differentiated THP-
1 cells (Figure 2.9A, white bars) (64 and 63 %, respectively).  The LPS-induced release 
of IL-1β was unaffected by the differentiation protocol (Figure 2.9). 
To account for the reduction in the cytokine response caused by the change in PMA-
differentiation protocol the THP-1 cells were co-stimulated with LPS and IFN-γ (10 ng / 
mL each).  The co-stimulation resulted in a significantly (p≤0.001) increased release of 
all three investigated cytokines compared to LPS-stimulation alone (IL-1β: +170 %, IL-
8: +300 %, and TNF-α: +210 %) (Figure 2.10).   
 
 
Figure 2.10 Release of IL-1β, IL-8, and TNF-α by 24h-differentiated THP-1 cells after 4h 
stimulation with 10 ng / mL LPS or 4h co-stimulation with IFN-γ and LPS (10 ng/mL each) 
(Average of N≥3 ± StDev; *p≤0.05 compared to the cytokine release of LPS stimulated cells)Development 
of a co-culture to mimic the healthy human intestine 
 
2.2.3.1 Formulation of criteria to be met by the stable co-culture 
The first aim of the project was to establish a co-culture of Caco-2 and PMA-
differentiated THP-1 cells to mimic the human intestine in homeostatic state 
(hereinafter ‘stable co-culture’).  To achieve a homeostatic co-culture it was of utmost 
importance that the cell lines do not negatively interfere with each other:
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1) The co-culture must not activate the THP-1 cells (Moyes et al., 2010). 
2) The presence of PMA-differentiated THP-1 cells must not affect the Caco-2 
barrier integrity permanently, e.g. via a long-lasting weakening of the TJs, 
destruction of the cytoskeleton and / or cytotoxic effect (Satsu et al., 2006; 
Watanabe et al., 2004). 
 
As seen in response to the stimulation with LPS, the activation of THP-1 cells can result 
in an increased release of pro-inflammatory cytokines, as well as ROS and RNS.  
Increased concentrations of these compounds can negatively affect the Caco-2 barrier 
integrity and cell viability (Watanabe et al., 2004; Susewind et al., 2016).  Therefore, in 
the homeostatic ‘stable’ co-culture the concentrations of pro-inflammatory cytokines 
and RNS should not exceed the levels measured in unstimulated THP-1 monocultures. 
Even if THP-1 cells are not activated in the co-culture, their baseline release of low 
concentrations of potentially stimulating compounds might affect the Caco-2 barrier 
negatively.  Hence, the barrier integrity measured as TEER should not be significantly 
lower compared to the Caco-2 monoculture, nor should the apical LDH release, an 
indicator for necrotic cell death, be notably increased.  From observations (data not 
shown) it was known that changes in the Caco-2 barrier environment can result in 
temporary TEER reduction.  A medium change for instance can reduce the TEER by up 
to 10 % for several hours.  Under normal conditions, these reductions do not represent 
impaired cellular health or barrier integrity and the TEER was re-established after a 
maximum of 24h.  Presumably, the introduction of an additional cell type is a more 
serious change to the Caco-2 environment than the exchange of CCM.  Therefore, a 
TEER reduction of ≤10 % in the stable co-culture compared to the Caco-2 monoculture 
was regarded as acceptable, if the barrier integrity was re-established to ≥95 % after 
24h.
51 
In summary, to realistically mimic the homeostatic human intestine the following 
criteria were developed for a stable co-culture of Caco-2 and THP-1 cells: 
 The barrier’s TEER decreases less than 10 % compared to the Caco-2 
monoculture control over the first 24h of co-culture. 
 The TEER is re-established to ≥95 % after 24h of co-culture.  
 The concentrations of pro-inflammatory cytokines in the BL compartment do 
not significantly exceed the cytokine release of 24h-differentiated THP-1 
monocultures (Figure 2.9B). 
 The LDH release on the AP side is not significantly higher compared to the 
Caco-2 monoculture. 
 
2.2.3.2 Barrier integrity of unstimulated Caco-2 / THP-1 co-cultures 
For the development of the stable co-culture, the primary focus was on meeting the 
barrier integrity criteria.  In a second step, the compliance with cytokine and LDH 
release was examined, which will be discussed in Chapter 3.  A schematic overview of 
the cell culture and co-culture set-up is given in Figure 2.11.   
Before the co-culture, THP-1 cells were 24h PMA-differentiated as described above 
(Section 2.1.2).  The PMA-differentiated THP-1 cells were transferred from the flask to 
transwell-appropriate well plates at a density of 1.8x10
5
 cells / well.  The cells were left 
undisturbed for 1.5h to re-attach on the plate.  To initiate the co-culture, the DCaco-2 
cells grown on transwell filters were transferred to the well containing re-attached 24h-
differentiated THP-1 cells without additional manipulation of either cell line (Figure 
2.11B).  To monitor the effect of the presence of THP-1 cells on the Caco-2 barrier the 
TEER was measured 4, 24, and 48h after the start of the co-culture.  As presented in 
Figure 2.12, the TEER of Caco-2 barriers co-cultured with 1.8x10
5
 24h-differentiated 
THP-1 cells (red graph) did not differ significantly from control barriers (blue graph) 
over a culture period of 48h.  
The co-culture was also attempted with 48h-differentiated THP-1 cells (Figure 2.11A).  
These experiments aimed to confirm the inadequacy of the differentiation protocol for 
the establishment of a stable co-culture, thereby substantiating the decision for 24h 
PMA-differentiation of THP-1 cells.  After 4h of co-culture, the TEER was equal to 
both the control and the co-culture with 24h-differentiated THP-1 cells.  Subsequently, 
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the TEER decreased significantly (p≤0.001) to 80 and 86 % of the control after 24 and 
48h, respectively (Figure 2.12).   
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Figure 2.11 Schematic overview: stable co-culture set-up with (A) 48h-differentiated and (B) 24h-differentiated THP-1 cells 
(changes to previous set-ups are marked by red circles)
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Figure 2.12 Barrier integrity measured as TEER over 48h Caco-2 monoculture (blue graph) or co-
culture with 24h (red graph) or 48h (dotted black graph) PMA-differentiated THP-1 cells  
(Average of N=3 ± StDev; *p≤0.05 compared to Caco-2 monoculture) 
 
2.2.4 Development of a co-culture to mimic the inflamed human intestine 
2.2.4.1 Formulation of criteria to be met by the inflamed co-culture 
After establishing the conditions for the stable co-culture set-up, the second aim of the 
project was addressed: The disruption of the stable co-culture through the induction of 
an inflammation-like response in THP-1 cells (hereinafter ‘inflamed’).  To keep the two 
co-culture models as comparable as possible, the number of variables between them had 
to be pared down to the minimum.  Preferably, no major changes should be made to the 
cell preparations and set-up of the stable co-culture.  
Additionally, the in vitro inflammation should resemble a biological response as closely 
as possible.  Hence, the following requirements were defined for the establishment of 
the inflamed model: 
 The inflammatory response is induced through a physiologically relevant 
stressor. 
 No substantial or permanent destruction of the Caco-2 barrier must occur. 
 Ideally, the system recovers itself and resolves the inflammation-like process 
without additional manipulation, e.g. medium change. 
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A major characteristic of intestinal inflammation is the significant reduction in barrier 
integrity by up to 50 %, which is fully restored after remission (Zeissig et al., 2007).  
Published studies on monocultures (Van De Walle et al., 2010; Wang et al., 2005) and 
co-culture models (Susewind et al., 2016; Leonard et al., 2010) of the inflamed intestine 
achieved TEER reductions between 15-25 % using LPS, IL-1β or a combination of 
both.  As shown by Susewind and colleagues (2016), a fully differentiated Caco-2 
barrier is able to cope with moderated barrier disruptions induced by physiologically 
relevant stressors and can fully re-establish its integrity.  Some groups reported TEER 
reductions of greater than 50 % in disrupted Caco-2 / THP-1 co-cultures (Detzel et al., 
2015; Satsu et al., 2006; Moyes et al., 2010).  Detzel and colleagues disrupted the 
barrier substantially using a non-physiological stressor (dimethyl palmitoyl ammonio 
propanesulfonate (PPS)) to enhance TJ permeability (Detzel et al., 2015).  Furthermore, 
neither Satsu et al. nor Moyes and colleagues intentionally activated the co-culture with 
a stressor but merely observed the adverse effect of high baseline cytokine release on 
the Caco-2 cell layer.  Altogether, a TEER reduction equal to or greater than 50 % of 
the monoculture control would be desirable but probably not feasible under the defined 
requirements.  As the LY permeability assay showed the Caco-2 barrier is still leaky 6 
days post-seeding with nearly 7 % dye translocation and a TEER of ~300 Ω∙cm².  At the 
start of the co-culture at day 21 the TEER is on average 391 ± 59 Ω∙cm².  Hence, a 
TEER reduction of 15 % is likely not sufficient as it would only decrease barrier 
integrity to ~330 Ω∙cm², higher than TEER at day 6.  Therefore, a minimum TEER 
reduction of 20-25 % of the Caco-2 monoculture control was aimed for to potentially 
achieve an increased permeability without permanently disrupting the barrier.  
As the model is intended to be used to study the barrier crossing of NMs in healthy and 
diseased tissue the barrier disruption had to be substantial, and persist for a pro-longed 
period of time.  Other than soluble chemicals, most particles remain in a more or less 
stable suspension.  The stability of this suspension, the disintegration, aggregation, 
agglomeration, and / or sedimentation of particles depends on the dispersant and particle 
characteristics, e.g. media viscosity, presence of proteins and ions, particle density and 
particle size (Teeguarden et al., 2007).  Using radio-labelled gold (Au)NPs (Section 
6.3.3), we found that particles with an original diameter of 30 nm required at least 6-24h 
to pass through a cell-free transwell filter in detectable numbers.  The density of Au 
(19.32 g / cm
3
)
 
is relatively high compared to other materials, e.g. Ag (10.49 g / cm
3
) or 
SiO2 (2.65 g / cm
3
).  Even though the sedimentation is influenced by more parameters 
than the particle density, it is reasonable to assume that NMs with a lower density than 
56 
Au require more time to sediment.  Hence, to be able to study the effect of an impaired 
Caco-2 barrier on the translocation of NMs the TEER reduction should prevail for at 
least 24h to allow for meaningful barrier crossing studies. 
Apart from the reduced barrier integrity, the presence of excess amounts of pro-
inflammatory cytokines is a pivotal sign of active inflammatory processes.  Depending 
on the cause and stage of the inflammation both intestinal epithelial cells and various 
cells of the innate immune system can be the source of the cytokine production (Strober 
and Fuss, 2011; Blumberg, 2009; Li et al., 1998).  Here, LPS will be used as 
physiologically relevant stressor to activate the PMA-differentiated THP-1 cells.  To 
prove a successful stimulation of an inflammation-like response in the system the 
concentration of the routinely monitored pro-inflammatory cytokines – IL-1β, IL-8, and 
TNF-α – should be significantly increased compared to the stable co-culture (Park et al., 
2007; Szczepanik et al., 2001).  
Altogether, the following criteria were defined to classify a co-culture as ‘inflamed’: 
 The TEER is reduced ≥20-25 % compared to the Caco-2 monoculture control. 
 A TEER reduction of minimally 20 % persists for at least 24h. 
 The concentrations of the pro-inflammatory cytokines IL-1β, IL-8, and TNF-α 
significantly exceed the amounts recovered in the stable co-culture after 4h of 
co-culture. 
 Ideally, the TEER is re-established to >90 % of the Caco-2 monoculture control 
after 48h of co-culture.  
 
2.2.4.2 Results of the individual adjustment steps and additions to the stable co-
culture protocol 
To not alter the stable co-culture set-up unnecessarily, the adjustments were introduced 
in individual steps, which will be presented in more detail hereinafter.  The co-culture 
was monitored by measuring the barrier resistance as TEER before the start (T0), as well 
as after 4, 24, and 48h of co-culture (T4-T48).  In later stages of the development (Step 2-
4), an additional TEER measurement time point after 18h was introduced.  The TEER 
results of all four steps are summarised in Figure 2.13.  A schematic description of the 
cell treatment and co-culture set-up in each step is given in Figure 2.15 and Figure 2.18. 
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Figure 2.13 Caco-2 barrier integrity measured as TEER over 48h co-culture with differently 
stimulated 24h-differentiated THP-1 cells 
Step1: LPS (10 ng / mL) addition to the BL compartment at T0; Step 2: co-culture of IFN-γ-primed Caco-
2 barriers and THP-1 cells stimulated with LPS (10 ng / mL) at T0; Step 3: co-culture of IFN-γ-primed 
Caco-2 barriers and THP-1 cells pre-stimulated with LPS (10 ng / mL) 4h in advance; Step 4: co-culture 
of IFN-γ-primed Caco-2 barriers and THP-1 cells pre-stimulated with LPS and IFN-γ (10 ng / mL each) 
(Average of N≥3 ± StDev; *p≤0.05 compared to Caco-2 monoculture) 
 
Step 1: LPS-stimulation of THP-1 cells in the BL compartment 
At first, 10 ng / mL LPS were added to the BL compartment at the start of the co-culture 
(T0) to activate the 24h-differentiated THP-1 cells without altering the stable co-culture 
set-up (Figure 2.15A).  Four hours after initiation of the co-culture, the TEER decreased 
significantly to ~85 % of the monoculture control (Figure 2.13, white circles).  
However, the barrier integrity quickly re-established to >90 % after 24h and, hence, did 
not fulfil the defined requirements. 
 
Step 2: IFN-γ priming of Caco-2 cells and LPS stimulation of THP-1 cells 
Since the mere addition of LPS in Step 1 was not sufficient to meet the above defined 
requirements, IFN-y-priming of Caco-2 cells was introduced as an additional change.  
As shown in Figure 2.14, the priming with IFN-γ did not induce a reduction in barrier 
integrity in the Caco-2 monoculture and the unstimulated stable co-culture.   
58 
 
Figure 2.14 Caco-2 barrier integrity measured as TEER after IFN-γ-priming 
Caco-2 barriers were primed with 10 ng / mL IFN-γ for 24h and cultured alone or co-cultured with 
unstimulated 24h-differentiated THP-1 cells for 48h (Average of N=2 ± StDev) 
 
To induce an inflammation-like response, the THP-1 cells were challenged basolaterally 
with 10 ng / mL LPS.  As shown in Figure 2.13 (white squares), the IFN-γ-priming 
increased the vulnerability of the Caco-2 barrier to the presence of LPS-activated THP-1 
cells, which is reflected in the extended duration of the barrier disruption.  With a 
maximum TEER reduction of 15.8 and 15.6 % after 18 and 24h, respectively, the effect 
was less pronounced than expected and not sufficient to meet the defined requirements. 
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Figure 2.15 Schematic overview: Inflamed co-culture set-ups (A) Step 1 and (B) Step 2  
(changes to previous set-ups are marked by red circles)
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Based on the LPS-exposure experiments performed in THP-1 monocultures, the release 
of pro-inflammatory cytokines should be high enough to induce a clear and prolonged 
barrier disruption, especially in IFN-γ-primed Caco-2 cells (Wang et al., 2005).  To 
investigate why this was not achieved, the BL cytokine contents of LPS-stimulated co-
cultures were analysed and compared to cytokine concentrations recovered from 
stimulated THP-1 monocultures.  Interestingly, the release of IL-1β and TNF-α was 
significantly reduced (p≤0.002) by around 90 % in LPS-stimulated co-cultures 
compared to THP-1 monocultures (Figure 2.16).  With 23 % reduction compared to 
LPS-exposed THP-1 monocultures the release of IL-8 was less affected.  
 
 
Figure 2.16 Release of IL-1β, IL-8, and TNF-α by LPS-stimulated (10 ng / mL) 24h-differentiated 
THP-1 cells in monoculture (white bars) or co-culture with Caco-2 cells (black bars)  
(Monoculture: Average of N=4; Co-culture: Average of N=2 ± StDev; *p≤0.05 compared to 
monoculture) 
 
A separate experiment was conducted to study the impact of Caco-2 cells on the 
cytokine response of LPS-stimulated THP-1 cells.  For this, THP-1 cells were pre-
stimulated with LPS 4h in advance of the co-culture (Figure 2.17A) or as before at the 
start of the co-culture (Figure 2.17B).  Supernatant samples of both conditions were 
taken at the start of the co-culture (T0), as well as after 4h of co-culture (T4).   
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Figure 2.17 Schematic overview: co-culture preparation and LPS exposure to study the down-regulating effect of Caco-2 cell
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The following results were obtained: When THP-1 monocultures were stimulated with 
LPS in advance of the co-culture, high concentrations of pro-inflammatory cytokines 
were released (Figure S1A).  After 4h co-culture with Caco-2 cells the cytokine 
concentrations were reduced, but still exceeded the release in the unexposed co-culture 
control (Figure S1B).  When exposing the THP-1 cells to LPS at the start of the co-
culture, the cytokine release was significantly reduced (Figure S1B).  The PMA-
differentiation protocol influenced the amount but not the general trend of cytokine 
release (Figure S2).  
 
Step 3: IFN-γ priming of Caco-2 cells and LPS pre-stimulation of THP-1 cells 
To overcome the above described down-regulation of the cytokine response, the THP-1 
cells were pre-exposed to LPS for 4h before the start of the co-culture to allow for a 
period of unrestricted response to the stressor (Figure 2.18A).  The increased generation 
of pro-inflammatory cytokines was expected to overwhelm the IECs at the start of the 
co-culture so that less or no downregulation of the THP-1 cytokine response could be 
imposed.  As shown in Figure 2.13 (white triangles), the pre-exposure induced a more 
pronounced and extended reduction in TEER compared to the previous Steps 1 and 2.  
Subsequent to a moderate decrease by 12.7 % after 4h of co-culture, the TEER reduced 
further to 80.7 % of the control after 18 and 24h.  At 48h of co-culture, the barrier 
integrity was fully re-established to 97.8 ± 5.5 % of the control.   
Altogether, this set-up fulfilled the minimum requirements defined before, but the 
results were close to lower limit of the criteria.  Whereas the barrier integrity decreased 
on average by 20 %, several individual cultures within one experiment failed to show 
adequate barrier disruption.  Furthermore, the reproducibility of the results heavily 
dependent on the response of THP-1 cells to the PMA-differentiation.  For unknown 
reasons, the pre-exposure to LPS alone was in several cases not sufficient to disrupt the 
co-culture. 
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Figure 2.18 Schematic overview: inflamed co-culture set-ups (A) Step 3 and (B) Step 4  
(changes to previous set-ups are marked by red circles) 
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Step 4: IFN-γ priming of Caco-2 cells and pre-stimulation of THP-1 cells LPS & 
IFN-γ before the co-culture 
With regard to the previously observed differences between exposure to LPS alone and 
combined exposure to LPS and IFN-γ on the THP-1 cytokine response it was decided to 
introduce IFN-γ as last additional change to the co-culture set-up (Figure 2.18B).  To 
compensate for the diminished impact of LPS alone, 24h-differentiated THP-1 cells 
were pre-exposed to LPS and IFN-γ (10 ng / mL each) simultaneously in advance of the 
co-culture.  After 4h of pre-exposure, the co-culture was initiated as before. 
As presented in Figure 2.13 (green line), the co-stimulation with LPS and IFN-γ had a 
significant effect on both the magnitude and duration of the induced TEER reduction.  
Within the first 4h of co-culture (i.e. 8h of LPS + IFN-γ exposure), the TEER decreased 
significantly (p≤0.001) to 78 ± 6.7 % of the unexposed Caco-2 monoculture control and 
further to 71 ±5.5 % and 73 ± 5.2 % after 18 and 24h of co-culture, respectively.  After 
48h, the TEER had re-established to ~97 % ± 4.3 % of the control without additional 
manipulation of the system.  Altogether, all barrier integrity-related requirements for the 
inflamed co-culture were met. 
 
2.3 Discussion 
The main outcomes of this chapter can be summarised in the following points: 
 The differentiation status of the THP-1 cells and the differentiation protocol 
greatly impact the cytokine response of the cells to stressors like LPS.  The 
cytokine release was significantly reduced after 24h compared to 48h PMA-
differentiation, but could be enhanced by co-stimulating the cells with LPS and 
IFN-γ. 
 A stable co-culture can be established with 24h but not 48h PMA-differentiated 
THP-1 cells. 
 The stable co-culture could not simply be turned into an inflamed model by 
addition of LPS to the BL compartment.  To induce an adequate barrier 
disruption according to the specified criteria the Caco-2 barrier had to be primed 
with IFN-γ and the THP-1 cells pre-stimulated with both LPS and IFN-γ 4h 
prior to the co-culture. 
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2.3.1 Caco-2 and THP-1 monocultures 
2.3.1.1 Caco-2 cells 
The barrier development of Caco-2 cells comprises two key aspects: 
1) The formation of a confluent cell layer containing intact AJs and TJs. 
2) The differentiation of Caco-2 cells from a colonic to a small intestinal-like 
phenotype. 
Since the differentiation of Caco-2 cells and expression of differentiation markers has 
been studied abundantly, we limited our efforts to three easy-to-monitor endpoints: The 
barrier integrity was measured by TEER and LY passage, the formation of the TJ 
network with ZO-1, and the indirect estimation of the development of microvillous 
structures with the detection and quantification of villin.   
When monitoring the formation of a cell barrier, the increase in TEER indicates the 
increasing restriction of the paracellular transport of ions by TJ (Anderson and Van 
Itallie, 2009).  The obtained TEER results were well above the often mentioned 
minimum barrier integrity of ~150-250 Ω•cm² (Narai et al., 1997; Foraker et al., 2003).  
Compared to other studies on Caco-2 cells the measured TEER ranks in the middle of 
reported maximum values, which range between 180 to above 1000 Ω•cm² (Hashimoto 
and Shimizu, 1993; Ranaldi et al., 2002).  Regarding the human intestinal tract, the 
electrical resistance of the Caco-2 cells is more comparable to the barrier integrity of the 
colon (300-400 Ω•cm²) than the small intestine (50-100 Ω•cm²) (Fleischer 1999).  The 
maximum TEER at 12 to 15 days post-seeding is in line with the findings of others 
working with the Caco-2 strain distributed by the German Collection of 
Microorganisms and Cell Culture (DSMZ) (Steffansen, 2013).  For Caco-2 strains 
obtained from other distributors and some Caco-2 clones, different growth behaviours 
were described.  In those studies the TEER either continued to increase even after 21 
days of culture, or a plateau was reached without subsequent reduction in TEER 
(Ranaldi et al., 2003).  
The formation of the TJ network and the, thereby, caused restriction of paracellular 
passage was additionally monitored with the quantification of LY translocation.  The 
results showed that after 12 days of culture virtually no translocation of LY occurred 
over 4h of incubation.  This confirmed the formation of a continuous functional barrier, 
which significantly restricted the diffusion of compounds from the AP to BL side.  The 
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Papp and the relative barrier crossing of LY at day 21 are in line with the results reported 
by others (Sandri et al., 2007; Nollevaux et al., 2006).   
Both the increase in ZO-1 protein expression and TEER are related to the proliferation 
of the cells until a dense, continuous cell layer is formed.  Upon reaching confluence, 
cell proliferation reduces and the cells spontaneously start to differentiate from colonic 
to small intestinal-like cells (Pinto et al., 1983).  This differentiation is reflected in the 
development of a microvillous apical membrane, indicating structural polarisation of the 
differentiated Caco-2 barrier, and the increase in brush border-associated hydrolases 
(Chantret et al., 1988; Hilgers et al., 1990).  In the GI-tract, villin expression marks the 
functional border between the gastric and the intestinal parts of the GI-tract (Braunstein 
et al., 2002).  Almost exclusively expressed in the intestinal epithelium, villin is the 
major actin-associated protein of the intestinal microvilli (Bretscher and Weber, 1979).  
Hence, the co-localisation of the villin-associated fluorescence signal with F-actin was 
not the result of unspecific binding but can be explained with the strong co-localisation 
of the two proteins.  It has, however, been shown that many human colon carcinoma 
cell lines express villin independently of enterocytic differentiation or the formation of a 
brush border (Chantret et al., 1988).   Even though the development of a brush border 
has been confirmed by Transmission Electron Microscopy (TEM) imaging numerous 
times before (Kitchens et al., 2007; Giannasca et al., 1996) we can only speculate that 
the increase in villin-associated FI indicates the development of a microvillous brush 
border.  To support this assumption the development of microvilli on Caco-2 cells 
should be analysed at different culture time points using TEM. 
 
2.3.1.2 THP-1 cells 
THP-1 cells are described as monoblastic cells, which depend on an external stimulus to 
induce the differentiation to a more mature macrophage-like phenotype (Tsuchiya et al., 
1982).  The most commonly used differentiation stimuli are 1,25-dihydroxyvitamin D3 
(VD3) and phorbol esters like PMA (Daigneault et al., 2010).  In contrast to PMA, the 
VD3-mediated differentiation enhances macrophage-associated features, e.g. cell 
adherence and the release of large cytokine quantities upon stimulation, to a lesser 
extend (Daigneault et al., 2010).  Additionally, PMA is more cost-effective and easier to 
handle than VD3. Therefore, PMA was chosen as differentiation stimulus within this 
project. 
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The maturation of the THP-1 cells could easily be followed by monitoring the change in 
adherence and morphology, which are both characteristic for phorbol ester-induced 
maturation (Tsuchiya et al., 1982).  The quantification of the cell surface receptors 
CD14 and CD68 resulted in ambiguous outcomes.  Generally, CD14 was expected to be 
nearly absent before the PMA-differentiation, since undifferentiated THP-1 cells hardly 
responded to the exposure to LPS.  Hence, the PMA-differentiation was assumed to 
induce a clear upregulation of CD14, as the cytokine response to LPS was 
unmistakeably enhanced.  It was therefore, surprising to find a clear presence of CD14 
on undifferentiated THP-1 cells and a reduction in CD14 expression after PMA-
differentiation. 
Both receptors are associated with monocytes and macrophages, but are not exclusively 
expressed by them (Funda et al., 2001; Kunz-Schughart et al., 2003).  The presence of 
the LPS-receptor CD14 is crucial for this project, as it largely determines cellular 
responsiveness to LPS (Wright et al., 1990).  It is involved in the recognition of 
pathogens and activation of the innate immune system by binding LPS, a PAMP found 
on the membrane of Gram-negative bacteria, and subsequent activation of immune cells 
(Komai-Koma et al., 2009).  The binding of LPS to CD14 initiates the release of pro-
inflammatory cytokines in vitro, e.g. TNF-α, IL-1β, and IL-8 (Meng and Lowell, 1997; 
van der Bruggen et al., 1999; Ngkelo et al., 2012).  Whereas CD14 is not essential to 
induce TNF-α in response to high concentrations of LPS (i.e. >100 ng / mL) it was 
found to be indispensable for the cytokine’s generation after exposure to lower 
concentrations of LPS (Borzecka et al., 2013).  The CD68 receptor was investigated as a 
potential marker to distinguish THP-1 and Caco-2 cells in the co-culture. 
A literature research revealed that reports on the expression and regulation of CD14 in 
THP-1 cells differ greatly between laboratories (Table 2.3).  Whereas some groups 
observed low to undetectable levels of the receptor in undifferentiated THP-1 cells 
(Martin et al., 1994; Schwende, 1996; Schilling et al., 2003) others found significant 
expression on 50 to 90% of control cells (Martin et al., 1994; Ciabattini et al., 2006).  
Furthermore, many groups saw a strong CD14-upregulating effect of PMA (Zhang et 
al., 2014; Takashiba et al., 1999).  Others noted weak or no impact (Schwende, 1996; 
Schilling et al., 2003).  A hypothesis that these differences might be related to the 
differing STR profiles of the cells could not be confirmed (Ciabattini et al., 2006; 
Schilling et al., 2003).  Many factors have already been shown to affect the expression 
and regulation of CD14 in THP-1 cells including the differentiation stimulus, its 
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concentration, as well as the exposure time (Schwende, 1996; Daigneault et al., 2010; 
Park et al., 2007).  But also less obvious aspects, e.g. cell culture density and resting 
times, were shown to exert influence (Daigneault et al., 2010; Aldo et al., 2013).   
Whereas numerous studies were found describing a PMA-induced increase in CD14 
expression, reports on reducing CD14 levels in response to PMA mostly involved 
peripheral blood monocytes (PMBCs) (Nomura et al., 2001; Kremlev and Phelps, 
1997).  When exposed to PMA, PBMCs shed the membrane-bound receptor, which was 
reflected in a parallel increase in soluble (S)CD14 (Nomura et al., 2001).  A similar 
observation was made for another human monocytic cell line – Mono Mac (MM)6 
(Zarember and Godowski, 2002).  Here, exposure to 12-O-Tetradecanoylphorbol-13-
acetate (TPA) induced a two-fold reduction in membrane (m)CD14, but no increase in 
sCD14.  Instead of shedding the receptor, the reduction in MM6 cells was related to a 
downregulation of mCD14 mRNA.  Only one account could be found describing a 
reduction of mCD14 in THP-1 cells claimed to be caused PMA-induced cleavage of the 
receptor (Puig-Kroger et al., 2004).  Taking into consideration that this report is part of 
an unpublished under-graduate research project the reliability of this source remains 
unclear.   
Altogether, it is possible that the exposure of THP-1 cells to PMA induced a shedding 
of mCD14.  Without additional analyses, however, this hypothesis cannot be verified.  
For further investigation, the supernatant could be collected after treatment with PMA 
and analysed by ELISA.  Even if this explained the reduction in CD14 it would not 
elucidate the generally observed differences in CD14 expression on THP-1 cells 
reported between laboratories (Table 2.3).  Since the project essentially depends on the 
THP-1 responsiveness to LPS these variations might greatly influence the model’s 
establishment and reproducibility in other laboratories. 
The high background cytokine levels of unstimulated 48h-differentiated THP-1 cells, 
which were also observed by other groups, were of more concern.  The THP-1 
differentiation protocols varied between the common stimuli PMA and VD3 (Watanabe 
et al., 2004; Schwende, 1996), or combinations of both with additional stressors like 
LPS (Xia et al., 2013; Taylor et al., 2014).  In the latter cases, the increase in cytokine 
release is not surprising, since a strongly stimulating compound is used during the 
differentiation.  
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Table 2.3 Literature examples for CD14 expression in THP-1 cells with and without exposure to PMA 
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Whereas the PMA-differentiation of THP-1 cells was, undoubtedly, necessary, the 
increased cytokine release associated with it could negatively affect Caco-2 cell barrier 
integrity.  As Watanabe et al. (2004) observed, the uncontrolled release of high 
concentrations of cytokines, in that case TNF-α, lead to a severe and permanent 
disruption of the Caco-2 cell layer.  Therefore, a reduction in cytokine release of 
unstimulated PMA-treated THP-1 cells without having to refrain from differentiating 
the cells was aimed for.  The most obvious approach was to adapt the PMA-
differentiation protocol, which is known to have a tremendous impact on the 
characteristics of THP-1 cells (Daigneault et al., 2010; Aldo et al., 2013; Schwende, 
1996).  The mere reduction in differentiation time was sufficient to inhibit the synthesis 
of the most potent inflammation-mediating cytokines (IL-1β and TNF-α) by 
unstimulated THP-1 cells.  The levels of IL-8 strongly reduced, but remained 
significantly higher compared to untreated THP-1 cells.  Since Smythies et al. (2005) 
observed a similar background level of IL-8 released by iMΦ we did not aim to further 
reduce the concentrations.   
The long term goal of establishing an inflamed co-culture strongly depended on the 
cells’ ability to produce large quantities of pro-inflammatory cytokines.  Therefore, the 
reduced response to LPS after 24h differentiation was critical and had to be 
compensated.  As others reported before, exposing THP-1 cells to LPS and IFN-γ 
simultaneously could greatly enhance the cells’ cytokine response (Tamai et al., 2003). 
 
2.3.2 Stable co-culture set-up 
The TEER results showed that Caco-2 cells and 24h-differentiated THP-1 cells could 
cohabit over a period of 48h without significant effects on the Caco-2 barrier integrity.  
The results obtained from co-cultures with 48h-differentiated THP-1 cells confirmed 
that THP-1 cells differentiated according to the initial protocol were not suitable for the 
establishment of a stable co-culture that fulfils the earlier defined criteria. 
For the development of the stable co-culture the increased release of pro-inflammatory 
cytokines was worrying, as it most likely would have been detrimental to the Cao-2 
barrier integrity.  Co-cultures of Caco-2 and PMA-differentiated THP-1 cells have 
already been attempted by other groups with mixed success.  In several cases, the co-
culture resulted in an uncontrolled cross talk between the cell lines, which ultimately 
caused severe and permanent barrier disruption in the IEC barrier (Moyes et al., 2010; 
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Satsu et al., 2006).  Studies reporting a reduction in Caco-2 barrier integrity 
demonstrated the presence of significant concentrations of pro-inflammatory cytokines 
(Moyes et al., 2010; Satsu et al., 2006 Watanabe et al., 2004).  Also in this study the 
release of cytokines, especially IL-8, has been identified as a potential problem in 48h-
differentiated THP-1 cells, which was confirmed in co-culture experiments.  With an 
overall TEER reduction of 15-20 % in these experiments, however, the barrier 
disruption was rather moderate.  In other studies, the TEER was reduced by 70-80 % of 
the control after 24-48h (Satsu et al., 2006; Moyes et al., 2010). 
Interestingly, the PMA-differentiation protocol differed between groups observing a 
barrier disruption.  Whereas both Watanabe et al. (2004) and Satsu et al. (2006) 
differentiated THP-1 cells with higher PMA concentrations (200 nM) and for a longer 
period of time (4 days), Moyes and colleagues (2010) applied the very same 
differentiation protocol as used here.  Even more so, the cell strain and source used by 
Moyes et al. is the same as used in here.  Hence, the results might confirm the already 
discussed heterogeneity of the cell line.  It suggests that the variability of the results 
does not only depend on the source of the cells and the differentiation protocol, but also 
the handling of the cells within a laboratory.  An interlaboratory study using THP-1 
cells published by Xia et al (2013) supports this hypothesis.  The study outcomes 
showed a considerable heterogeneity between the participating laboratories, even 
though the same protocols and materials were applied in all laboratories.   
In contrast to this project, Moyes et al. used a slightly higher THP-1 cell density of 
1.05x10
5
 cells / cm
2
 (vs. 7.8x10
4
 cells / cm
2 
well surface).  This could indicate that, 
apart from the heterogeneity of the cell line, the ratio between the cell types of the co-
culture is crucial.  The importance of the cell type ratio on the behaviour and responses 
of a system has already been demonstrated in other non-intestinal co-culture set-ups 
(Bodet et al., 2005; Burguera et al., 2010).  It is possible, that an unbalanced ratio of 
macrophages to IECs induced a disruption in the system.  In favour of this explanation 
are two studies working with similar intestinal co-culture models that did not observe a 
reduction in barrier integrity.  Both Leonard et al. (2010) and Susewind et al. (2016) 
combined Caco-2 cells with macrophages and DCs, either differentiated from PBMCs 
or cell lines.  Both, however, used significantly lower seeding densities of roughly 
9x10
3
 cells / cm
2
 of each leukocyte cell type.   
 
72 
Alternatively, the use of undifferentiated THP-1 cells might have been possible, but 
without prior differentiation the cells hardly responded to stimulation with LPS even 
though different groups reported otherwise (Detzel et al., 2015; Araujo et al., 2004).  
Since the ability to stimulate the cells with pathophysiological stresses and the release 
of pro-inflammatory cytokines was of utmost importance for the development of the 
inflamed co-culture the use of undifferentiated cells was discarded. 
In summary, co-cultures of Caco-2 and 48h-differentiated THP-1 cells failed to meet the 
defined criteria and could, therefore, not be rated as ‘stable’.  Based on the barrier 
integrity results, 24h-differentiated THP-1 cells were found to be suitable for the 
establishment of a stable co-culture.  The term ‘stable co-culture’, henceforth, refers to a 
co-culture of 24h-differentiated THP-1 cells with DCaco-2 cells. 
 
2.3.3 Development of the inflamed co-culture 
To make the stable and inflamed co-culture as comparable as possible, the number and 
severity of adjustments to the stable co-culture set-up was kept to the necessary 
minimum.  Therefore, a very minor change was introduced first with the mere addition 
of LPS to the BL compartment (Step 1).  Studies have shown that LPS can affect the 
barrier integrity and lead to significant barrier disruption in Caco-2 cells (Van De Walle 
et al., 2010; Wells et al., 1993).  However, in order to disrupt barrier integrity high 
concentrations of 10 to 50 µg / mL had to be used (Van De Walle et al., 2010; Yu et al., 
2005).  In this project, the aim was to induce the barrier disruption through the induction 
of an inflammation-like response in the THP-1 cells instead of imposing unrealistically 
high stresses on the IECs.  Hence, a low concentration of 10 ng / mL LPS was used, 
which was not expected to cause any negative effects on the Caco-2 barrier.  This 
assumption was confirmed in a set of control experiments on Caco-2 monocultures 
presented and discussed in Chapter 3 (Sections 3.3.2 & 3.4.2).   
More importantly, such low concentrations of LPS were shown to be sufficient to 
stimulate macrophages to release high concentrations of pro-inflammatory cytokines 
(Meng and Lowell, 1997).  In experiments on THP-1 monocultures, significant 
concentrations of IL-1β, IL-8, and TNF-α were detected, which confirmed the 
stimulation induced by 10 ng / mL LPS.  Both IL-1β and TNF-α are known to be able to 
disrupt intestinal barrier integrity (Van De Walle et al., 2010; Shen, 2012).  The 
concentration of IL-1β released by LPS-stimulated 24h-differentiated THP-1 cells is far 
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below the amount reported (>10 ng / mL IL-1β) to induce the desired TEER reduction 
of 20-25 % (Al-Sadi and Ma, 2007).   
Therefore, the focus was laid on TNF-α.  The cytokine can affect the barrier 
permeability of Caco-2 cells by itself but only at high concentrations of at least 10 ng / 
mL (Shen, 2012; Cui et al., 2010).  When THP-1 cells were stimulated with LPS at the 
start of the co-culture, only very low concentrations of TNF-α (~100 pg / mL) were 
released.  This could explain why exposure to LPS alone did not result in a prolonged 
barrier disruption.  The effective dose of TNF-α can be lowered significantly with the 
addition of IFN-γ (Chen et al., 2012; Wang et al., 2005).  As described by Wang and 
colleagues, the Caco-2 barrier integrity was reduced in case both cytokines are 
simultaneously present in the BL compartment or the Caco-2 cells were first exposed to 
IFN-γ and subsequently in contact with TNF-α (Wang et al., 2005).  This latter 
‘priming’ effect of IFN-γ induces an up-regulation of TNF-α receptor (TNFR) 1 and 2 
in Caco-2 cells, which are located at the BL cell membrane (Wang et al., 2006).  
Binding of TNF-α to TNFR2 but not TNFR1 leads to an increased expression of MLCK 
(Blumberg, 2009), which in turn results in amplified phosphorylation of MLC (Zhou et 
al., 2005).  Phosphorylation of MLC, leading to contraction of the actomyosin ring, has 
been demonstrated to regulate intestinal epithelial permeability by re-organisation of TJ 
proteins.  This re-organisation of TJ protein causes an increased paracellular 
permeability of the barrier and a strong reduction in TEER (Turner et al., 1997; Wang et 
al., 2005; Zhou et al., 2005). 
In the presence of IFN-γ, the TNF-α concentration necessary to cause a barrier 
disruption has been shown to be between 1-2.5 ng / mL (Wang et al., 2005).  These 
concentrations can be achieved with stimulated THP-1 cells, as other groups (Park et 
al., 2007; Szczepanik et al., 2001) and earlier discussed experiments on THP-1 
monocultures confirmed.  However, the co-culture probably lacked the ability to 
produce sufficient levels of IFN-γ.  Whereas no information could be found for Caco-2 
cells, the IFN-γ release of THP-1 cells has been reported to be drastically reduced after 
PMA-differentiation (Satsu et al., 2006).  Also Moyes et al. did not detect any release of 
IFN-γ in Caco-2 / THP-1 co-cultures (Moyes et al., 2010).  Since none of the main 
sources of IFN-γ, i.e. neutrophils, T-cells and natural killer cells (Lin and Young, 2013) 
were planned to be introduced in the co-culture the cytokine had to be substituted, 
which was partially achieved through the IFN-γ-priming of Caco-2 cells (Step 2).   
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In contrast to the expectations, the priming of Caco-2 cells and LPS-stimulation in the 
BL compartment did not induce the desired barrier disruption of 20-25 % over 24h.  
The quantification of cytokine release in BL supernatants revealed a significantly 
reduced release of all three investigated cytokines compared to LPS-stimulated THP-1 
monocultures.  These results might reflect a downregulation of the macrophage-driven 
stress response in presence of Caco-2 cells.  IECs are well-known to play an active role 
in the regulation of homeostasis in healthy intestinal tissue.  IECs discriminate between 
commensal “self” and harmful “non-self” antigens present in the intestinal lumen 
(Rakoff-Nahoum et al., 2004) and control the responsiveness of immune cells in the 
lamina propria (Rimoldi, 2005; Parlesak et al., 2004).  Without the IEC-mediated 
downregulation of the immune system the intestine would likely be subject to constant 
inflammation caused by non-harmful antigens.  Whereas the adjustment of macrophage 
number and PMA-differentiation was crucial to establish the stable co-culture, it greatly 
complicated the induction of a pro-inflammatory response.  On one side, it allows Caco-
2 cells to exert control over the immune cells, as shown by the significant 
downregulation of the THP-1 response to LPS.  On the other side, it reduces the LPS-
stimulated cytokine release of THP-1 cells, thereby suppressing the evolvement of a 
pro-inflammatory process.  A similar immuno-modulating effect of IEC cell lines had 
already been reported in combination with primary murine or human mononuclear cells 
(Parlesak et al., 2004; Nathens et al., 1995), but not for co-cultures of Caco-2 and THP-
1 cells. 
Why the Caco-2 cells inhibit the THP-1 driven pro-inflammatory response cannot be 
answered with certainty.  A possible explanation might be related to the stress applied to 
stimulate the cells – LPS.  Under certain circumstances, IECs can be activated to initiate 
an immune response themselves, for instance when binding of a PAMP to Toll-like 
Receptors (TLR) or nucleotide binding oligomerisation domains (NODs) (Cario and 
Podolsky, 2000) occurs.  Once the cells are activated they respond with the release of 
pro-inflammatory cytokines and chemokines (Haller, 2000).  One of the most studied 
PAMPs is E. coli-derived LPS, which was used in this study.  Its ubiquitous presence in 
the intestinal lumen and known involvement in intestinal inflammation (Guo et al., 
2013) made it the most meaningful choice of stimulus to induce an inflammation-like 
reaction.  However, the necessary cell surface receptors for LPS recognition are 
insufficiently expressed by primary enterocytes (Cario and Podolsky, 2000) and Caco-2 
cells (Abreu et al., 2001; Melmed et al., 2003).  Hence, whereas LPS readily binds to 
THP-1 cells it cannot bind and, therefore, should not activate IECs at the low 
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concentrations used here.  This is the reason why the co-cultures were exposed to LPS 
from the BL instead of the AP side.  The lack of LPS recognition by Caco-2 cells might 
also explain the strict downregulation of the THP-1 stress response: In homeostatic gut 
tissue, immune cells are closely regulated and do not respond to the encounter of non-
harmful antigens.  IECs are suspected to be at least partially involved in imposing and 
maintaining this systemic tolerance (Peterson and Artis, 2014). 
Another possible explanation relates to the general de-sensitisation of monocytes in the 
proximity of the intestinal barrier as described by Smythies et al. (2005).  The group 
observed a TGF-β-mediated downregulation of cytokine release in PBMCs, but only 
after incubation with stromal cell-conditioned and not epithelial cell-conditioned 
medium.  Since incubating THP-1 cells with Caco-2 cell conditioned medium (cCCM) 
did not have a noticeable effect on the LPS-stimulated cytokine release (Figure S3) the 
downregulation is likely not induced by a continuously produced factor.  Instead, the 
Caco-2 cells might actively respond to the presence of THP-1 cells in the co-culture.  It 
remains unclear, whether the downregulation results from the mere presence of the 
macrophage-like cells or is triggered by an event related to the LPS-stimulation of THP-
1 cells. 
To induce a barrier disruption through the activation of THP-1 cells, the observed 
downregulation by Caco-2 cells had to be overcome.  The most obvious solution was to 
pre-expose the THP-1 cells before the co-culture.  The hypothesis was that the exposure 
to LPS prior to the co-culture will allow for an unrestricted response and cytokine 
synthesis similar to LPS-exposed THP-1 monocultures can be achieved.  Furthermore, it 
was assumed that the increased cytokine concentrations will overwhelm the Caco-2 
cells at the start of the co-culture so that no downregulation can be imposed.   
As the results of Step 3 showed, the pre-exposure to LPS alone increased the barrier 
disruption further, but could not always achieve the minimum requirements of the 
defined criteria.  Presumably, exposure to LPS as single stimulant could not induce the 
release of sufficiently high concentrations of cytokines, as was observed in the THP-1 
monoculture experiments.  From these monoculture experiments it was known that the 
co-stimulation of 24h-differentiated THP-1 cells with LPS and IFN-γ significantly 
increases the release of pro-inflammatory cytokines.  This synergistic effect of LPS and 
IFN-γ is linked to the up-regulation of proteins of the LPS receptor complex and has 
been demonstrated to influence the release of IL-8 by THP-1 cells (Tamai et al., 2003).  
After pre-exposing the THP-1 cells to LPS and IFN-γ (Step 4) before the co-culture the 
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downregulation by Caco-2 cells could eventually be overcome.  As will be discussed in 
Chapter 3, the release of IL-8, IL-1β, and TNF-α was significantly increased after co-
stimulation compared to LPS-stimulation alone.   
Since all defined criteria were fulfilled and could be reproduced reliably the term 
‘inflamed co-culture’ hereinafter refers to a co-culture according to Step 4: 24h-
differentiated THP-1 cells, 4h pre-exposed to LPS and IFN-γ before being brought in 
co-culture with 24h IFN-γ-primed DCaco-2 cells. 
 
2.4 Conclusions 
The characterisation of the cell lines in monoculture showed how critical the (PMA)-
differentiation protocol and the type of stimuli are for the subsequent cytokine response 
by THP-1 cells.  Without additional stimulation, Caco-2 and THP-1 cells can cohabit in 
a co-culture model without negatively affecting the Caco-2 barrier integrity confirming 
the chapter’s first hypothesis.  Against the second hypothesis, it was not possible to 
disrupt the barrier integrity of the stable co-culture simply by stimulating the THP-1 
cells with a physiologically relevant stressor.  Several alterations, e.g. IFN-γ-priming of 
Caco-2 cells and pre-stimulation prior to the co-culture, had to be introduced to the 
stable co-culture set-up to induce an inflammation-like response.  To achieve the 
hypothesised barrier disruption the Caco-2-mediated downregulation of the THP-1 pro-
inflammatory response to LPS had to be overcome.  For this the introduction of IFN-γ 
as one of the key mediators of inflammation was essential. 
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3 Characterisation of the stable and inflamed co-culture 
3.1 Aims and hypotheses 
Throughout the protocol development, the characterisation of the stable and the 
inflamed co-cultures was limited to the measurement of barrier integrity by means of 
TEER.  Apart from affecting the barrier integrity the induction of an inflammation-like 
response is expected to result in other significant differences between the co-culture 
conditions.  Therefore, the co-culture models were further investigated regarding the 
cell viability, the presence of cytokines, and nitrite (NO2ˉ), as well as the intactness and 
integrity of the Caco-2 barrier.   
Since the stable co-culture was supposed to be used to study the inflammatory potential 
of NMs a control was included to investigate whether an inflammation-like response 
can be induced. 
Additional hypotheses regarding the further characterisation of the two co-culture 
models were: 
 The investigated endpoints, i.e. pro-inflammatory cytokine release, LDH levels, 
and NO2ˉ generation, will be similar between the stable co-culture and the Caco-
2 monoculture control. 
 A pro-inflammatory reaction, marked by the presence of pro-inflammatory 
cytokines, can be induced in the stable co-culture.  
 The outcomes obtained from the inflamed co-culture will be significantly 
different from the Caco-2 monoculture and the stable co-culture. 
 The release of pro-inflammatory cytokines, LDH levels, and NO2ˉ generation 
will be significantly increased in response to LPS / IFN-γ in the inflamed co-
culture compared to the Caco-2 monoculture and the stable co-culture. 
 The paracellular permeability to LY will be increased in the inflamed co-culture 
compared to the Caco-2 monoculture and the stable co-culture. 
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3.2 Materials and Methods 
3.2.1 Chemicals 
Lithium lactate (L2250), Iodonitrotetrazolium chloride (INT) (I-8377), Phenazine 
Methosulfate (PMS) (P-9625), β-Nicotinamide Adenine Dinucleotide sodium salt 
(NAD) (N-0632), Tris-base (T4661), Tris-HCl (T3253), sulfanilamide (SA) (S9251), N-
(1-Naphthyl)-ethylenodiamine (NEDA) (222488), and sodium nitrite (NaNO2) (237213) 
were purchased from Sigma.  
 
3.2.2 Quantification of cytokines using ELISA 
The release of IL-1β, IL-8, TNF-α, and in specific cases TGF-1β (R&D, DY240) was 
quantified in supernatants taken from the BL compartment after 4, 24, and 48h of co-
culture.  TGF-1β was additionally quantified in AP supernatants.  The analysis was 
performed as described earlier (Section 2.1.8).  
 
3.2.3 Lactate dehydrogenase (LDH) Assay 
The LDH assay was used to study the necrotic cell death in Caco-2 monocultures and 
the co-culture models.  To measure the LDH activity, 50 µL of 200 mM TRIS (10.6 mg 
Tris-base and 22.2 mg Tris-HCl in 1 L H2O), 50 µL of 50 mM lithium lactate, and 50 
µL mix of INT, PMS, and NAD were added to a 96-well plate at concentrations of 1.32 
mg / mL, 0.36 mg / mL and 3.44 mg / mL, respectively.  To each prepared well, a 
sample of cell-free supernatant (50 µL) was transferred and incubated for 5 minutes at 
RT.  The optical density was measured spectrophotometrically at 490 nm.  A 
background control in complete CCM was subtracted from the results to account for the 
absorbance of phenol red and potential LDH activity of FBS.  Cells exposed to 0.1 % 
Triton-X100 for 24h served as positive control. 
 
3.2.4 Detection of NO2ˉ with the Griess reaction 
The Griess reaction was used to indirectly assess the formation of the radical nitric 
oxide (NO) through the quantification of its stable metabolite NO2ˉ.  For the NO2ˉ 
quantification, supernatant samples were taken after 48h of Caco-2 monoculture, stable, 
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or inflamed co-culture.  To each sample (100 µL), SA (stock: 1 mM in MilliQ H2O), 
H3PO4 (stock: 1.8 M), and NEDA (stock: 1 mM in 95 % EtOH) were added to a final 
concentration of 100 μM, 170 mM, and 100 μM, respectively.  The final volume of each 
sample was 130 µL.  Each step was separated by 30 min incubation time at RT.  The 
background and dye absorbance were measured spectrophotometrically at 548 nm.  A 
calibration curve was prepared in CCM using NaNO2) (0-50 µM) dissolved in H2O.   
 
3.2.5 Barrier permeability assay and Papp calculation 
To assess the permeability of Caco-2 cell layers the flux of LY from the AP to the BL 
compartment was measured in all three culture models.  Two different approaches were 
tested:  
1) The culture models were set-up and maintained for 24h to allow their complete 
establishment.  Subsequently, the supernatant was removed and the assay 
performed as described before (Section 2.1.4).  AP and BL supernatants were 
taken after 0, 2 and 4h.   
2) LY was dissolved in MEM-based CCM (5 mg / mL) and added to the AP 
compartment at the start of the co-culture.  The co-culture conditions were 
maintained for 48h.  From both sides, 100 μL samples were taken immediately 
after addition of LY and after 4 and 18h of incubation / co-culture. 
The sample volumes were not replenished in the AP and BL compartments.  The 
measurement of FI and calculation of the Papp were performed as described in Section 
2.1.5. 
 
3.2.6 Activation of the stable co-culture 
To investigate whether the stable co-culture is detect a pro-inflammatory potential of 
test materials the stable co-culture was exposed to 2.5 mM EDTA on AP and BL side 
and LPS.  LPS was added to the AP compartment at the same mass concentration as 
used in the pre-exposure of the inflamed co-culture (i.e. 15 ng / well = 30 ng / mL in the 
AP compartment).  The culture was analysed for cytokine release in BL supernatants 
after 4, 24, and 48h exposure. 
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3.3 Results 
3.3.1 Stable vs. inflamed co-culture 
3.3.1.1 TEER 
The TEER values of the stable and inflamed co-cultures over a period of 48h are 
summarised again in Figure 3.1 to underline the differences in barrier integrity between 
both conditions.  The graph combines results already shown and discussed in Sections 
2.2.3.2 & 2.2.4.2. 
Just 4h after the initiation of the co-culture, the TEER of the inflamed condition (Figure 
3.1, green line) was significantly reduced to 78 ± 6.7 % compared to the monoculture 
(blue line) and stable co-culture (red line).  The barrier integrity reduced further to 71 ± 
5.4 % after 18h of co-culture.  Over the following 6h, the TEER began to increase 
slightly to 73 ± 5.2 % but remained significantly below the monoculture and stable co-
culture.  After 48h, the TEER was fully re-established to 96 ± 4.3 % of the monoculture.  
 
 
Figure 3.1 Comparison of the barrier integrity measured as TEER over 48h Caco-2 monoculture 
(blue), stable (red), and inflamed co-culture (green)  
N.B.: the figure was combined from above discussed data presented in Figure 2.12 and 2.13 (Average of 
N≥3 ± StDev, *p≤0.05 compared to Caco-2 monoculture, #p≤0.05 compared to stable co-culture) 
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3.3.1.2 Cytokine release 
To study the cytokine release in the three culture models supernatant samples were 
collected after 4h of culture from the AP (TGF-β1) and BL (IL-1β., IL-8, TNF-α, and 
TGF-β1) compartment.  The results for IL-1β, IL-8, and TNF-α of Caco-2 
monocultures, stable, and inflamed co-cultures are summarised in Figure 3.2.  TGF-β1 
was only expressed at very low concentrations (<10 pg / mL; data not shown) and no 
differences in expression were observed between the culture models.   
In Caco-2 monocultures (Figure 3.2, white bars), IL-8 and TNF-α were expressed at 
very low concentrations (61 ± 64 and 6.76 ± 18 pg / mL, respectively), whereas IL-1β 
was below the detection limit (Table 2.2).  In the stable co-culture set-up (striped bars), 
IL-1β was slightly increased to 18 ± 19 pg / mL, but TNF-α remained low to absent 
with 3.2 ± 7.4 pg / mL.  A clear release of ~1,000 pg / mL IL-8 was detected after 4h of 
stable co-culture.  The release of cytokines in the stable co-culture was not significantly 
higher compared to the THP-1 monoculture (p=0.193, 0.074, and 0.197 for IL-1β, IL-8, 
and TNF-α, respectively).  
 
 
Figure 3.2 Quantification of IL-1β, IL-8 and TNF-a after 4h Caco-2 monoculture, stable, and 
inflamed co-cultures  
(Average of N≥3 ± StDev; *p≤0.05 compared to the corresponding cytokine release in Caco-2 
monoculture, 
#p≤0.05 compared to the corresponding cytokine release in stable co-culture) 
 
Compared to the Caco-2 monoculture and stable co-culture, an unambiguous induction 
of IL-1β, IL-8, and TNF-α was detected in the inflamed condition. Whereas both IL-1β 
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and TNF-α were nearly absent in the other conditions, strongly increased concentrations 
of roughly 350 and 860 pg / mL, respectively, were recovered in BL supernatants of the 
inflamed model.  Most striking was the release of IL-8, which increased to >15,000 pg / 
mL after 4h of co-culture (i.e. 8h of stimulation with LPS and IFN-γ).  For IL-8 and 
TNF-α, the release was significantly higher (p=0.004 and p=0.034, respectively) 
compared to LPS/IFN-γ-stimulated THP-1 monocultures.  
 
3.3.1.3 LDH release 
The measurement of LDH release was included to assess the occurrence of necrotic cell 
death in response to the presence of THP-1 cells in the stable co-culture, as well as the 
impact of THP-1 activation in the inflamed model.  The supernatant samples were taken 
from the AP and BL compartments after 48h of mono- or co-culture.   
 
 
Figure 3.3 LDH release after 48h Caco-2 monoculture, stable, and inflamed co-culture  
Triton-X100 at a concentration of 0.1 % was used as positive control representing 100 % cell lysis 
(Average of N≥4 ± StDev; *p≤0.05 compared to Caco-2 monoculture; #p≤0.05 compared to stable co-
culture) 
 
The LDH release quantified in Caco-2 monoculture served as baseline.  Very low 
enzymatic activity was detected in both AP and BL compartment of the monoculture 
(Figure 3.3).  No significant increase in LDH was detected in either compartment of the 
stable co-culture compared to the monoculture.  In contrast to the stable co-culture, the 
analysis of the inflamed co-culture supernatants showed a significant increase (p≤0.001) 
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in LDH release in the AP compartment (260 % of the control) and a moderate, non-
significant increase in the BL compartment (150 % of the control). 
 
3.3.1.4 Quantification of NO2ˉ  
As summarized in Figure 3.4, the background levels of NO2ˉ in Caco-2 monocultures 
are very low to undetectable.  For the correct interpretation of the data it should be 
mentioned that the reliable detection limit of the Griess reaction is around 3 μM of NO2ˉ 
(Malinski et al., 1996).  Hence, results below 3 μM can be regarded as negligible.  After 
48h of stable co-culture, no change in NO2ˉ was detected.  In the supernatants of 
inflamed co-cultures, a significant increase to ~6 μM NO2ˉ was quantified in both AP 
and BL compartment (Figure 3.4).   
 
 
Figure 3.4 Quantification of NO2ˉ in AP and BL supernatants after 48h Caco-2 monoculture, stable, 
and inflamed co-cultures  
(Average of N=3 ± StDev; *p≤0.05 compared to Caco-2 monoculture control) 
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3.3.1.5 Integrity of the cytoskeleton and the TJ network 
To further investigate barrier integrity in presence of non-stimulated and stimulated 
THP-1 cells the Caco-2 barrier was microscopically analysed for its cytoskeletal 
structure and the TJ network.  The filters of all three culture models were fixed after 48h 
and stained for nucleic acid (blue), F-actin (green) and ZO-1 (red) (Figure 3.5). 
The Caco-2 monoculture (Figure 3.5A) served as control compared to the Caco-2 
barriers after 48h of stable (Figure 3.5B) and inflamed (Figure 3.5C) co-culture.  After 
23 days of culture, the Caco-2 monoculture formed a dense cell layer occupying the 
entire growth area of the filter.  The layer was heterogeneously organised, with regional 
multilayers and scattered dome formation.  Due to this growth behaviour of Caco-2 
cells a quantitative analysis of FI based on the cell number was not possible.  Visually, 
no variation between the stable co-culture barrier (Figure 3.5B) and the monoculture 
was noted.  In the inflamed co-culture barrier (Figure 3.5C), no gaps were observed but 
the TJ network and cytoskeleton seemed irregular and less organised compared to the 
monoculture.  Furthermore, an occurrence of nuclear fragmentation was observed (red 
arrows) and the nuclear surface appeared increased compared to the monoculture and 
stable co-culture (Figure 3.5C). 
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Figure 3.5 Fluorescently labelled nuclei (blue), F-actin (green), and ZO-1 (red) after 48h (A) Caco-2 monoculture, (B) stable, or (C) inflamed co-culture 
Images were acquired in Apotome mode at 40x magnification, scale bar: 20 µm, applies to all images 
86 
3.1.1 Induction of an inflammation-like response in the stable co-culture 
Apart from its reproducibility, the model’s applicability to study the pro-inflammatory 
potential was investigated.  To induce a pro-inflammatory response in the stable co-
culture, an approach described by Detzel et al. (2015) was adapted.  Briefly, they 
exposed C2BBe1 (a clone of the Caco-2 cell line) cell layers to 0.01 % PPS to increase 
the TJ permeability and allow for the translocation of apically added LPS.  In this 
project, PPS was replaced by 2.5 mM EDTA, which was added to the AP and BL 
compartment to reduce cell-to-cell attachment (Meng and Takeichi, 2009) and enable 
apically added LPS to translocate to the BL compartment.  After the addition of EDTA 
to the stable co-culture at T0, the TEER rapidly decreased by ~80 % over 4h compared 
to the unexposed Caco-2 monoculture control (Figure 3.6).  After 4h of exposure, the 
apical CCM was exchanged to counteract the calcium-chelating effect of EDTA.  The 
TEER did, however, not recover before the end of the co-culture at 48h.  The long-
lasting TEER reduction to ~20 % of the control suggested the cell barrier to be 
extensively and permanently damaged.   
 
 
Figure 3.6 Barrier integrity measured as TEER over 48h of stable co-culture exposed to EDTA and 
LPS  
(Average of N≥2 ± StDev) 
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In Caco-2 monocultures, the exposure to 10 ng / mL LPS in the AP and / or BL 
compartment did not cause comparable TEER reductions (Figure 3.7A).  No TEER 
reduction was observed in the stable co-culture over 48h apical exposure to LPS or LPS 
and IFN-γ (10 ng / mL each) (Figure 3.7B).   
A 
 
B 
 
Figure 3.7 Barrier integrity measured as TEER over 48h (A) Caco-2 monoculture with AP and / or 
BL exposure to LPS (10 ng / mL) and (B) stable co-culture with AP exposure to LPS (10 ng / mL) 
or LPS + IFN-γ (10 ng / mL each)  
(Caco-2 monoculture: Average of N≥2 ± StDev; Stable co-culture: Average of n=3 from one experiment 
± StDev) 
88 
The magnitude of the barrier disruption was confirmed by analysis of Caco-2 barriers 
fluorescently labelled for the cytoskeleton and TJ network.  As the images show (Figure 
S4), the majority of the cells had detached from the transwell filters.  Both the 
cytoskeleton and TJ network were discontinuous and scarcely covered the filter.  In line 
with both the TEER measures and the microscopic analysis, the LDH release was 
significantly increased (p≤0.001) in the AP and BL compartment of EDTA + LPS-
exposed stable co-cultures compared to the stable co-culture control (Figure 3.8).  No 
interference of EDTA with the assay was noted (Figure S5). 
 
 
Figure 3.8 LDH activity quantified after 48h stable co-culture with and without exposure to EDTA 
and LPS  
EDTA (2.5 mM) was added to the AP and BL compartment; LPS (30 ng / mL) was added to the AP side 
(Control = stable co-culture, Average of N=5 ± StDev; EDTA+LPS: Average of N=2 ± StDev; 
#
p≤0.05 
compared to control) 
 
For cytokine analyses, supernatant samples were taken from the BL compartment after 
4, 24, and 48h of exposure and co-culture.  The results were compared to the unexposed 
stable co-culture control.  The following conditions were included as controls to exclude 
the possibility that any observed effect was induced by EDTA or LPS alone: the stable 
co-culture was apically exposed to LPS without addition of EDTA; Caco-2 
monocultures were treated with EDTA and LPS; THP-1 monocultures were exposed to 
EDTA alone.  The results are summarised in Figure 3.9 and Figure 3.10 below.  
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After 4h stable co-culture, IL-1β and TNF-α were expressed at very low concentrations 
below 10 pg / mL (Figure 3.9A).  Only IL-8 was noticeably released with ~350 pg / mL.  
At this time point, no significant differences in cytokine release were observed between 
the EDTA/LPS-exposed and the unexposed stable co-culture control.  
With increasing exposure time, the IL-8 concentration increased significantly (p≤0.01) 
to >2,000 pg / mL after 24h (Figure 3.9B) and >3,400 pg / mL after 48h (Figure 3.9C).  
Both IL-1β and TNF-α were slightly but significantly (p≤0.001 and p≤0.037, 
respectively) elevated compared to the stable co-culture control after 24 and 48h 
exposure.   
To analyse the impact of IFN-γ a control was included in which the stable co-culture 
was exposed to a mix of EDTA, LPS, and IFN-γ (Figure 3.10).  The presence of IFN-γ 
strongly increased the release of all three cytokines compared to stable co-cultures 
exposed to EDTA and LPS alone after 24h (IL-1β +360 %, IL-8 +430 %, TNF-α +1,800 
%) and 48h (IL-1β +360 %, IL-8 +480 %, TNF-α +1,880 %). 
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Figure 3.9 Quantification of IL-1β, IL-8, and TNF-a after (A) 4, (B) 24, and (C) 48h stable co-
culture with and without exposure to EDTA / LPS  
EDTA (2.5 mM) was added to the AP and BL compartment; LPS (30 ng / mL) was added apically 
(Control 24h: Average of N=2; Rest: Average of N=3 ± StDev; *p≤0.05 compared to IL-1β in stable co-
culture control; 
#p≤0.05 compared to IL-8 in stable co-culture control; +p≤0.05 compared to TNF-α in 
stable co-culture control) 
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Figure 3.10 Quantification of IL-1β, IL-8, and TNF-α by Caco-2 and THP-1 cells in mono- or stable 
co-culture  
(A) 24h or (B) 48h apical exposure to EDTA (2.5 mM), LPS (30 ng / mL), EDTA and LPS (30 ng / mL), or 
EDTA+LPS (30 ng / mL)+IFN-γ (30 ng / mL) (Average of n=3 of one experiment ± StDev) 
 
3.3.3 Translocation of LY in the inflamed and stable co-cultures  
To compare the barrier permeability between the co-culture models the translocation of 
LY was studied and expressed as Papp.  Two different approaches were investigated as 
described in Section 3.2.5.  At first, the co-culture conditions were established and 
maintained for 24h before the wells were washed and exposed to LY dissolved in 
HBSS
+/+ 
(Figure 3.11, white squares).  After the supernatant was exchanged for 
HBSS+LY the TEER quickly re-established and significantly exceeded the barrier 
integrity of the Caco-2 monoculture after 28h (116 %) and 48h (151 %) (red squares).  
Since the exchange of supernatant for HBSS
+/+ 
apparently favoured a quick recovery of 
the Caco-2 barrier integrity, a second approach was tested.   
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Instead of letting the condition establish before the assay, LY was dissolved in CCM 
and added to the AP compartment at the start of the co-culture.  The inflamed co-culture 
could be established normally in presence of LY (Figure 3.11, green triangles), reaching 
a similar reduction in TEER as the inflamed co-culture control (Figure 3.11, black 
circles).  Even though the inflamed co-culture fulfilled the defined requirements 
regarding the magnitude and duration of the barrier disruption no increased Papp for LY 
was detected after 4 and 18h (Figure 3.12).  To exclude potential adverse effects of LY 
on cell viability or barrier integrity, a control in Caco-2 monoculture and stable co-
culture was included (Figure 3.12).   
 
 
Figure 3.11 Barrier integrity measured as TEER over 48h inflamed co-culture with and without 
supernatant replacement for LY barrier crossing studies  
(Average of n=3 of one experiment ± StDev)
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Figure 3.12 Papp of Caco-2 monoculture, stable, and inflamed co-culture  
(A) 4h treatment with LY starting after 24h of co-culture; (B) after 18h treatment with LY starting at the 
initiation of the co-culture (Average of n≥3 ± StDev) 
 
3.4 Discussion 
3.4.1 Characterisation of the stable and inflamed co-cultures 
The characterisation of co-culture models revealed significant differences:   
 No increased release of cytokines, NO2ˉ, or LDH was detected after co-culture 
of Caco-2 and unstimulated THP-1 cells, indicating that no activation of the 
macrophages occurred.  The results on the cytoskeleton and TJ network 
confirmed that unstimulated THP-1 cells did not negatively affect Caco-2 barrier 
integrity. 
 The activation of THP-1 cells with LPS and IFN-γ caused a significant increase 
in pro-inflammatory cytokines, NO2ˉ, and LDH, which underlined the 
detrimental effect of activated macrophages on Caco-2 cells.  
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 The positive control using EDTA and LPS confirmed that the stable co-culture 
can be activated.  Additional controls, however, underlined the crucial role of 
IFN-γ for the induction of inflammation-like processes. 
 Even though the barrier integrity was significantly impaired in the inflamed 
model no increased paracellular permeability for LY was detected. 
 
3.4.1.1 Cytotoxicity 
The enzyme LDH is present in virtually all mammalian cells and released after cell 
damage or necrotic cell death.  Therefore, the quantification of the enzymatic activity is 
a widely accepted method to assess cytotoxicity (Chan et al., 2013).  Whereas a 
significantly increased release of LDH was measured in the AP supernatants of the 
inflamed co-cultures no change was detected in the stable co-culture compared to the 
Caco-2 monoculture.  Together with the results on TEER and the cytokine release these 
results support the hypothesis that unstimulated 24h-differentiated THP-1 cells did not 
exert adverse effects on the Caco-2 barrier over 48h co-culture.  The increase in LDH 
activity in AP supernatants after induction of an inflammation-like process indicates the 
occurrence of necrosis in the Caco-2 cell layer.  Based on the LDH release alone, no 
estimation can be given on the magnitude of the cell damage.  Since the barrier 
integrity, measured as TEER, is fully re-established after 48h and the 
immunocytochemical analysis of the cell layer showed a continuous barrier it can be 
assumed that no excessive necrotic cell death occurred.  
Apart from the reduction in barrier integrity intestinal inflammation is strongly 
associated with the occurrence of cell death in IECs.  Even though the majority of the 
reports concern the observation of apoptotic cell death the occurrence of necrosis in 
IBD patients has been reported as well (Nunes et al., 2014; Dourmashiin et al., 1983).  
Several inflammation-related mediators are known to induce necrotic cell death, e.g. 
TNF-α and NO (Miura et al., 1995; Bonfoco et al., 1995).  Both TNF-α and NO were 
present at significantly higher concentrations in the inflamed model compared to the 
stable co-cultures and might have induced necrotic processes.  In contrast to these 
results other groups reported an increased release of LDH in presence of THP-1 cells 
even without additional activation of the macrophages (Watanabe et al., 2004; Satsu et 
al., 2006).  Watanabe et al. nicely demonstrate the correlation of TNF-α and LDH 
release: In presence of anti-TNF-α Ab the levels of LDH were reduced significantly to 
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those of the monoculture control (Watanabe et al. , 2004).  In contrast to our co-
cultures, Satsu and colleagues used almost twice as many THP-1 cells (3x10
5
) on the 
same well surface.  This underlines the importance of ratios of cell types in the 
development of co-cultures.  As discussed before (Section 2.3.3), intestinal homeostasis 
greatly depends on the interplay between IECs and the various parts of the GALT.  This 
regulation by IECs, which was observed during the development of the inflamed co-
culture, might not be possible in case an overwhelmingly high numbers of immune cells 
are present.   
In contrast to Satsu et al. and Watanabe et al., Susewind and colleagues (2016) did not 
detected increased LDH levels in either the non-inflamed or inflamed intestinal co-
culture of Caco-2, THP-1, and MUTZ-3 cells after challenge with IL-1β.  In contrast to 
TNF-α, IL-1β has been found to induce cell death indirectly through the generation of 
NO.  The exposure to IL-1β caused both apoptotic and necrotic cell death in β-cells of 
pancreatic islets (Hoorens et al., 2001; Ankarcrona et al., 1994).  Several groups 
reported an adverse effect of IL-1β on the barrier integrity of Caco-2 cells and induction 
of NO synthesis (Van De Walle et al., 2010; Al-Sadi and Ma, 2007).  However, no 
occurrence of necrotic or apoptotic cell death was observed (Al-Sadi and Ma, 2007).  
Satsu et al. (2006) even demonstrated that in IL-1β was not responsible for the observed 
increase in LDH release in the group’s co-culture of Caco-2 cells and activated THP-1 
cells.   
Altogether, these results underline how variations in a culture set-up or the use of 
different stimuli to evoke the same effect – here an inflammation-like response – can 
lead to significantly different outcomes in specific endpoints.   
 
3.4.1.2 Cytokine release 
Another hallmark of intestinal inflammation is the presence of pro-inflammatory 
cytokines like TNF-α, IL-8, and IL-1β, which can be released by both immune cells and 
IECs (Coccia et al., 2012; Mazzucchelli et al., 1994).  In the Caco-2 monoculture the 
concentrations of all three cytokines were close to or below the detection limit (Table 
2.2).  In contrast, the release of IL-8 was enhanced in the stable co-culture, but did not 
significantly exceed the levels recovered in unstimulated THP-1 monocultures (Section 
2.2.2.2).  In the inflamed co-culture, the release of all three investigated cytokines was 
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markedly increased.  Interestingly, TGF-β1 was not detected in any of the culture 
models.  
IL-1β, TNF-α, and IL-8 are well known for their role in the onset and maintenance of 
inflammatory processes.  The absence of cytokine release by unstimulated Caco-2 cells 
is well in line with the reported findings of other (Kucharzik et al., 1997).  Even after 
the adjusted PMA-differentiation protocol the release of IL-8 was significantly 
increased in the stable co-culture compared to the Caco-2 monoculture.  As mentioned 
before, it is possible that this release is a typical background level synthesized by the 
macrophages and does not indicate an activation / stimulation of either cell line 
(Smythies et al., 2005).  This was further supported by the fact that no disruption of the 
Caco-2 barrier integrity was noted.   
The high release of pro-inflammatory cytokines in the inflamed co-culture was both 
expected and desired.  In contrast to LPS exposure at the start of the co-culture (Section 
2.2.4.2) the pre-exposure to LPS and IFN-γ induced high levels of cytokines even in 
presence of Caco-2 cells.  The levels for IL-8 and TNF-α were significantly higher in 
the co-culture compared to LPS/IFN-γ-exposed THP-1 monocultures (Section 2.2.2.2).  
These results further support the hypothesis that the presence of Caco-2 cells down-
regulated the macrophage-mediated cytokine response to LPS in earlier experiments.  It 
is not clear whether the co-culture enhanced the cytokine release by THP-1 cells or 
Caco-2 cells contributed to the recovered concentrations.  Caco-2 cells are able to 
synthesise several pro-inflammatory cytokines but are mainly associated with the 
release of IL-8.  However, several groups showed no or very low cytokine response in 
Caco-2 cells after challenge with LPS (Schuerer-Maly et al., 1994) or various non-
pathogenic and pathogenic bacterial strains (Parlesak et al., 2004; Haller et al., 2000).  
In contrast to LPS, already low concentrations of 100 pg / mL of IL-1β induced a 
significant release of IL-8 of around 2 ng / mL (Schuerer-Maly et al., 1994).  
Furthermore, higher concentrations of TNF-α (50 ng / mL) were found to induce IL-8 
release in Caco-2 cells (Van De Walle et al., 2010).  It is, therefore, possible that the 
cytokines released by activated THP-1 cells stimulated the cytokine synthesis in Caco-2 
cells. 
The absence of TGF-β1 was surprising as it is known for its immunosuppressive and 
barrier protective effects in intestinal epithelia (Howe et al., 2005).  The cytokine has 
been shown to be involved in the regulation of cytokine release by other cell types, e.g. 
endothelial cells, PBMCs, and lamina propria mononuclear cells (Lügering et al., 1998; 
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Kucharzik et al., 1997).  More precisely, it is known to down-regulate the generation of 
IL-8 in macrophages (Schuerer-Maly et al., 1994).  Hence, the absence of TGF-β1 
might be involved in the still high releases of IL-8 in the stable co-culture.  
Furthermore, TGF-β was shown to enhance the barrier integrity of intestinal epithelial 
cells (Howe et al., 2005), which could have explained the here observed re-
establishment of TEER in the inflamed co-culture.  
 
3.4.1.3 Nitrous stress 
In the Caco-2 monoculture and stable co-culture the levels of detectable NO2ˉ were 
generally close to or below the lower detection limit of the Griess reaction (~3 µM).  It 
could not be distinguished, whether both cell lines were involved in the NO2ˉ generation 
or the generated NO2ˉ
 
translocated from AP to BL compartment or vice versa.  Both 
Caco-2 and THP-1 cells have been demonstrated to express iNOS and release NO2ˉ 
upon stimulation (Vignoli et al., 2001; Chen et al., 1996).  It should be noted, though, 
that the reported results on the NO2ˉ
 
release by THP-1 cells vary significantly.  Whereas 
some groups observed the induction of both NO2ˉ and the expression of iNOS, others 
could not detect NO generation upon stimulation (Weinberg, 1998).  Also in our 
laboratory, the NO synthesis of THP-1 cells was variable.  Often a significant release of 
NO2ˉ could be triggered by exposing PMA-treated THP-1 cells to LPS (100 ng / mL) 
(not shown).  In some cases, however, the cells did not respond to the stress, 
independent of the differentiation status and concentration of the stressor.  Similar 
results were obtained throughout the co-culture experiments.  Whereas in some cases a 
clear and significant increase was measured, other experiments failed to cause NO2ˉ 
generation.   
After its discovery, most research on the release of NO has been performed using non-
human macrophages (Weinberg, 1998).  It turned out that even though murine 
monocytic cells responded to common activating stimuli, e.g. LPS, IFN-γ, and TNF-α, 
with the release of high concentrations of NO, human primary monocytes and cell lines 
did not (Pham et al., 2003).  It was long questioned, whether human macrophages are 
capable of generating NO via the iNOS pathway suggesting that reported NO-detections 
were attributable to in vitro artefacts (Schneemann et al., 1997).  Interestingly, 
macrophages isolated from lung transplant patients could be stimulated to synthesise 
NO in vitro, whereas macrophages of healthy controls were largely unresponsive (Fang 
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and Vazquez-Torres, 2002).  In human macrophages the regulation of iNOS and 
synthesis of NO appears to heavily depend on the type of stimulus.  For instance, iNOS 
was not up-regulated in human monocytes and macrophage cell lines in response to LPS 
(Pham et al., 2003), whereas they strongly responded to infection with different strains 
of mycobacteria (Jung et al., 2012) or incubation with serum derived from Kawasaki 
disease patients (Cheung et al., 2005).  Furthermore, the differentiation state of the cells 
might be important, but also here the reported findings are ambiguous.  Daigneault et al. 
(2010) observed a release of NO by LPS-stimulated monocytes and VD3-differentiated 
THP-1 cells, but not in macrophages or PMA-differentiated THP-1 cells.  In this case, 
the variations observed in this project might be related to an incomplete differentiation 
of the THP-1 cells in some runs.  Why the cells would respond differently to PMA 
between experimental runs remains a separate question.  Pham and colleagues (2003) 
did not note any effect by LPS on monocytes or undifferentiated THP-1 cells.  
Altogether, it is not fully elucidated yet what determines the NO-induction in 
macrophages in vitro and why large variations persist in the outcomes between 
laboratories.   
In contrast to THP-1 cells, Caco-2 cells have clearly been shown to synthesise NO in 
response to several pro-inflammatory cytokines, as well as LPS.  A combination of IL-
1β, TNF-α, IFN-γ, and LPS was demonstrated to act more effectively than the 
individual compounds alone (Van De Walle et al., 2010).  Chen and Kitts (2008) ranked 
the inducers according to their effectiveness on NO synthesis as follows: IFN-γ > IL-1β 
> TNF-α > LPS.  Even though several known inducers of NO were available in every 
inflamed co-culture run apical NO2ˉ was only detected in some of the experiments.  The 
detection of AP and BL NO2ˉ occurred exclusively in parallel.  It is unlikely that the 
NO2ˉ in both AP and BL compartment is attributable to the Caco-2 cells alone, as the 
majority of Caco-2-derived NO2ˉ is released to the AP side (Kim et al., 2002).  The NO 
generation in Caco-2 cells has been shown to be influenced by several factors, e.g. 
passage, culture / differentiation time, and stimulation time (Chen and Kitts, 2008).  
Whereas the differentiation and stimulation time did not change considerably, the 
passage number of the cells varied between the experiments.  It is possible that a 
minimum number of passages was necessary to induce NO generation in Caco-2 cells.  
In many studies observing an NO release the cells were exposed apically to stressors in 
contrast to this project (Chen and Kitts, 2008; Kim et al., 2002; Eckmann et al., 2000).  
Others did not observe a significant induction of NO in basolaterally exposed cells 
(Satake et al., 2001), which suggests a different response to stimuli depending on the 
99 
side of encounter.  In accordance to this hypothesis, Quadrhiri et al. (1999) reported an 
interesting observation regarding the impact of IL-6 and IFN-γ on the intracellular 
growth of Listeria monocytogenes.  Whereas IL-6 was exclusively beneficial when 
added on the BL side of Caco-2 cells, IFN-γ was significantly more active on the AP 
side of the cells.  It is possible that a similar effect is observed here.  This could also 
explain the noted variability in NO2ˉ detection – at least in Caco-2 cells.  As will be 
discussed later (Chapter 4), IL-6 release occurred in the inflamed co-culture.  However, 
the absolute concentrations varied strongly between the individual runs, whereas the 
presence of IFN-γ and other NO-inducing cytokines like TNF-α and IL-1β was rather 
constant.   
 
3.4.2 Activation of THP-1 cells in the stable co-culture 
To demonstrate the stable co-culture’s ability to react to pro-inflammatory stimuli, an 
increase in cytokine release induced by the AP exposure to a stressor was documented.   
To stimulate the stable co-culture two approaches were initially discussed: 
I. Targeting the IEC barrier: stimulating the Caco-2 cells to initiate a pro-
inflammatory response. 
II. Targeting the THP-1 cells: aiming for a translocation of the stressor from the AP 
to the BL compartment to stimulate the macrophage-like cells. 
In the first approach, the aim would be to stimulate the release of pro-inflammatory 
cytokines and chemokines from Caco-2 cells to activate the THP-1 cells indirectly.  
This could be achieved with the exposure to pro-inflammatory chemical compounds 
(e.g. arsenic species) (Calatayud et al., 2014), the use of enteroinvasive bacterial strains 
(e.g. Shigella, enteroinvasive Escherichia coli [EIEC], and pathogenic strains of 
Listeria) (Gaillard, 1987; Jung, 1995) or the exploitation of bacterial enteroinvasive 
toxins (e.g. Shiga toxin) (Yamasaki, 1999).  
For the second approach, targeting the THP-1 cells requires the stressor to penetrate the 
epithelial barrier to pass from the AP to the BL compartment.  Again, pathogenic 
bacterial strains (e.g. Salmonella and E. coli) (Finlay, 1990; Philpott et al., 1997), 
bacterial toxins (e.g. verotoxin-1) (Philpott et al., 1997; Izumikawa et al., 1998), or 
PAMPs like LPS would be suitable candidates.  Some stressors like verotoxin-1 are 
capable of translocating across the epithelium by themselves (Philpott et al., 1997), 
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whereas others, e.g. LPS, require the addition of a stressor to target the TJ network or 
cytoskeletal integrity of the Caco-2 cells to reach the BL side (Detzel et al., 2015; Haller 
et al., 2000).  
Any concept involving the use of live bacterial cultures was overruled, due to the lack 
of adequate facilities, which left a choice between bacterial toxins and PAMPs.  The use 
of Shiga (-like) toxins would have been the more interesting and elegant solution as it 
did not require a second stressor to disrupt the Caco-2 barrier.  However, its use would 
have required extensive additional characterisation of the toxin’s effects in Caco-2 and 
THP-1 monocultures, as well as stable and inflamed co-cultures.  For reasons of 
practicality it was, therefore, decided to adapt the approach described by Detzel and 
colleagues (Detzel et al., 2015) to activate the stable co-culture.  A translocation of LPS 
to the BL compartment was regarded as necessary, since the AP exposure to such low 
concentrations of LPS does not stimulate Caco-2 cells to release pro-inflammatory 
cytokines or messenger chemokines like MCP-1 (Schuerer-Maly et al., 1994; Haller et 
al., 2000). 
As the results showed, the AP exposure of the stable co-culture to EDTA induced a 
rapid and permanent reduction in Caco-2 barrier integrity due to detachment of the cells.  
After 24 and 48h of exposure the cytokine release was significantly increased compared 
to the stable co-culture control, indicating an activation of the THP-1 cells.  The 
controls confirmed that neither the exposure to EDTA in THP-1 cells nor the treatment 
of Caco-2 cells with LPS and EDTA caused an elevated synthesis of pro-inflammatory 
cytokines.  Furthermore, the AP exposure of the stable co-culture with LPS in absence 
of EDTA failed to induce cytokine release.  This confirms that  
(1) Caco-2 cells do not respond with the release of IL-8, TNF-α, or IL-1β to the 
apical presence of LPS.  
(2) LPS is not able to translocate across the epithelial barrier without an 
additional stressor disrupting the barrier integrity. 
It can, therefore, be concluded that the cytokine release was caused by LPS after 
translocation to the BL compartment.  Even though the increase of all three cytokines 
was significant, only IL-8 reached levels comparable to those of the inflamed co-
culture, whereas IL-1β and TNF-α remained at levels of questionable biological 
importance.  A control using LPS, EDTA, and IFN-γ resulted in greatly enhanced 
cytokine concentrations, underlining the importance of IFN-γ for the induction of an 
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inflammation-like response.  This is in line with the crucial role of IFN-y in intestinal 
inflammation, which has been demonstrated before in IFN-γ-/- mice (Ito et al., 2006).  In 
inflammation, IFN-γ is directly involved in the recruitment of immune cells, as well as 
the induction of chemokines (Su et al., 2015; Ito et al., 2006).  Furthermore, IFN-γ can 
indirectly amplify the effect of other pro-inflammatory mediators, e.g. TNF-α, by up-
regulating specific binding sites (Wang et al., 2006).  Since the presence of IFN-γ seems 
to have a pivotal role in the artificial induction of inflammation its lack in the stable co-
culture might affect the model’s applicability to study the pro-inflammatory potential of 
NMs.   
 
3.4.3 Translocation of LY  
The integrity of the intestinal barrier is a crucial factor to determine its gate function.  A 
reduction in barrier integrity (here primarily measured by means of TEER) is associated 
with an increased transport of ions and macromolecules from the AP to the BL 
compartment.  One of the distinguishing characteristics of the inflamed co-culture 
model was the significantly reduced TEER indicating a temporary disruption in barrier 
integrity.  This led us to hypothesise that the barrier’s gate function is impaired 
temporarily, which should allow molecules like LY to pass the inflamed barrier at a 
higher rate than in the Caco-2 monoculture and stable co-culture.  However, the results 
showed that no increased translocation of LY occurred even though the TEER was 
reduced by 30-40 %.   In the first approach this observation was not surprising, since the 
barrier integrity re-established promptly after addition of LY in HBSS
+/+
.  Probably, the 
diffusion rate of the dye was slower than the re-establishment of the barrier integrity.  
Surprisingly, no increased translocation of LY was seen in the second approach either.   
These results are in clear contrast to the reports of others showing a significantly 
increased translocation of molecules in response to cytokine-induced TJ opening.  A 30 
% reduction in Caco-2 barrier integrity resulted in a 20-fold increase in the paracellular 
permeability for inulin (5,000 g / mol) (Al-Sadi and Ma, 2007).  The exposure to IL-6 
reduced barrier integrity up to 40 %, but only increased the translocation rate of very 
small molecules like urea, and not for mannitol, inulin (5,000 g / mol), or dextran 
(10,000 g / mol) (Al-Sadi et al., 2014).  The barrier disruption in the inflamed co-culture 
is most likely primarily induced by the synergistic effect of IFN-γ and TNF-α.  In Caco-
2 barriers individually exposed to either TNF-α or IFN-γ, an increased flux of LY has 
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been reported (Cui et al., 2010; Koda et al., 2003).  The effects of simultaneous 
exposure have, so far, only been assessed using dextran (3-4 kDa), for which the 
paracellular transport was clearly increased (Cao et al., 2013; Wang et al., 2005).  Since 
all permeability-enhancing cytokines seem to induce different pathways the results 
obtained from TNF-α and IFN-γ individually should not be extrapolated to a combined 
exposure scenario.   
In general, LY seems to be an insensitive marker for barrier permeability albeit the low 
molecular weight.  In accordance with this, the dye is mostly used to assess barrier 
development and cytotoxic effects, but less commonly applied to study TJ functionality 
(Di and Kerns, 2016).  When studying the correlation between TEER and paracellular 
permeability for two low molecular weight molecules (LY and mannitol) and a higher 
weight molecule (40-50 kDa dextran) Konsoula and Barile (2005) observed LY 
translocation in case of heavy reduction in TEER of at least 60 %.  It is unlikely that an 
uptake and subsequent entrapping of LY within the Caco-2 cells causes the lack of 
translocation (Mashukova et al., 2011).  Interestingly, in case the epithelial barrier was 
substantially disrupted using Ca
2+
 chelators the flux of LY was notably increased and 
even exceeded the rates obtained with molecules of significantly higher molecular 
weight (Walczak et al., 2015; Bouwmeester et al., 2011).   
Most likely, the nature of the molecules used for transport studies (e.g. molecular 
weight, hydrodynamic diameter, polarity, and charge) has to be considered in addition 
to the variations in mechanisms and might explain the apparent discrepancies.  In IECs 
the paracellular pathway was shown to be more permeable to cationic than anionic or 
neutral molecules (Palm et al., 1999).  Apart from its rather large size (12.2 x 9.9 x 2.6 
Å), LY is a highly polar molecule with an overall negative charge (Kanaporis et al., 
2011).  Whereas cytotoxicity causes a complete detachment of the cells most cytokines 
cause a structural or quantitative change in TJ proteins.  Hence, in the former case the 
size and charge-selective pores are increasingly destroyed, whereas they are still intact 
in the latter.  This further implies that the gate function including the size and charge 
selectivity (mainly regulated by proteins of the claudin family) is functioning after 
exposure to cytokines (Chiba et al., 2008).  Altogether, this could explain why no 
increased paracellular permeability is observed for LY albeit the significant reduction in 
TEER and render the dye an unsuitable probe to study this endpoint.  
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3.5 Conclusions 
For most of the investigated endpoints (LDH, NO, barrier integrity, and TNF-α release) 
no significant differences were noted between the Caco-2 monoculture and stable co-
culture.  In contrast to the hypothesis, both IL-1β and IL-8 levels were significantly 
elevated in the stable co-culture, but no negative effect on the barrier integrity was 
measured.  It was hypothesised that the stable co-culture is suitable to study the pro-
inflammatory potential of NMs.  Even though the release of pro-inflammatory cytokines 
could be stimulated this hypothesis could not be fully confirmed due to the observed 
importance of IFN-γ in inflammation.  The stimulation of THP-1 cells with LPS and 
IFN-γ in the inflamed co-culture caused remarkable differences in barrier integrity, 
release of pro-inflammatory cytokines, NO formation, and LDH release.  Even though 
the presence of activated THP-1 cells induced necrotic cell death the histochemical 
analysis of the Caco-2 barrier showed no signs of reduced cell numbers.  It can, 
therefore, be assumed that the observed reduction in TEER is primarily caused by 
cytokine-induced restructuring of TJ proteins and not cytotoxicity.  The inflammation-
like process, however, appeared to affect the nuclear integrity of Caco-2 cells, as well as 
the TJ network and cytoskeletal structure.  The cause for the re-establishment of the 
TEER in the inflamed co-culture after 48h could not be elucidated.  The applicability of 
LY to study the potential increase in paracellular permeability in the inflamed co-culture 
was questionable.  Therefore, it can only be concluded that reduced barrier integrity 
does not result in an increased translocation of LY but might allow for increased 
paracellular passage of other substances. 
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4 Application of the co-culture model to study the effect of AgNPs in 
homeostatic and inflamed conditions 
4.1 Introduction 
According to the Consumer Products Inventory (2016), Ag is the most abundantly used 
NM in consumer products with over 400 registered applications to date.  AgNPs are 
most commonly used in medical devices (Roe et al., 2008; Maneerung et al., 2008), and 
food contact materials (Llorens et al., 2012), due to their bactericidal activity against 
both Gram-positive and negative bacteria, including multi-drug resistant strains (Lara et 
al., 2009; Sondi and Salopek-Sondi, 2004).  Due to their broad application in consumer 
products, a wide public is likely exposed to AgNPs on a regular base.  Therefore, 
assuring their safety for human health is of utmost importance. 
 
4.1.1 AgNPs exposure effects  
4.1.1.1 Effects of AgNPs exposure in vitro 
The effects of AgNP-exposure have been extensively studied in a variety of cell types 
from human and animal origin, including organ-specific cell types and leukocytes.  
Most commonly assessed endpoints include cytotoxic (Sambale et al., 2015; Beer et al., 
2012), genotoxic (Li et al., 2012; Foldbjerg et al., 2011), and immuno-toxic effects.  
Depending on the cell type, AgNPs induced effects in a dose- and size-dependent 
manner either with smaller particles acting more potently than larger sized particles 
(Gliga et al., 2014; Huk et al., 2014) or vice versa (Kim et al., 2012b).   
It is still debated whether AgNPs exert toxicity through the release of Ag ions (Ag
+
) or 
as nano-specific effects related to size and shape of the particles (Kittler et al., 2010).  
Furthermore, it remains unclear whether the mechanisms differ between species, cell 
types, or even case by case (Stensberg et al., 2011).  Park et al. (2010b) suggested a 
‘Trojan-horse’ type mechanism for AgNP-induced cytotoxicity, meaning that 
particulate Ag is taken up by the cells and subsequently ionised within.  In line with 
this, a study by Xiu et al. (2012) on E. coli observed a strongly reduced cytotoxic 
potential of AgNPs when the exposure was performed under anaerobic compared to 
aerobic conditions.  The group argued that anaerobic conditions did not allow for the 
oxidation of Ag(0) to Ag
+
 and, therefore, concluded the release of Ag
+
 to be the main 
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cause for toxicity (Xiu et al., 2012).  Pratsinis and colleagues (2013) suggested different 
toxicity mechanisms in relation to the particle size.  Whereas the toxicity of AgNPs 
smaller than 10 nm is supposed to be related to the release of Ag
+
, larger AgNPs are 
proposed to exert effects directly through cell-particle interactions. 
 
4.1.1.2 Effects of AgNPs exposure in IECs and macrophages in vitro 
AgNPs can be taken up by IECs in a size-dependent manner (Georgantzopoulou et al., 
2016; Miethling-Graff et al., 2014).  For intestinal epithelial cell lines, large variations 
regarding the susceptibility to AgNPs are reported in the literature.  Whereas some 
studies report the induction of cytotoxicity at concentrations as low as 1 µg / mL in 
HT29 cells (Nguyen et al., 2013), others show remarkable resilience towards 
concentrations up to 100 µg / mL in Caco-2 cells (Georgantzopoulou et al., 2016).  
Apart from the exposure concentration and exposure time, AgNP-induced effects were 
shown to depend on the particle size and surface coating (Nguyen et al., 2013; Sanpui et 
al., 2011).  Next to cytotoxicity, the induction of genotoxicity (Sahu et al., 2014), 
oxidative stress (Aueviriyavit et al., 2014; Miethling-Graff et al., 2014; Nguyen et al., 
2016), cell cycle arrest (Miethling-Graff et al., 2014), and pro-inflammatory responses, 
e.g. the release of pro-inflammatory cytokines (Abbott Chalew and Schwab, 2013; 
Georgantzopoulou et al., 2016) have been reported in IECs.  
Apart from the particle characteristics the developmental state of the cells influenced the 
severity of AgNP-induced effects.  In proliferating IECs, very low particle 
concentrations (0.1 µg / cm²) induced cell cycle arrest and strongly inhibited 
proliferation, whereas no effects were noted in differentiated, non-proliferating cells 
(McCracken et al., 2015).  These significant variations in susceptibility might be one 
reason for the large differences in toxic doses reported in the literature. 
As in IECs, AgNPs can be taken up by monocytic cell lines (Gnanadhas et al., 2013; 
Greulich et al., 2011), as well as primary blood monocytes (Krystek et al., 2015).  Also 
in monocytic cells and macrophages the particle characteristics, like surface 
modifications, coatings and size, affected the toxic potential.  When exposed to 
uncoated AgNPs, a size and dose-dependent induction of cytotoxicity occurred, with 
smaller particles being more cytotoxic than larger particles at the same mass-volume 
concentrations (Nguyen et al., 2013).  In murine macrophages, the cytotoxic potential 
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could be reduced by coating the particles with citrate or PVP (Nguyen et al., 2013).  In 
human monocytic cells, however, PVP coated AgNPs of similar size induced necrotic 
cell death at much lower concentrations, with an EC50 of just 2.5 µg / mL compared to 
no observable cytotoxicity at 50 µg / mL in murine macrophages (Foldbjerg et al., 2009; 
Nguyen et al., 2013).  Peptide-coated particles proved to be less toxic in human 
monocytic cells with an EC50 of around 150 µg / mL (Haase et al., 2011).  These results 
suggest that the effects of particle exposure might not only differ between cell types, but 
also between cell lines of the same cell type.  
In intestinal co-culture models, AgNPs induced less severe adverse effects in IECs 
compared to the corresponding monoculture controls (Susewind et al., 2016; 
Georgantzopoulou et al., 2016).  Apart from pro-inflammatory and cytotoxic effects, 
AgNPs impacted the expression of proteins in a manner that was distinguishable from 
ionic Ag (Georgantzopoulou et al., 2016; Oberemm et al., 2016; Gioria, unpublished 
results).   
Most studies investigating different sizes of AgNPs observed size-dependent exposure 
effects.  However, most authors apply equal mass / volume concentrations for different 
AgNPs without considering changes in particle number and specific surface area or 
normalising the results to a comparable characteristic.  Hence, the interpretation of the 
results obtained from differently-sized AgNPs might be misleading.  At identical 
mass/volume concentrations, smaller-sized particles induced stronger effects than larger 
AgNPs (Haase et al., 2011; Georgantzopoulou et al., 2016). These differences 
disappeared after normalising the results to the specific surface area of the particles 
(Haase et al., 2011).   
 
4.1.2 AgNPs exposure effects in vivo 
The exposure effects of AgNPs were investigated in numerous in vivo studies mostly 
using rodent species.  Since the here developed model aims to study the effects of orally 
ingested NMs in the intestine the focus was put on oral exposure in vivo studies.  
Thereinafter, a brief overview will be given for in vivo studies applying other routes of 
exposure (dermal, inhalation, and intravenous / intraperitoneal injection). 
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4.1.2.1 Oral exposure 
Numerous in vivo studies have investigated the effects of orally ingested AgNPs (10-
323 nm) over 14-days (Skalska et al., 2015; Park et al., 2010a), 28-days (van der Zande 
et al., 2012; Loeschner et al., 2011; Kim et al., 2008; Lee et al., 2013; Park et al., 2010a; 
Jeong et al., 2010), or 90-days (Kim et al., 2010) repeated exposure.  The most 
commonly studied endpoints included organ distribution, organ toxicity (van der Zande 
et al., 2012; Loeschner et al., 2011; Kim et al., 2008; Lee et al., 2013; Skalska et al., 
2015; Park et al., 2010a), and immunotoxicity (Ebabe Elle et al., 2013; van der Zande et 
al., 2012; Park et al., 2010a; Lee et al., 2013).  Most of the orally administered Ag was 
excreted with the faeces, hence, probably did not enter the organism at all (van der 
Zande et al., 2012).  In case Ag was detected in organs, serum, or urine it was not clear, 
whether it was taken up in particulate or ionic state.  Notwithstanding the low uptake, 
Ag could be detected in several organs, including the stomach, intestine, liver, spleen, 
kidney, testis, and brain (van der Zande et al., 2012; Loeschner et al., 2011).  Whereas 
Ag was rapidly cleared from most organs, it was found to persist surprisingly long in 
the brain and testes (van der Zande et al., 2012; Lee et al., 2013).  A bio-accumulation, 
and hence, chronic toxic effects cannot be fully excluded.  Additionally, Skalska and 
colleagues (2015) reported the occurrence of nano-sized granules in the brain structures 
of Wistar rats after oral exposure to AgNPs (10 nm) but not Ag citrate, indicating a 
nano- rather than an Ag-associated effect.  Several groups observed an increase in 
hepatotoxicity markers (Kim et al., 2010; Kim et al., 2008; Lee et al., 2013; Park et al., 
2010a), as well as indications for the induction of an immune response.  Reported 
effects included the infiltration of organs by immune cells (Lee et al., 2013; Park et al., 
2010a), increased release of cytokines (Lee et al., 2013; Park et al., 2010a; Ebabe Elle et 
al., 2013), and increase in oxidative stress markers (Ebabe Elle et al., 2013).  
Furthermore, pro-longed oral uptake of AgNPs affected the composition of the 
intestinal microbiota and induced upregulation of genes related to the gut-associated 
immune response (Williams et al., 2015). 
It has to be kept in mind that most in vivo studies are not comparable to realistic 
exposure scenarios regarding the administration (oral gavage) and concentrations.  
Whereas the average oral daily intake for Ag species (both particulate and ionic) is 
estimated between 70-90 µg (Böhmert et al., 2014), exposure concentrations of up to 
1,000 mg / kg / day were applied.  Based on a 28-day and 90-day oral exposure study a 
NOAEL (no observable adverse effects level) of 30 mg / kg bodyweight and a LOAEL 
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(lowest observable adverse effect level) of 125 mg / kg bodyweight were established 
(Kim et al., 2008; Park et al., 2010a). 
Recently, a study on AgNP-exposure in human subjects was published (Munger et al., 
2014).  Munger and colleagues administered an off-the-shelf colloidal Ag solution to a 
group of healthy volunteers over a period of 14 days.  None of the investigated 
endpoints, including white blood cell count, pro-inflammatory cytokines, and ROS, 
showed significant changes. 
 
4.1.2.2 Other exposure routes 
Dermal: Due to their bactericidal effects, AgNPs are of interest for the application in 
wound dressing or anti-bacterial ointments.  In a study with healthy human volunteers, 
AgNPs of a commercially available wound dressing were shown to be able to 
translocate across the epidermis of intact skin but did not reach systemic circulation 
(George et al., 2014).  However, wound dressings and ointments are often in contact 
with damaged areas of the skin where the barrier function is most likely impaired.  It 
remains unclear, whether AgNPs would be able to enter deeper tissue layers in this case.  
Studies on mice and guinea pigs indicated that dermally applied AgNPs might cross all 
layers of the skin and enter the systemic circulation after prolonged exposure (5 days to 
13 weeks) to concentrations between 36 and 10,000 µg / mL (Tak et al., 2015; Korani et 
al., 2013).   
Inhalation: Several in vivo inhalation studies reported pro-inflammatory reactions in 
response to short-term (Seiffert et al., 2015; Braakhuis et al., 2014) and long-term (Sung 
et al., 2008; Roberts et al., 2013) exposure to AgNPs.  Most commonly, mixed cell 
infiltration into the lung tissue was noted in rats after both single-dose and repeated 
dose exposure (Seiffert et al., 2015; Sung et al., 2008; Braakhuis et al., 2014).  AgNPs 
could translocate across the lung, enter the systemic circulation, and were distributed to 
other organs, e.g. the liver, kidney, spleen, heart and testes in mice and rats (Kwon et 
al., 2012; Takenaka et al., 2001).  Whereas AgNPs were rapidly cleared from lung 
tissue, blood, and most organs clearance in the testes was slow (Kwon et al., 2012). 
Injection: Intravenous, intramuscular, or subcutaneous exposure might occur after 
contact with medical equipment containing loosely-bound AgNPs.  Most study designs 
are based on a single exposure and varying periods of recovery time before the animals 
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were sacrificed (Rahman et al., 2009; Xue et al., 2012).  Few studies exposed animals to 
a repeated dose of particles between 2 and 28 days (Sarhan and Hussein, 2014; 
Lankveld et al., 2010; De Jong et al., 2013).  When mice were exposed intravenously, 
the particles were rapidly cleared from the blood stream and detected in various organs 
(Xue et al., 2012).  Ag was mainly found in the spleen, liver, and kidneys (Xue et al., 
2012; Dziendzikowska et al., 2012; De Jong et al., 2013; Lankveld et al., 2010).  In rats 
exposed to 5 mg / mL AgNPs, an accumulation of Ag-species was noted in the brain 
with higher deposition concentrations for 20 nm compared to 200 nm particles 
(Dziendzikowska et al., 2012).  Rahman et al. (2009) observed an upregulation of genes 
associated with oxidative stress in rats exposed to 500-1,000 mg / kg bodyweight.  Tang 
et al. (2008) noted increased levels of Ag in brain tissue of rats exposed to nano- but not 
micro-sized Ag (both 62.8 mg / kg) as well as structural changes in the brain tissue.  
After both intravenous and intraperitoneal injection of AgNPs at concentrations as low 
as 6 mg / kg bodyweight several biomarkers for renal toxicity and hepatotoxicity were 
increased in rats (Sarhan and Hussein, 2014; De Jong et al., 2013).  Apart from organ-
specific toxicity, immuno-modulating effects like increased counts of white blood cells 
(Sarhan and Hussein, 2014), infiltration of immune cells (De Jong et al., 2013), and 
organ-specific pro-inflammatory processes (Xue et al., 2012) were reported in mice and 
rats.   
 
4.1.3 Knowledge gaps concerning the exposure to AgNPs 
Even though many studies aimed to elucidate the potential health effects of AgNPs and 
Ag ions, many questions and contradicting results remain.  Deleterious effects were 
often demonstrated in vitro and to a lesser extent in vivo, but the actual risk of human 
exposure remains unclear.  From the few available human exposure studies no 
immediate concerns arise.  However, these studies did not account for prolonged 
exposure and potential accumulation of AgNPs, which might induce chronic toxicity.  
Furthermore, the great majority of in vitro and in vivo models do not account for 
impaired health conditions, e.g. IBD.  Several studies indicated that the localisation of 
NMs differs between inflamed and healthy intestinal tissue (Hassani et al., 2009; 
Schmidt et al., 2013; Lamprecht et al., 2001).  Apart from changes in the uptake, 
impaired tissue might be more susceptible to the exposure to NMs due to the continuous 
stress induced by pro-inflammatory cytokines, ROS, and RNS.  Despite this clear gap in 
the literature and the need for disease models (Lefebvre et al., 2015), only very few 
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groups attempted the development of appropriate in vitro models.  Such models are of 
utmost importance to study 
 potential pro- or anti-inflammatory effects of NMs. 
 the influence of the health status at the time of exposure on the effects of NM-
exposure. 
One of the most disputed effects is the impact of AgNPs on the immune system and 
inflammatory processes.  Several studies observed anti-inflammatory effects both in 
vitro (Parnsamut and Brimson, 2015; Shin et al., 2007) and in vivo (Hebeish et al., 
2014; Wong et al., 2009).  Other studies found AgNPs to act pro-inflammatory, e.g. 
inducing release of pro-inflammatory cytokines (Yang et al., 2012; Greulich et al., 
2011), modulation of immune cell distribution (Park et al., 2010a), induction of ROS 
(Greulich et al., 2011; Park et al., 2011; Yang et al., 2012) and RNS (Mollick et al., 
2015; Singh and Ramarao, 2012).   
 
4.1.4 Aims and hypotheses 
The aim was to study the effect of non-toxic exposure concentrations of AgNPs and 
silver nitrate (AgNO3) (as ion control) in relation to the health status of the in vitro 
model at the time of exposure.  The following hypotheses were investigated: 
 AgNO3 causes significant cytotoxicity at lower concentrations than AgNPs. 
 AgNPs and AgNO3 concentrations that were tested to be sub-toxic in UDCaco-2 
monocultures can be applied as non-toxic concentration in DCaco-2 cells. 
 A one-time exposure of the stable co-culture to non-toxic concentrations of 
AgNPs will affect at least one of the investigated endpoints. 
 A one-time exposure of the inflamed co-culture to non-toxic concentrations of 
AgNPs will affect at least one of the investigated endpoints. 
 The exposure to sub-toxic concentrations of AgNO3 will cause different effects 
than sub-toxic concentrations of AgNPs. 
 The effects induced by AgNPs and AgNO3 in the stable co-culture will be 
different from the effects in the inflamed co-culture. 
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4.2 Materials & Methods 
4.2.1 Chemicals 
Citrate, tannic acid (403040), silver nitrate (AgNO3) (209139), Alcian Blue (A5268), 
and Resazurin sodium salt (R7017) were purchased from Sigma. 
 
4.2.2 AgNPs synthesis 
The particles were kindly synthesised by Rita La Spina from the ‘Synthesis & 
Characterisation’ (S&C) CG (NBS Unit, JRC, Italy).  The synthesis of AgNPs is carried 
out by reduction of AgNO3 with citrate and tannic acid according to a modified 
procedure described by Dadosh (2009).  For the synthesis, 120 µl of tannic acid (2x10
-3
 
M) were added to 6 ml of citrate (28 mM) and stirred at 60°C for 15 min.  
Subsequently, 6 ml of the solution were added to 94 ml of 0.55 mM AgNO3 in boiling 
condition and vigorous stirring and kept at 97°C for 40 min.  The solution was heated 
using a microwave synthesis reactor (Discover S, CEM Corporation).  The suspension 
was rapidly cooled down to 40°C and subsequently RT.  Every batch of AgNPs was 
characterised after synthesis to confirm compliance with previous particle 
characteristics.  For dispersant controls, 5 mL of the particle suspension were 
centrifuged (5,000 rpm, 20 minutes) to sediment the particles.  Of the supernatant 90 % 
were taken from the sample and stored separately at 4°C.  This solution primarily 
contained H2O and citrate, but also low concentrations of non-reacted tannic acid and 
AgNO3 could have been present. 
The particle stock suspension was analysed for potential endotoxin contamination using 
a commercially available endotoxin quantitation kit (Thermo Fisher Scientific, 88282) 
according to the manufacturer’s instructions.  The analysis was kindly performed by 
Sabrina Gioria from the IBS CG (NBS Unit, JRC, Italy).  No endotoxin contamination 
was detected.  
 
4.2.3 Characterisation 
The AgNPs were characterised in dispersant, as well as after 0, 4, 24, and 48h 
incubation in MEM-based CCM (Section 2.1.2) at standard culture conditions.  All 
particle suspensions had a concentration of 5 µg / mL. 
112 
4.2.3.1 Dynamic Light Scattering (DLS) 
The particle size distribution of AgNPs was determined by DLS using a Zetasizer Nano-
ZS (Malvern Ltd, UK). Each sample was measured in triplicate at 25°C after an 
equilibration step of 120 seconds and using an acquisition time of 80 seconds. The 
hydrodynamic diameter was calculated by the DLS internal software. 
 
4.2.3.2 Centrifugal Liquid Sedimentation (CLS) 
CLS was used to determine the particles’ hydrodynamic diameter in dispersant and 
CCM.  The disc centrifuge (CPS Instruments, CD24000UHR) was run at 22,000 rpm.  
A sucrose gradient was established ranging from 8-24 % (w/w) by successively 
injecting 9 varying ratios of a low density (2 g in 23 g H2O) and a high density (6 g in 
19 g H2O) sucrose solution and capped with 0.5 mL of dodecane.  The gradient was 
allowed to equilibrate for a minimum of 30 min.  The gradient’s quality was confirmed 
with a reference particle analysis (AgNPs 40 nm, Sigma Aldrich, 730807).  A PVC 
calibration standard (0.1 mL) was measured prior to each sample to validate the 
gradient’s stability.  Each sample was injected in a volume of 0.1 mL.   
 
4.2.3.3 Spectroscopy using UV-Visible 
The AgNPs suspension was analysed with UV-Vis to study the particle size and 
integrity in dispersant, as well as in CCM.  For the measurement, 1 mL of particle 
suspension was pipetted into clear plastic cuvettes.  The baseline was set with water for 
a wavelength spectrum of 300 to 800 nm.  The measurement interval was set to 0.2 nm.  
Each sample was measured three times.  The result is presented as the average of three 
runs.  A background analysis of the appropriate medium was included and subtracted 
from the AgNP suspension results. 
 
4.2.3.4 TEM analysis 
TEM imaging and analysis was kindly performed by Isaac Ojea Jiménez from the S&C 
CG (NBS Unit, JRC, Italy).  For TEM imaging, ultrathin Formvar-coated 200-mesh 
copper grids (Tedpella Inc.) were coated with Alcian Blue as described by Mast and 
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Demeestere (2009).  The grids were placed onto a drop a particle suspension for 20 min.  
The particles were visualised using a TEM (JEOL 2100, Japan), at an accelerating 
voltage of 200 kV.  Energy-dispersive X-ray spectroscopic (EDS) analysis was 
performed with a QUANTAX EDS detector for TEM (Bruker, USA) in automatic 
acquisition mode and with the same background correction.  Samples were stored at 
4°C protected from light and analysed within 5 days of sample preparation.  The images 
were subsequently analysed using the software ImageJ. 
 
4.2.4 Cell culture 
Caco-2 and THP-1 cells were cultured and maintained as described in Section 2.1.2.   
Stable co-culture: For PMA-differentiation, THP-1 cells were seeded in 25 cm
2
 culture 
flasks (3-3.5x10
5 
cells in 6 mL CCM) and exposed to 100 nM PMA for 24h.  After the 
differentiation, the adherent cells were washed once with 5 mL pre-warmed PBS.  
Subsequently, 1 mL pre-warmed Accutase was added to the flask and incubated for 5-
10 min at 37°C.  The cells were collected and counted in 3 mL fresh pre-warmed CCM.  
An adequate volume of the cell suspension was transferred to a 12-well plate to achieve 
a final density of 1.8x10
5
 THP-1 cells / well.  Additional fresh CCM was added to 
obtain a final volume of 1 mL / well and the cells were left to re-attach for 1.5 h at 
standard culture conditions.  After exchanging the supernatant with 1.5 mL fresh RPMI-
based CCM without mercaptoethanol, a transwell insert with DCaco-2 cells was 
transferred to each well to start the co-culture.  All experiments were performed without 
mercaptoethanol since Ag is known to form complexes with thiol-groups (Hsiao et al., 
2015), which otherwise could have influenced the outcomes. 
Inflamed co-culture: Before the start of the co-culture, Caco-2 layers were basolaterally 
primed for 18-24h with 10 ng / mL IFN-γ as described by Wang et al. (2005).  After the 
priming, the supernatant was discarded and the BL side of the cell layer washed twice 
with 1 mL pre-warmed PBS.  The cells were left to recover for 2 h before starting the 
co-culture.  THP-1 cells were culture, differentiated, detached and plated as described 
above.  After the cells re-attached to the well bottom, the supernatant was exchanged 
with 1.5 mL fresh CCM containing LPS and IFN-γ (10 ng / mL each).  The cells were 
stimulated for 4h at standard culture conditions before starting the co-culture.  
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In each exposure experiment an unexposed control of all three culture models (Caco-2 
monoculture, stable, and inflamed co-culture) was included.  The control co-cultures 
had to fulfil the criteria defined earlier (Section 2.2.3.1 & 2.2.4.1).   
The transwell cultures were monitored with regular measurements of TEER (Section 
2.1.4) at the start of the co-culture, as well as after 4, 18, 24, 28 and 48h. 
 
4.2.5 AgNPs and AgNO3 exposure 
96-well plate: Caco-2 cells were seeded onto a flat-bottom plate at 1x10
4
 cells / well and 
maintained for 72h at standard culture conditions.  THP-1 cells were seeded at a density 
of 4x10
4 
cells / well and differentiated with 100 nM PMA for 24h.  The AgNPs and 
AgNO3 exposure suspensions/solutions were prepared freshly before each experiment 
by diluting the stock suspension (0.5 and 0.55 mM, respectively) to 0.02-20 µg / mL in 
fresh CCM.  For the exposure, the cell supernatant was discarded and replenished with 
50 µL fresh CCM / well.  By adding 50 µL of the AgNP suspension or the AgNO3 
solution the exposure concentrations were diluted 1:2, eventually ranging from 0.01-10 
µg / mL.  After 24-48h of exposure, the supernatants were collected for the 
quantification of LDH (Section 3.2.3) before the metabolic activity was measured using 
the Alamar Blue assay (Section 4.2.6).  Subsequently, the cells were used for high 
content analysis (HCA) using the IN Cell Analyzer (Section 4.2.8). 
Transwell plates: For transwell experiments, non-toxic exposure concentrations of 
AgNPs and AgNO3 were chosen based on the cytotoxicity results in UDCaco-2 
monocultures.  The Caco-2 monoculture and both co-culture models were set up as 
described before (Section 4.2.4) and allowed to equilibrate for 24h before being exposed 
to 1 or 10 µg / mL AgNPs or AgNO3 equivalent to 1 µg / mL AgNPs.  For AgNPs, the 
exposure suspension was prepared as described above.  Briefly, a suspension containing 
2 or 20 µg / mL AgNPs was prepared in fresh CCM.  By transferring 250 µL of the 
suspension to 250 µL CCM in the AP compartment a final exposure concentrations of 1 
and 10 µg / mL AgNPs, respectively, were obtained.  The AgNO3
 
(stock: 0.55 mM) was 
directly added to the CCM in the AP compartment. 
The exposed transwell cultures were analysed for various endpoints (Figure 4.1).  After 
4h of co-culture (T4) and 4 and 24h of exposure (T28 and T48), supernatant samples were 
taken from the BL compartment for the quantification of pro-inflammatory cytokines 
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(Section 4.2.9).  At the end of the co-culture (T48), both AP and BL supernatants were 
analysed for LDH release (Section 4.2.7) and NO generation (Section 3.2.4).  
Subsequently, the cells were fixed in 3.7 % formaldehyde and used for HCA using the 
IN Cell Analyzer (Section 4.2.8). 
 
 
Figure 4.1 Schematic overview of the co-culture and exposure time line 
 
4.2.6 Alamar Blue assay 
The Alamar Blue Assay was used to study the cytotoxic effect of AgNPs and AgNO3 
UDCaco-2 and THP-1 monocultures via the quantification of metabolic activity.  
After 24-48h exposure to AgNPs or AgNO3, the cells were washed twice with HBSS.  
Subsequently, 100 μL fresh CCM containing 100 μM Resazurin was added to each well 
and the plates incubated for 2h at standard culture conditions.  The fluorescence was 
measured spectrophotometrically at 530 nm emission and 590 nm excitation 
wavelength.  Each experiment included a negative control, a dispersant control, a 
positive control (20 µM sodium chromate), and a blank in cell-free CCM.  The results 
were corrected for the blank and expressed as metabolic activity in % of the negative 
control.  
 
4.2.7 LDH assay 
The LDH assay was used to study the cytotoxic effect of AgNPs and AgNO3 via the 
enzymatic activity of LDH after 24-48h exposure.  The assay was mainly used for the 
assessment of cytotoxicity after cellular exposure in transwells. Sample acquisition and 
analysis was performed as described earlier (Section 3.2.3). 
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4.2.8 IN Cell Analyzer: Count of DAPI-stained nuclei 
To confirm the results obtained from the Alamar Blue and / or LDH assay an 
automatized cell count was performed based on the imaging and analysis of DAPI-
stained nuclei with the IN Cell Analyzer 2200 (GE Healthcare, UK).  The image 
acquisition and analysis was kindly performed by Patricia Urbán from the IBS CG 
(NBS Unit, JRC, Italy). 
After the exposure to AgNPs, AgNO3,
 
and / or at the end of the co-culture, Caco-2 cells 
were stained as described in Section 2.1.6.   
96-well plates:  During acquisition, a minimum of 12 fields were imaged per well using 
a 20x objective.  The data analysis was performed on the IN Cell Investigator Software 
(GE Healthcare, UK) using in-house developed protocols with a minimum of 10,000 
cells in the negative control.  The cell viability was calculated by determining the 
percentage of nuclei in the exposure conditions compared to the number of nuclei in the 
negative control.   
Transwell plates: During acquisition, a minimum of 12 fields per filter were imaged 
using a 60x objective.  To obtain a higher resolution, images were acquired as a z-stack 
of three images (1 µm each), which was eventually converted into a 2D image using the 
IN Cell Investigator Software.  The data analysis was performed on the IN Cell 
Investigator Software and in-house developed protocols.  The analysis protocol was 
developed using three different targets for the nuclei: seed, nuclei, and bright nuclei.  
The ‘seeds’ were analysed to enable an accurate segmentation of the nuclei, since the 
filter-grown monolayers contained high numbers of densely packed and partially 
overlaying cells.  The ‘nuclei’ target was used to count the total number of cells in each 
sample.  The ‘bright nuclei’ target was defined to identify small excessively bright 
nuclei that were seen in some of the experimental conditions.  Using these three targets, 
the analysis protocol measured in each condition: the number of nuclei, the number of 
bright nuclei, the total intensity of the nuclei, the intensity of the bright nuclei, the total 
intensity per cell number, and the percentage of bright nuclei per total number of nuclei.  
4.2.9 Cytokine quantification  
Apart from the analysis of IL-1β, IL-8, and TNF-α with conventional ELISA (Section 
2.1.8), the concentrations of MCP-1, MIP-1α, IFN-γ, IL-4, IL-6, and Granulocyte 
Macrophage Colony-Stimulating factor (GM-CSF) were quantified using a magnetic 
bead-based assay analysed with the Bio-Plex MAGPIX Multiplex Reader (Bio-Rad, 
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171B50-004, 006, 018, 019, 021, 022, 026).  For the analysis, supernatant samples were 
taken from the BL compartment at T28 (Figure 4.1).   
The magnetic anti-cytokine beads (25x stock) were diluted 12.5-times in Bio-Plex 
Assay Buffer and a master mix was prepared of all anti-cytokine beads at equal 
concentrations.  To each well, 25 µL of master mix were added and washed 3x with 100 
µL washing buffer before addition of samples, standards, or the blank.  Of monoculture 
and stable co-culture supernatants 50 µL were added to each well.  The supernatant 
samples of inflamed co-cultures were first diluted 1:2 in diluent buffer.  After addition 
of the samples, the plate was incubated for 30 min at RT on a shaker.  After 3 washing 
steps, 12.5 µL of the detection antibody master mix (1:25 dilution in antibody diluent) 
were added to each well and the plate incubated for 30 min at RT on a shaker.  After 3 
washing steps, the wells were incubated with 25 µL streptavidin-PE (1:100 diluted in 
Assay Buffer) and incubated for 10 min at RT on a shaker.  All wells were washed and 
the beads re-suspended in 150 µL Assay Buffer for the read-out (Bio-Plex MAGPIX, 
Bio-Rad).  For each plate a standard curve (8 concentrations plated in duplicate), as well 
as two blanks were included.  The results were analysed as 4 parameter logfit.  Parts of 
the sample analysis were kindly performed by Dr. Nilesh Kanase from the Nano-Safety 
Research Group at Heriot-Watt University (Edinburgh, UK). 
 
4.3 Results  
4.3.1 Characterisation of AgNPs 
After the synthesis, the AgNPs suspension showed a clear, brown-orange colour without 
visible particulate matter or sediments.  Stored at 4°C and protected from light, the 
AgNPs suspension remained stable with no visible signs of particle precipitation or 
sedimentation over the course of 6 months (not shown).  The characteristics of AgNPs 
were studied in dispersant and CCM at relevant cell exposure concentrations and 
conditions.  The results obtained with TEM, CLS, and DLS are summarised in Table 
4.1.  
Table 4.1 Characterisation of AgNPs in dispersant and cell culture medium 
118 
 
Nota bene: CLS and DLS results do not account for decreased density of the particles 
resulting from protein corona formation.  
 
The quantitative analysis of TEM-acquired images resulted in an average diameter of 23 
± 4.2 nm in dispersant with a low-level occurrence of rod-shaped particles (Figure 4.2).  
The imaging of AgNP suspensions in CCM and subsequent analysis showed an 
increasing heterogeneity and particle size changes after extended incubation up to 48h.  
Whereas the particles were evenly shaped and feature a clear-cut border in dispersant, 
they appeared to bleb in CCM, resulting in the presence of smaller particles (Figure 
4.2A).  This formation of smaller ‘satellite’ particles with a size of 2-5 nm was also 
notable in the quantitative image analysis of the time points and the resulting average 
particle size and size distribution (Figure 4.2B).  After 48h incubation, the average 
particle size decreased from 23 nm in dispersant to ~19.1 nm in CCM.  The appearance 
of a second population of smaller particles resulted in an increased StDev (from 4.21 
nm for pristine particles to 8.34 nm after 48h in CCM).  
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Figure 4.2 TEM imaging of AgNPs in dispersant and CCM and quantitative analysis  
(A) Representative TEM images; (B) Quantitative analysis of AgNPs in dispersant (pristine) and after 4, 
24, and 48h incubation in CCM at 37°C, 5 % CO2 (The graphs were kindly provided by Isaac Ojea 
Jiménez.) 
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The measurements of hydrodynamic diameter by CLS confirm the observations by 
TEM.  In dispersant, an average hydrodynamic diameter of 23.6 ± 1.3 nm (Figure 4.3A) 
was measured.  The slight shoulder on the left side of the peak (Figure 4.3A) suggested 
the occurrence of rod-shaped particles in the suspension.  When incubated in CCM 
(Figure 4.3B), the AgNP-associated peak intensity gradually reduced to 57 % of AgNPs 
in dispersant after 48h.  Furthermore, a left-shift of the peak was noted indicating a 
reduction of the average hydrodynamic diameter to 18.3 nm after 48h. 
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Figure 4.3 Hydrodynamic diameter of AgNPs according to CLS 
(A) Stock suspension of AgNPs in dispersant (59 µg / mL); B) AgNPs suspended in dispersant or MEM-
based CCM (5 µg / mL) after 4-48h (T4-T48 MEM) incubation at 37°C, 5 % CO2  
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The DLS analysis of the particles revealed a high polydispersity index (PDI) in both 
dispersant and CCM (>0.5 and >0.4, respectively), indicating a substantial 
heterogeneity of the suspension.  The suspected heterogeneity in dispersant was 
reflected in the occurrence of two peaks in the corresponding DLS graph at 37.21 nm 
(~72%) and 2.97 nm (~28%) (Error! Reference source not found.).  In dispersant, the 
Z-average was 13.09 nm.  In CCM, the DLS analysis showed a slightly decreased PDI 
(0.443-0.482) compared to the measurement in dispersant.  After 4h incubation in 
CCM, the average size of both peaks increased to roughly 77 and 10 nm.  Whereas the 
second population with a size of ~10 nm remained constant throughout the incubation 
of 48h, the average size of the larger sized population varied reaching an average of 67 
nm after 24h and 83 nm after 48h incubation.  It is unclear whether the population of 
small AgNPs is affected by aggregation / agglomeration or the formation of a protein 
corona after incubation in CCM.  Alternatively, the population might not have changed 
but its signal is overlaid by large quantities of serum protein in the CCM.  The latter 
could explain why the average size of the first peak remains stable at ~10 nm, whereas 
the average diameter of the second peak changed considerably over a period of 48h.  
The UV-Vis spectrum of AgNPs in dispersant (Figure 4.4A) showed a surface plasmon 
resonance peak at around 400 nm, which is characteristic for nearly-monodisperse 20-
30 nm AgNPs (Oldenburg, accessed 2016).  Over an incubation time of 24h at standard 
culture conditions no change in the spectrum was observed.  When incubated in CCM, 
however, the UV-Vis spectrum showed a progressive reduction in AgNP-associated 
peak intensity, as well as an absorbance shift to higher wavelengths (Figure 4.4B). 
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Figure 4.4 Absorbance of AgNPs in (A) dispersant amd (B) CCM as measured by UV-Vis 
Absorbance was measured immediately after addition to CCM (green), or after 4h (red), 24h (blue), and 
48h (black) incubation in CCM at 37°C, 5 % CO2 
 
4.3.2 Cytotoxic potential of AgNPs and AgNO3 
The cytotoxic potential of AgNPs and AgNO3 was investigated in monocultures of 
PMA-treated THP-1 cells, non-confluent, and confluent UDCaco-2 cells.  In Caco-2 
cells, cytotoxicity was studied by assessing the metabolic activity with the Alamar Blue 
assay, LDH release, and number of cells per well by HCA of DAPI-stained nuclei.  
AgNO3 served as ion control.  For THP-1 cells, only the metabolic activity and LDH 
release were quantified.  
Since the transwell cultures will be exposed from the AP side only, Caco-2 cells will 
most likely be in contact with higher concentrations of AgNPs than the underlying 
THP-1 cells.  Furthermore, studies on the translocation across the intestinal barrier of 
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NMs so far indicate little to no passage of particles (Schleh et al., 2012; Schmidt et al., 
2013).  Therefore, higher concentrations were used for the cytotoxicity studies on Caco-
2 than for THP-1 cells (1-10 µg / mL vs. 0.01-10 µg / mL, respectively). 
Studying the toxicity of AgNPs and AgNO3 in Caco-2 cells was a two-step approach.  
Firstly, monocultures of UDCaco-2 cells were used to establish a range of non-toxic 
exposure concentrations.  Subsequently, these concentrations were used for exposure 
experiments using the co-culture models and DCaco-2 monocultures as controls.  
Performing the cytotoxicity testing on UDCaco-2 cells was decided for several reasons: 
1) Methodological limitations:  Initial experiments on DCaco-2 transwell cultures 
showed that colorimetric assays might not adequately reflect cellular well-being.  
For instance, whereas the results obtained with the Alamar Blue assay suggested no 
change in metabolic activity both measurement of TEER and fluorescent imaging 
of the cells’ nuclei showed significant damage of the cell layer (data not shown). 
2) As has been shown in the past, Caco-2 cells normally become less sensitive to 
stressors with increasing confluence and state of differentiation (Gerloff et al., 
2013; McCracken et al., 2015).  Since this study aimed to investigate the effect of 
non-toxic concentrations it was decided to establish the exposure dose using the 
most sensitive (undifferentiated/sub-confluent) and medium sensitive 
(undifferentiated/confluent) state of the cells.  The notion was that any 
concentration not inducing an effect in these conditions most likely does not induce 
adverse effects in DCaco-2 cultures.  
3) Financial considerations: The use of transwell cultures is more cost intensive than 
the application of standard cell culture plates.  Firstly, the transwell inserts and 
compatible well plates need to be purchased.  Secondly, the cultures had to be 
maintained over a period of three weeks, which required larger quantities of serum-
containing CCM than a 72h cell culture in 96-well plates. 
 
4.3.2.1 Metabolic activity quantified with the Alamar Blue assay 
As presented in Figure 4.5A, concentrations of up to 10 µg / mL of AgNPs did not 
induce a reduction in metabolic activity after 24-48h of exposure in confluent UDCaco-2 
cells.  It was noted that the confluence of the cells at the time of exposure greatly 
influenced the cells’ vulnerability.  Whereas 10 µg / mL AgNPs did not induce any 
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observable effect in confluent UDCaco-2 cells, a significant reduction (p≤0.001) in 
metabolic activity by 27 and 30 % after 24h and 48h exposure, respectively, was 
observed in sub-confluent UDCaco-2 cells (Figure 4.5A, 10 SC).   
In contrast to AgNPs, the exposure to AgNO3 reduced the metabolic activity in dose-
dependent manner starting from concentrations equal to 4 μg / mL AgNPs (Figure 
4.5B).  No significant differences were observed between 24 and 48h exposed cells.  
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Figure 4.5 Metabolic activity of Caco-2 cells measured with the Alamar Blue assay after 24 and 48h 
exposure to (A) AgNPs and (B) AgNO3  
(Average of N=3 ± StDev; *p≤0.05 compared to corresponding control) 
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The THP-1 cells were expected to be exposed to a much lower concentration of AgNPs, 
if any at all.  Hence, a range including lower exposure concentrations was chosen to 
assess the cytotoxic potential of AgNPs in PMA-treated THP-1 cells (Figure 4.6).  
AgNPs concentrations of up to 10 µg / mL did not induce a significant reduction in 
metabolic activity in PMA-treated THP-1 cells after 48h exposure.   
 
 
Figure 4.6 Metabolic activity of THP-1 cells measured with the Alamar Blue assay after 48h 
exposure to AgNPs  
(Average of N=3 ± StDev) 
 
Furthermore, AgNO3 exposure concentrations of up to 1 µg / mL did not cause a 
significant reduction in metabolic activity (not shown). 
 
4.3.2.2 Quantification of LDH release in UDCaco-2 cells 
As shown in Figure 4.7A, neither 24h nor 48h exposure to AgNPs resulted in an 
increased release of LDH from UDCaco-2 cells at concentrations below 10 µg / mL.  
After 24h and 48h of exposure to 10 µg / mL, the LDH release was slightly increased 
compared to the negative control.  The changes were not statistically significant 
(p=0.741 and p=0.097, respectively). 
After 24h exposure to AgNO3 (Figure 4.7B), the levels of LDH were significantly 
increased in cultures treated with 6 and 8 µg / mL AgNO3.  After 48h, a dose-dependent 
increase in LDH activity was detected at exposure concentrations between 2 and 6 µg / 
mL AgNO3 (Figure 4.7B).  For exposure concentrations between 4 and 6 µg / mL 
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AgNO3 the increase in LDH release was statistically significant (p≤0.006).  
Interestingly, at exposure concentrations ≥8 µg / mL AgNO3 the enzymatic activity 
increased after 24h exposure, whereas it decreased in samples treated for 48h. 
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Figure 4.7 LDH release of Caco-2 cells after 24h and 48h exposure to (A) AgNPs and (B) AgNO3  
(Average of N=3 ± StDev; *p≤0.05 compared to corresponding control) 
 
4.3.2.3 HCA of DAPI-stained Caco-2 nuclei 
In addition to the quantification of metabolic activity and LDH release the cytotoxic 
effect of AgNPs and AgNO3 on UDCaco-2 cells was quantified with the analysis of 
DAPI-stained nuclei using the IN Cell Analyzer (Figure 4.8).   
The analysis showed that 24h exposure to up to 10 µg / mL AgNPs did not induce a 
significant reduction in cell number compared to the negative control (Figure 4.8A).  
Surprisingly, after 48h exposure the cell numbers were significantly reduced for 
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exposure concentrations of 4 and 6 µg / mL (p=0.003 and p=0.044, respectively).  At 
lower and higher concentrations of AgNPs no significant differences were detected.  
In cultures exposed to AgNO3, the cell numbers reduced drastically in a dose-dependent 
manner from concentrations as low as 4 µg / mL (Figure 4.8B).  The cell numbers were 
slightly but not significantly lower after 24h compared to 48h exposure.  At the highest 
exposure concentration of 10 µg / mL AgNO3 virtually no cells remained in the wells. 
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Figure 4.8 Quantification of DAPI-stained nuclei after 24 and 48h exposure to (A) AgNPS and (B) 
AgNO3  
(Average of N=2, Dispersant and AgNO3 10 µg / mL: Average of n=3 from one experiment ± StDev; 
*p≤0.05 compared to corresponding control) 
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4.3.3 Exposure of transwell cultures to AgNPs and AgNO3 
The Caco-2 monoculture, stable, and inflamed co-cultures were established as described 
earlier.  The cultures were used as unexposed controls or exposed to AgNPs (1 or 10 µg 
/ mL) or AgNO3 (Ag-equivalent to an exposure concentration of 1 µg / mL AgNPs).  
 
4.3.3.1 TEER 
To monitor the course of the co-cultures and exposures, the TEER was measured before 
the start of the co-culture (T0) as well as after 4, 18, 24, 28 (i.e. 4h after exposure to 
AgNPs or AgNO3) and 48h (i.e. 24h exposure to AgNPs or AgNO3) of co-culture 
(Figure 4.1 and Table 4.2).  The results are grouped according to the type of exposure (1 
or 10 μg / mL AgNPs, and AgNO3) and summarised in Figure 4.9A-C.  
 
Table 4.2 Culture and exposure time points for Caco-2 monoculture, stable, and inflamed co-
culture 
 
 
In the three exposure scenarios, the three culture models (monoculture, stable, and 
inflamed co-cultures) were directly compared to an unexposed control of each culture 
model (Figure 4.9, dotted lines).  For reasons of practicality only the StDev of the 
exposed cultures are shown.  The StDev of the control conditions were within 3.9-9.2 % 
(monoculture), 2.8-10.3 % (stable co-culture), and 2.3-7.6 % (inflamed co-culture).  The 
control culture conditions were run additionally in each experiment.   
The stable co-culture control was in line with the requirements defined earlier:  The 
TEER did not differ significantly from the monoculture control at any of the 
investigated time points.  In contrast, the TEER of the inflamed co-culture reduced 
rapidly by ≥25 % compared to the monoculture.  From the start (T0) until 28h of co-
culture (T28) the TEER of the inflamed condition was significantly reduced compared to 
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the monoculture (p≤0.001) (Figure 4.9A-C; statistical significance not marked).  At T48, 
the TEER of the inflamed co-culture was fully re-established compared to the 
monoculture control. 
As presented in Figure 4.9A, a very low non-toxic concentration of 1 μg / mL AgNPs 
did not induce a significant effect on the TEER over an exposure period of 24h in any of 
the three culture models.   
When increasing the concentration to 10 μg / mL (Figure 4.9B), the TEER dropped 
significantly (p≤0.003) by 8-14 % in all three culture models after 4h of exposure (T28).  
After 24h of exposure (T48), the TEER of the Caco-2 monoculture and stable co-culture 
recovered and were equal to the results of the unexposed controls.  In the inflamed co-
culture, the TEER was significantly increased (p≤0.001) above the control (127 ± 17.9 
%) after 48h of co-culture / 24h of exposure.   
To be able to distinguish potential nano-Ag effects from ion effects, AgNO3 was 
included as ion control (Figure 4.9C).  The concentration roughly equals the amount of 
Ag atoms in an exposure concentration of 1 μg / mL AgNPs.  Hence, this dose 
represents the worst case scenario of a complete dissolution of the particles over an 
exposure time of 24h.  After the first 4h of exposure, no statistically significant 
differences in TEER were noted in any culture condition.  In the inflamed co-culture, 
24h exposure to AgNO3 induced a significant (p≤0.001) increase (133 ± 9.9 %) in 
TEER compared to the Caco-2 monoculture control.  Exposure to AgNO3 also induced 
a significant (p≤0.003) TEER increase in the Caco-2 monoculture (120 ± 9.6 %) and 
stable co-culture (116 ± 8.4 %) after 48h.  
 
 
130 
A 
 
B 
 
C 
 
Figure 4.9 Barrier integrity measured as TEER over 48h exposure to (A) 1 µg / mL AgNPs, (B) 10 
µg / mL AgNPs or (C) AgNO3 (equivalent to 1 µg/mL AgNPs) in Caco-2 monoculture, stable, and 
inflamed co-culture 
Black line marks start of exposure (Average of N≥3 ± StDev, *p≤0.05 monoculture compared to 
corresponding control; 
#p≤0.05 stable co-culture compared to corresponding control, +p≤0.05 inflamed 
co-culture compared to corresponding control)  
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4.3.3.2 LDH release in Caco-2 monoculture, stable, and inflamed co-cultures 
The LDH assay was used to quantify potentially occurring necrotic cell death in AgNPs 
and AgNO3-exposed transwell cultures.  As before, the LDH activity was measured in 
AP and BL supernatants collected at T48. 
Similar to earlier results (Section 3.3.1.3), no differences in LDH release were observed 
in the AP supernatants of the monoculture and stable co-culture (Figure 4.10).  In the 
BL samples of the stable co-culture, a slight non-significant increase in LDH release 
was noted compared to the Caco-2 monoculture (0.14 ± 0.04 vs. 0.16 ± 0.04).  In 
inflamed co-culture supernatants, the LDH release was significantly increased in both 
AP and BL compartment.   
The exposure to 1 µg / mL AgNPs did not induce an increase in LDH levels compared 
to the control values in any of the three culture models.  The LDH release in the 
inflamed co-culture control was still significantly higher in the AP and BL compartment 
compared to the monoculture control (p≤0.001 and p=0.004, respectively), but not 
different from the inflamed co-culture control (p=0.646 and p=0.528, respectively).  In 
the AgNP-exposed stable co-culture control, the LDH content of BL supernatants was 
slightly but significantly (p=0.03) decreased compared to the stable co-culture control.  
After 24h exposure to 10 µg / mL AgNPs the LDH content of AP supernatants was 
significantly (p≤0.006) increased in all three culture models compared to the 
monoculture control (Figure 4.10).  The effect was most pronounced in the inflamed co-
culture with a 2.1-fold and 3.7-fold increase compared to the inflamed co-culture 
control and monoculture control, respectively.  In the exposed monoculture and stable 
co-culture the increase was less clear with 1.12- and 1.14-fold compared to the 
monoculture control, respectively.  In the BL supernatants, no change was noted for the 
monoculture and stable co-culture.  In inflamed co-cultures, the BL LDH release was 
significantly increased compared to the unexposed Caco-2 monoculture (p=0.001), but 
not compared to the unexposed inflamed co-culture (p=0.801).   
The exposure to AgNO3 also resulted in higher AP LDH levels in the monoculture and 
stable co-culture with an increase of 1.29 and 1.57 compared to the corresponding 
control (Figure 4.10).  In the inflamed co-culture, the AgNO3 treatment induced a LDH 
release which was slightly lower than after exposure to 10 µg / mL AgNPs but still 
significantly higher compared to the inflamed and monoculture controls (p≤0.001). 
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Figure 4.10 LDH release in Caco-2 monoculture, stable, and inflamed co-cultures with and without 
24h exposure to AgNPs or AgNO3  
Cultures were exposed to AgNPs (1 or 10 µg / mL) or AgNO3 (equivalent to 1 μg / mL AgNPs) (Average 
of N≥3 ± StDev; *p≤0.05 compared to monoculture control, +p≤0.05 compared to stable co-culture 
control; 
#p≤0.05 compared to inflamed co-culture control) 
 
4.3.3.3 Cytokine release 
The cytokine release was investigated in BL supernatants after 4h (T28) and 24h of 
exposure (T48) to AgNPs (1 or 10 μg/mL) and AgNO3.  Supernatants collected after 4h 
exposure were analysed for TNF-α, IFN-γ, IL-4, IL-6, MIP-1α, MCP-1, and GM-CSF 
(Figure 4.11 and Figure 4.12).  The supernatant samples collected after 24h of exposure 
were analysed for the presence of TNF-α, IL-8, and IL-1β (Figure 4.13). 
 
4.3.3.3.1 Cytokine release after 4h exposure 
For 6 out of the 7 investigated cytokines the results are expressed in pg / mL.  For MIP-
1α, the concentrations in the inflamed co-culture were above the detection limit (Table 
4.3) even after 1:2 dilution of the supernatants.  Therefore, the MIP-1α results were 
expressed as the FI for all three culture models as measured by the Magpix Bioplex 
instrument. 
 
133 
Table 4.3 Upper and lower limits of detection of the investigated cytokines according to the 
information made available by the manufacturer 
 
 
In the Caco-2 monoculture, most of the investigate cytokines were present at 
concentrations close to or below the detection limit (Figure 4.11A, white bars).  Only 
GM-CSF and MIP-1α (Figure 4.11B) were released at slightly higher concentrations, 
however, with high StDev.   
In the unexposed stable co-culture, MIP-1α, MCP-1, and GM-CSF were present at 
concentrations above the detection limit (Figure 4.11, grey bars).  Compared to the 
monoculture, GM-CSF was expressed at slightly lower concentrations (76 ± 96 vs. 124 
± 155 pg / mL).  Of MIP-1α and MCP-1 only the levels of the former were significantly 
higher (p=0.012) in the stable co-culture compared to the monoculture.  
In contrast to the monoculture and stable co-culture, most of the investigated cytokines 
were released at high concentrations in the inflamed co-culture control (Figure 4.11, 
black bars).  The levels of TNF-α, IFN-γ, IL-6, MCP-1, and MIP-1α were significantly 
increased compared to both the monoculture and stable co-culture (p≤0.001).  The 
concentrations of IL-4 and GM-CSF did not change.   
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Figure 4.11 Cytokine release after 28h Caco-2 monoculture, stable, or inflamed co-culture  
(A) TNF-a, IFN-γ, IL-4, IL-6, MCP-1 and GM-CSF expressed in pg / mL, (B) MIP-1α expressed as FI 
(Average of N=6 ± StDev; *p≤0.05 compared to monoculture, #p≤0.05 compared to stable co-culture) 
 
For some cytokines, the release varied considerably between the individual exposure 
scenarios.  Therefore, the effects of AgNPs and AgNO3 exposure were expressed in % 
compared to the corresponding control condition (Figure 4.12A-C).  GM-CSF 
concentrations did not change between the culture models and exposure conditions 
remained close to or below the detection limit.  Therefore, the cytokine was excluded 
from the following graphs.  
In the exposed Caco-2 monocultures (Figure 4.12A), TNF-α, IFN-γ, IL-6, and IL-4 
remained below the detection limit of the assay.  In 2 replicates of the cultures exposed 
to AgNO3 the release of MIP-1α was greatly increased.  In the majority of the samples, 
however, the concentrations remained comparable to the unexposed control.  The 
A 
 
B 
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exposure to 1 and 10 µg / mL AgNPs induced a non-significant increase in the levels of 
MCP-1 to 330 ± 655 and 223 ± 184 % of the control.   
In the stable co-culture (Figure 4.12B), TNF-α, IFN-γ, IL-6, and IL-4 were below the 
detection limit.  After the exposure to 10 µg / mL AgNPs, both MIP-1α and MCP-1 
were reduced to 21 ± 17 and 44 ± 33 % of the unexposed control.  For MCP-1 the 
reduction was statistically significant (p=0.033). 
In contrast, all cytokines were detected in the exposed inflamed co-cultures (Figure 
4.12C), IL-4 remained close to the detection limit with a maximum of 2.5 pg / mL.  
Neither the exposure to AgNPs nor AgNO3 caused statistically significant changes in 
the release of cytokines compared to the inflamed co-culture control. 
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Figure 4.12 Relative change in the release of cytokines after 4h exposure to AgNPs (1 or 10 µg / mL) 
or AgNO3 (equivalent to 1 µg / mL AgNPs) in (A) Caco-2 monoculture, (B) stable, or (C) inflamed 
co-culture compared to the corresponding unexposed control 
(Average of N=3 ± StDev, 
#p≤0.05 compared to unexposed stable co-culture control; BD = below 
detection limit) 
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4.3.3.3.2 Cytokine release after 24h exposure 
After 48h of co-culture, a clear difference in the release of IL-1β, IL-8, and TNF-α was 
detectable between the controls of the three culture models (Figure 4.13A-C).  In the 
Caco-2 monoculture, IL-1β and TNF-α are expressed at concentrations close to or 
below the assay’s detection limit (0.6 ± 1.02 and 3.9 ± 6.4 pg / mL respectively) (Figure 
4.13A).  IL-8 was detectable in most samples with an average of 123 ± 43.7 pg / mL.   
In the stable co-culture, slightly higher concentrations of IL-1β were detected (37.1 pg / 
mL) (Figure 4.13B).  However, considering the overall low release and high StDev of ± 
64 pg / mL the amount is negligible.  Whereas TNF-α concentrations remained low to 
undetectable (3.9 ± 4.5 pg / mL) the release of IL-8 was markedly increased to ~3,500 
pg / mL.  Based on the knowledge that unstimulated PMA-treated THP-1 cells readily 
release IL-8, this concentration is most likely attributable to the THP-1 rather than the 
Caco-2 cells.   
In contrast to the monoculture and stable co-culture the release of all three cytokines 
was significantly increased in the inflamed co-culture (IL-1β: 286 ± 254 pg / mL, IL-8: 
16,190 ± 5,442 pg / mL, TNF-α: 539 ± 190 pg / mL) (Figure 4.13C).   
After the exposure to AgNPs or AgNO3 very few statistically significant differences 
were observed in the three culture models.  In the Caco-2 monoculture, the exposure to 
AgNO3 resulted in a significant (p=0.048) 10-fold increase in IL-1β to 6.09 ± 14.2 pg / 
mL.  In both the stable and inflamed co-culture exposure to AgNO3 did not cause a 
change in the release of the three investigated cytokines.   
The exposure to 10 μg / mL AgNPs induced a slight but significant increase (p=0.027) 
in TNF-α in the stable co-culture (11.1 ± 13.5 pg / mL) and a decrease (p=0.05) of IL-
1β in the inflamed co-culture (80.1 ± 50.8 pg / mL).  Even though these alterations were 
statistically significant it remains questionable, whether such minimal changes in 
cytokine release would have a pathophysiological impact. 
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Figure 4.13 Release of IL-1β, IL-8, and TNF-α after 24h exposure to AgNPs (1 or 10 µg / mL) or 
AgNO3 (equivalent to 1 µg / mL AgNPs) in (A) Caco-2 monoculture, (B) stable co-culture, and (C) 
inflamed co-culture 
(Average of N≥3 ± StDev; *p≤0.05 compared to corresponding control) 
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4.3.3.4 Quantification of NO2ˉ release 
At T48, cell supernatants from the AP and BL compartment were analysed for the 
presence of NO2ˉ (Figure 4.14).  As mentioned earlier (Section 3.4.1.3), the presence of 
NO2ˉ
 
could not always be detected in inflamed co-cultures.  Also after the treatment 
with Ag-species, NO2ˉ was not detected in the inflamed co-culture of all experimental 
runs.  Since the inflamed co-culture served as positive control only runs with clearly 
detectable concentrations of NO2ˉ in the inflamed co-culture control were used for the 
analysis.  No valid results could be generated from co-cultures exposed to 10 μg / mL 
AgNPs.   
In Caco-2 monocultures, very low concentrations below 3 µM NO2ˉ
 
were detected in 
both AP and BL compartments (Figure 4.14, white bars).  In the inflamed co-culture the 
detectable concentration of NO2ˉ was significantly increased in both AP and BL 
compartments compared to the monoculture (250 and 270 %, respectively) and stable 
co-culture (290 and 270 % respectively) control.  After exposure to 1 μg / mL AgNPs 
and AgNO3, the release of NO2ˉ decreased in both the AP (43 and 35 %) and BL (16 
and 53 %) compartment of Caco-2 monocultures.  These changes were, however, not 
statistically significant.  In contrast, treatment with 1 μg / mL AgNPs elevated the NO2ˉ 
concentration in the stable co-culture by 130 and 180 % in the AP (p=0.41) and BL 
(p=0.004) compartment, respectively.  In samples from inflamed co-cultures exposed to 
AgNPs or AgNO3 the levels of NO2ˉ significantly exceeded the concentrations 
measured in exposed monocultures and stable co-cultures (not marked), but were not 
significantly different from the inflamed co-culture control. 
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Figure 4.14 Quantification of NO2ˉ in AP and BL supernatants after 48h Caco-2 monoculture, 
stable, or inflamed co-culture (CC) with and without 24h exposure to AgNPs (1 µg / mL) or AgNO3  
(Control: Average of N=3 ± StDev; AgNPs Monoculture: Average of n=3 ± StDev from one experiments; 
Stable and inflamed co-culture: Average of N=2 ± StDev, AgNO3: Average of N=2 ± StDev; *p≤0.05 
compared to Monoculture control,
 #p≤0.05 compared to stable co-culture control) 
 
4.3.3.5 Quantification of Caco-2 nuclei and nuclear fragmentation  
At T48, Caco-2 cell layers of all culture models and exposure conditions were stained for 
nucleic acid and subsequently imaged using the IN Cell Analyzer.  In total, 12 
conditions were analysed: Caco-2 monocultures, stable, and inflamed co-cultures as 
unexposed controls or after 24h exposure to AgNPs (1 and 10 µg / mL) or AgNO3.  
Example images of all conditions are summarised in Figure 4.15.  The results of the 
quantitative image analysis are presented in Figure 4.16.  
In the control conditions of all three culture models the Caco-2 cells form a dense and 
continuous barrier (Figure 4.15A, E, and I).  In the inflamed co-culture control (Figure 
4.15I) a number of fragmented nuclei are visible, which are absent in both the Caco-2 
monoculture (Figure 4.15A) and stable co-culture control (Figure 4.15E).   
No change in total nuclei number was noted after 24h exposure to AgNO3.  However, 
an increased rate of nuclear fragmentation was observed in the monoculture (Figure 
4.15B) and inflamed co-culture (Figure 4.15J).   
 
141 
Exposure effects of AgNPs were depending on the concentration and culture model.  In 
the Caco-2 monoculture and stable co-culture no changes were noted after exposure to 1 
µg / mL (Figure 4.15C and F).  In the inflamed co-culture (Figure 4.15K) the surface 
area of the nuclei appeared enlarged. In inflamed co-cultures treated with 10 µg / mL 
AgNPs (Figure 4.15L) a reduction in nuclei and clear increase in nuclear fragmentation 
was observed compared to the inflamed co-culture control.  In the monoculture (Figure 
4.15D) and stable co-culture control (Figure 4.15H) no or very low effects were 
observed after exposure to AgNPs.  
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Figure 4.15 DAPI stained nuclei after 48h (A-D) Caco-2 monoculture, (E-H) stable co-culture, and (I-L) inflamed co-culture with or without 24h exposure to AgNPs or 
AgNO3  
Cell cultures were apically exposed to AgNPs (1 or 10 µg / mL) or AgNO3 (equivalent to 1 µg / mL AgNPs) after 24h of mono- or co-culture (imaged with IN Cell Analyzer, 60x 
magnification, scale bar=25 µm) 
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The images were analysed quantitatively based on the nuclear staining.  The total 
number of nuclei and ‘bright nuclei’ were investigated as individual parameters (Figure 
4.16A).  Since the total number of nuclei varied between the samples, the number of 
bright nuclei was expressed per 1,000 counted nuclei (Figure 4.16B).  The graphs are 
based on a very limited amount of samples.  Therefore, no statistical analysis was 
performed.  
As summarised in in Figure 4.16A, no major differences in the total number of nuclei 
were noted between the monoculture and stable co-culture control.  In the inflamed co-
culture the total number of nuclei was slightly decreased compared to the monoculture 
control (Figure 4.16A).  More interestingly, the number of bright nuclei increased from 
19 / 1,000 nuclei in the monoculture to 92 / 1,000 in the inflamed co-culture (Figure 
4.16A&B).   
After exposure to AgNO3, the total number of nuclei was drastically reduced in the 
monoculture sample (5,902 ± 1,354 vs. 2,907 nuclei).  This might change if more 
samples were analysed.  No change was noted in the stable and inflamed co-culture 
compared to the corresponding control conditions.  The number of bright nuclei 
increased in all three models after AgNO3-exposureto 84, 50, and 159 / 1,000 nuclei in 
the monoculture, stable, and inflamed co-culture, respectively. 
In response to 1 µg / mL AgNPs, the total number of nuclei increased slightly in all 
three models (Figure 4.16A).  Whereas the number of bright nuclei rose marginally in 
the monoculture and inflamed co-culture it decreased in the stable co-culture compared 
to the corresponding control (21 vs. 44 / 1,000 nuclei, respectively) (Figure 4.16B).  
After treatment with 10 µg / mL AgNPs, the number of nuclei decreased in all three 
culture models compared to the corresponding control (Figure 4.16A), whereas the 
number of bright nuclei increased clearly.  The increase in bright nuclei was most 
pronounced in the monoculture and inflamed co-culture with 3.6 and 2.8-fold to 66 and 
261 / 1,000 nuclei, respectively.  In the stable co-culture the number rose moderately 
(1.8-fold) to 84 / 1,000 nuclei (Figure 4.16B).  
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Figure 4.16 Quantitative analysis of images acquired of DAPI-stained nuclei of Caco-2 
monoculture, stable, and inflamed co-culture barriers after exposure to AgNPs or AgNO3  
(A) Total counts of nuclei and bright nuclei and (B) number of bright nuclei per 1,000 counted nuclei in 
Caco-2 monoculture, stable, and inflamed co-culture (CC) without exposure (control) and after 24h 
exposure to AgNO3 or AgNPs (1 or 10 µg / mL) (Controls: Average of n=3 of N=3 ± StDev; AgNO3 
monoculture: n=1 of N=1; AgNO3 rest: Average of n=2 of N=2 ± StDev; 1 µg / mL AgNPs monoculture: 
n=1 of N=1, rest: Average of n=2 of N=2 ± StDev; 10 µg / m AgNPs: Average of n=2 of N=2 ± StDev) 
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4.4 Discussion 
The most important findings of this chapter can be summarised in the following points: 
 AgNPs slowly dissolved in CCM at standard culture conditions.  Hence, cells 
are likely not only exposed to 23 nm AgNPs, but also increasing numbers of 
smaller particles and ionic Ag. 
 AgNO3 was more toxic to Caco-2 cells than AgNPs.  Whereas concentrations of 
up to 10 µg / mL AgNPs did not induce a reduction in cell viability AgNO3 
concentrations equivalent to ≥4 µg / mL AgNPs damaged Caco-2 cells 
significantly.  
 AgNPs and AgNO3 induced differential effects in the three culture models: 
Whereas low concentrations of AgNPs did not affect the Caco-2 barrier integrity 
higher concentrations significantly increased the TEER of the inflamed co-
culture.  The exposure to AgNO3 markedly increased the barrier integrity in all 
three culture models. 
 The exposure to high concentrations of AgNPs and AgNO3 caused an increased 
LDH release in all three culture models.  Treatment with AgNPs caused a clear 
increase in the occurrence of fragmented nuclei in the monoculture, stable, and 
inflamed co-culture, whereas effects of AgNO3 were only detected in the Caco-2 
monoculture and inflamed co-culture.  
 Neither the exposure to AgNPs nor to AgNO3 caused an effect on the release of 
cytokines or the formation of NO. 
 
4.4.1 Characterisation of AgNPs 
The here used AgNPs showed a homogenous and narrow size distribution in dispersant 
with an average size of 23 nm.  The great majority of particles was of spherical shape 
with a low level occurrence of rod-shaped particles.  After extended incubation in CCM 
at standard culture conditions the particles appeared to slowly dissolve, which resulted 
in the formation of a separate population of smaller particles of around 5 nm. 
The stability of the particle suspension and the integrity of the particles throughout the 
exposure are important points to consider for cell-based experiments.  The composition 
of the surrounding matrix, e.g. the presence of proteins and salts, as well as the time of 
storage and temperature conditions can greatly alter the characteristics of NMs 
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(Teeguarden et al., 2007).  The particles might aggregate or agglomerate, which 
ultimately impacts the particle size distribution, as well as the sedimentation behaviour 
(Halamoda-Kenzaoui et al., 2015).  In the context of metallic NMs, the dissolution of 
NMs results in the generation of metal ions, which often have distinct effects on 
biological systems.   
With regard to AgNPs, biological media were demonstrated to negatively affect the 
integrity, especially of non-stabilised particles (Sharma et al., 2014; Stebounova et al., 
2011).  The particles used in this study were charge-stabilised by citrate, but not surface 
modified.  In comparison with other capping agents, e.g. polyethylene glycol or 
polyvinylpyrrolidone, citrate stabilisation was shown to be less effective (Tejamaya et 
al., 2012).  Apart from biological media, the extended storage of particles in the 
dispersant itself was shown to result in increasing concentrations of Ag
+
, which lead to 
a considerable rise in toxicity (Kittler et al., 2010).   
The incubation in protein-containing solutions usually leads to the formation of a 
protein corona.  The protein corona greatly determines the ‘biological identity’ of NMs 
and can have a significant impact on cellular uptake and NP-induced toxicity (Cheng et 
al., 2015; Docter et al., 2014).  The formation of the protein corona can drastically 
increase the hydrodynamic diameter, which is measured by both DLS and CLS.  
Whereas the size-calculation by CLS is based on the light scattering of a particle and the 
time a particle requires to travel across the sucrose gradient, DLS measurements solely 
rely on optical properties of the tested material.  Since changes in light scattering caused 
by the protein corona cannot easily be taken into account it can greatly influence the 
results calculated by DLS.  Hence, the results obtained by DLS might not be accurately 
reflecting the state of the AgNPs.  In this study, the measurements performed with CLS 
generated more reliable results.  However, also here, care has to be taken regarding the 
interpretations.  The protein corona reduces the particles’ density compared to the 
density of the uncoated, pristine material.  Since the size calculations are based on the 
original density, an underestimation of the particle diameter is possible. 
Depending on the particle characteristics and the type of protein, the incubation of 
AgNPs with proteins can have beneficial or unbeneficial effects.  Whereas both human 
serum albumin and BSA had a stabilising effect, incubation with high density 
lipoproteins was shown to even enhance the dissolution (Shannahan et al., 2015).  In 
this project, the incubation in serum-containing biological media affected AgNP-
stability negatively.  With TEM, the appearance of a population of smaller sized NPs 
147 
was demonstrated and the particles’ clear-cut border became blurry.  It is not clear, how 
the fraction of small AgNPs developed.  The small AgNPs could be remains of 
dissolving 23 nm particles.  Alternatively, they could have originated from Ag
+
 released 
from 23 nm AgNPs, which subsequently precipitated with chloride ions (Groh et al., 
2015).   
Also the absorbance results obtained with UV-Vis require careful interpretation.  The 
reduction in peak intensity and simultaneous shift of the absorbance maximum from 
400 to ~430 nm could indicate a time-dependent aggregation or agglomeration of 
AgNPs in CCM.  Whereas an absorbance maximum at 400 nm is characteristic for 
AgNPs between 10 and 30 nm, the increase in absorbance maximum and reduction in 
peak intensity are associated with larger particles of 60-100 nm (Oldenburg and 
Saunders, accessed 2016; Evanoff and Chumanov, 2005).  However, the combination of 
peak intensity and maximum absorbance at 430 nm is uncharacteristic for larger 
AgNPs.  Furthermore, such a conclusion would contradict the results obtained from 
TEM and CLS, which pointed towards a size reduction.  Based on Mogensen and 
Kneipp (2014), the decreasing peak intensity and blue-shift in the absorbance spectrum 
can also indicate a decrease in particle size.   
Altogether, the characterisation of AgNPs in dispersant showed an evenly dispersed 
particle suspension with an average diameter of 23 nm.  The great majority of particles 
were of spherical shape with a low occurrence of rod-shaped particles.  Based on the 
analysis in CCM using TEM, CLS, and UV-Vis, the AgNPs probably dissolve partially 
over time.  Therefore, exposed cells are in contact with metallic, particulate Ag with an 
average diameter of 23 nm, but will likely also face increasing concentrations of smaller 
particles (2-5 nm), as well as ionic Ag. 
 
4.4.2 AgNPs-induced cytotoxicity in Caco-2 and THP-1 monocultures 
When the UDCaco-2 cells were grown to confluence before the exposure, they proved to 
be more resilient to the exposure to AgNPs.  Whereas the viability of sub-confluent 
UDCaco-2 cells was negatively affected by the exposure to 10 µg / mL AgNPs, no 
significant effect was detected in confluent cells in any of the three cytotoxicity 
endpoints.  In contrast to AgNPs, all cytotoxicity assays confirmed the detrimental 
effect of AgNO3 exposure.  Even at very low concentrations equivalent to 4 µg / mL 
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AgNPs a significant reduction in metabolic activity, number of nuclei, and increase in 
LDH release were detected. 
Induction of cytotoxicity is one of the most commonly reported exposure effects of 
AgNPs.  However, large variations regarding the minimum effective dose were reported 
in relation to the cell type and the differentiation status of cells.  For UDCaco-2 cells, 
concentrations of 15 and 25 µg / mL were reported to reduce cell viability by 50 and 80 
%, respectively (Aueviriyavit et al., 2014; Böhmert et al., 2014).  In this context, the 
here presented results suggest that not only the differentiation state but also the 
confluence are important determinants for the cells’ sensitivity.  Caco-2 cells begin to 
differentiate into enterocyte-like cells upon reaching confluence (Pinto et al., 1983).  In 
general, a period of 20-30 days of culture is accepted to regard Caco-2 cells as fully 
differentiated.  Even though some differentiation markers might be enhanced after 3 
days treatment with growth supplements, a culture period of just 72h is generally not 
sufficient for Caco-2 cells to differentiate (Ferruzza et al., 2012).  Hence, the cells used 
for the initial cytotoxicity tests represent undifferentiated cells.   
The higher cytotoxicity of AgNO3 compared to AgNPs was in line with the findings 
reported by other groups (Oberemm et al., 2016).  Since the ion release from AgNPs 
could not be quantified in this project, an AgNO3 exposure concentration equivalent to 
1 µg / mL AgNPs was chosen as ion control.  This concentration represents the worst 
case scenario of 100 % AgNPs dissolution.  Neither we nor others observed any 
cytotoxic effects in UDCaco-2 cells at such low concentrations of AgNO3 (Nguyen et al., 
2013). 
In comparison to the metabolic activity, the LDH release was more variable after the 
exposure to AgNPs and AgNO3, indicated by large standard deviations.  The variations 
might partially be caused by an interference of Ag-species with the assay similar to the 
observations by Han et al. (2011).  The group demonstrated that copper (Cu) NPs can 
interfere with the LDH assay through the inactivation of the enzyme.  Another group 
observed that citrate-capped and bare AgNPs can interfere with the assay by adsorbing 
LDH onto the particle surface (Oh et al., 2014).  This could give an explanation for both 
the generally lower LDH results after 48h compared to 24h exposures and the strongly 
reduced LDH release after 48h exposure to 8 µg / mL AgNO3.  It is not clear at what 
concentrations AgNPs and / or Ag
+
 start to interfere with the accuracy of the assay.  It is 
possible, that Ag-induced cellular damage resulted in LDH releases below the detection 
limit of the assay.  Another possible explanation might be that exposure to Ag species 
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also induced apoptotic processes.  In that case, a reduction in metabolic activity would 
not be paralleled by an increase in LDH release.   
Altogether, concentrations of 1-10 µg / mL AgNPs and an AgNO3 concentration 
equivalent to 1 µg / mL AgNPs were found to not induce cytotoxic effects in confluent 
UDCaco-2 cells.  Since the vulnerability of Caco-2 and other adenocarcinoma cell lines 
is known to be inversely related to the state of confluence and differentiation status 
(Pelletier et al., 1990; Böhmert et al., 2014) these concentrations were used as ‘non-
toxic’ in the subsequent co-culture exposure studies.   
 
4.4.3 Effects of AgNPs and AgNO3 in the co-culture conditions 
4.4.3.1 TEER 
The effect of AgNPs on the culture models was dependent on the exposure 
concentration.  Low concentrations of 1 µg / mL did not affect the TEER in any of the 
three models.  Higher concentrations of 10 µg / mL, however, caused a significant 
increase in TEER in the inflamed co-culture, but did not affect the Caco-2 monoculture 
or stable co-culture.  A similar effect was observed after treatment with the AgNO3 ion 
control equivalent to the Ag content of 1 µg / mL AgNPs.  Whereas the barrier integrity 
did not change after short-term exposure (4h) a significant increase in TEER was noted 
after 24h in all three culture models.  It is unlikely that this increase in TEER was 
caused by the physical properties of Ag.  In this case, the effect should have become 
apparent immediately after the exposure and in all culture models equally. 
Based on the reported cytotoxic and barrier disruptive potential of AgNPs and Ag
+
 
(Martirosyan et al., 2014; Susewind et al., 2016) the significant increase in TEER was 
surprising.  When monitoring the formation of a cell barrier, the increase in TEER 
corresponds to the cell density and the increasing restriction of the paracellular ion 
transport by TJ (Anderson and Van Itallie, 2009).  An increase in TEER might, 
therefore, indicate a tightening of the barrier, e.g. due to increased cell numbers or a 
reduction of intra- and intercellular space as a result of cell swelling.  Also others 
measured a transient increase in electrical resistance in Caco-2 barriers after exposure to 
NMs.  These measures were obtained by means of impedance monitoring and showed 
an increase in resistance before a drastic decrease in resistance as a result of cell death 
(Böhmert et al., 2012; Sperber et al., 2015).  Increases in impedance have been 
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associated with expanding cell size (e.g. due to cell swelling) and, in parallel, 
decreasing extra-cellular volume (Olsson et al., 2006).  Cell swelling can be a sign of 
necrotic cell death (Bonfoco et al., 1995), as was also observed in our group: after the 
exposure to AgNPs, the analysis of A549 cell surface using the IN Cell Analyzer 
revealed a substantial increase in the surface area at cytotoxic exposure concentrations 
(Urbán, unpublished).  It was therefore hypothesised that in the present study a 
significant level of necrotic cell death is induced by the exposure to very low 
concentrations of AgNO3 in all three conditions and by 10 µg / mL AgNPs in the 
inflamed co-culture. 
Other groups studying the effect of AgNPs in intestinal co-culture models obtained 
highly different outcomes on cytotoxicity and IEC barrier integrity.  Susewind et al. 
(2016) worked with a model of Caco-2, THP-1, and MUTZ-6 cells in non-inflamed or 
inflamed state.  In contrast to us, the group observed the highest sensitivity to AgNPs in 
the Caco-2 monoculture with a significant TEER reduction (~20 %) after exposure to 
concentrations equal to or higher than 78.1 µg / cm².  Both the non-inflamed and 
inflamed co-cultures were more resilient with barrier disruption starting at exposure 
concentrations of 312.5 and 156.25 µg / cm², respectively (Susewind et al., 2016).  
Georgantzopoulou and colleagues (2016) studied the effects of AgNPs and AgNO3 in a 
co-culture of Caco-2 and HT29-MTX cells without involvement of immune cells.  The 
group did not observe any effect on the barrier integrity in cell monocultures or the co-
culture for either AgNPs or AgNO3 (Georgantzopoulou et al., 2016).  Interestingly, 
Bouwmeester et al. (2011) observed a similar increase in in barrier resistance after the 
exposure of Caco-2 cells to AgNPs and AgNO3.  Even though the TEER increased to 
120-130 % of the control the group did not investigate or discuss this increase further. 
 
4.4.3.2 LDH release 
The quantification of LDH activity in AP and BL supernatants confirmed that both 
AgNO3 and 10 µg / mL AgNPs induced significant cytotoxicity even though both were 
found to be non-toxic in UDCaco-2 cultures.  Again, the effect was most pronounced in 
the inflamed co-culture, supporting the hypothesis that a stressed Caco-2 barrier is more 
susceptible to the exposure.   
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The LDH results obtained from AgNO3- and AgNP-exposed DCaco-2 cells clearly 
contradict the results from numerous studies, which usually showed an increased 
resilience of Caco-2 cells after differentiation (Gerloff et al., 2013; McCracken et al., 
2015).  However, a similar observation was reported by Thit et al. (2013) and the 
exposure of epithelial cells to Cu oxide (CuO) NPs.  Differentiated, non-dividing cells 
were significantly more affected by the exposure to CuO NPs than dividing cells.  As a 
result of the differentiation process of cells, many genes and pathways are up-regulated 
(Tadjali et al., 2002).  It is possible that certain pathways protecting undifferentiated 
cells against Ag-induced effects are not active anymore after differentiation.  Likewise, 
the differentiation might lead to the formation of additional apical membrane receptors 
that allow for an increased and / or easier uptake of AgNO3 but not AgNPs (Thit et al., 
2013).  It is puzzling, though, that this effect has not been observed by other groups. 
The results obtained from DCaco-2 monocultures and the co-culture models are in clear 
contrast to the findings reported by Susewind et al. (2016) and Georgantzopoulou et al. 
(2016).  Both groups observed the Caco-2 monoculture to be more sensitive to the 
exposure to AgNPs than co-cultures with goblet cells (Georgantzopoulou et al., 2016) 
or immune cells (Susewind et al., 2016).  Furthermore, no adverse effects were noted 
after exposure to similar concentrations of AgNPs as used in this project.  Also the 
exposure to similar concentrations of AgNO3 was not found to induce cytotoxicity by 
other groups (Oberemm et al., 2016; Georgantzopoulou et al., 2016).  Interestingly, 
Susewind and colleagues obtained very different results in their inflamed model.  The 
induction of inflammation did not result in increased levels of LDH, indicating that the 
cell viability was not affected.  Furthermore, hardly any difference in response to 
AgNPs exposure was noted between the non-inflamed and inflamed co-culture.  In the 
here presented experiments, however, the inflamed co-culture reacted significantly more 
sensitive to the exposure to AgNPs and AgNO3 compared to the stable co-culture, 
which was reflected in a drastic increase in LDH release. 
The induction of necrotic cell death and the associated cellular swelling could explain 
the TEER increase in the inflamed co-culture (treated with AgNO3 and AgNPs), as well 
as in Caco-2 monocultures and stable co-cultures (treated with AgNO3).  It remains 
unclear why no increase in TEER was observed in Caco-2 monoculture and stable co-
cultures after exposure to 10 µg / mL AgNPs.  This is unexpected since the exposure 
induced similar levels of cytotoxicity according to the LDH results. 
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4.4.3.3 Quantification of nuclei and nuclear fragmentation 
With the HCA of DAPI-stained nuclei we intended to confirm the occurrence of 
necrotic cell death in response to the exposure to AgNO3 and 10 µg / mL AgNPs.  In the 
monoculture and stable co-culture a very low rate of condensed or fragmented nuclei 
was found.  The induction of inflammation-like processes, however, resulted in 
increased nuclear fragmentation and reduced number of nuclei.  The fragmentation was 
further increased after exposure to AgNO3 and 10 µg / mL AgNPs.  Interestingly, higher 
concentrations of AgNPs also elevated the occurrence of fragmented nuclei in the 
monoculture and stable co-culture, but no effect was noted for lower concentrations.  
Whereas AgNO3 increased the occurrence of bright nuclei in the monoculture and 
inflamed co-culture it did not induce obvious changes in the stable co-culture.   
Whereas the LDH outcomes showed the same trend for all three culture models, the 
results on the number of nuclei in the different exposure conditions were inconclusive.  
For instance, the exposure to AgNO3 reduced the number of nuclei in the monoculture 
but not in either of the co-culture models.  In the monoculture and the inflamed co-
culture, AgNO3 increased the occurrence of fragmented nuclei.  In the stable co-culture 
virtually no effects were noted even though the LDH release and TEER were clearly 
increased.  In contrast, 10 µg / mL AgNPs clearly reduced the total number of nuclei 
and increased the rate of bright nuclei in all three models.  This is in line with the LDH 
release, which showed a significant increase in all models, but in contrast to the TEER 
results, which were only significantly increased in the inflamed co-culture.   
The FI, as well as the mean size of the nucleus are important indicators for cellular 
health and integrity.  The binding of DAPI is related to the condensation state of 
chromatin in the nucleus (Mascetti et al., 2001).  The condensation of chromatin and 
nuclear fragmentation are late events in apoptotic cell death (Tounekti et al., 1995; 
Collins et al., 1997).  Hence, the FI and mean nuclear size can be used for the 
identification of apoptotic events. 
Apoptosis can be induced through various mechanisms, which makes pinpointing the 
exact route of induction challenging.  On the one hand, it could have originated from the 
IFN-γ-priming of Caco-2 cells before the start of the co-culture.  The extended exposure 
of Caco-2 cells to IFN-γ has been demonstrated to induce apoptosis and to decrease cell 
proliferation (Nava et al., 2010).  On the other hand, the cell damage might be directly 
linked to co-culture with stimulated THP-1 cells.  TNF-α is known for its ability to 
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induce apoptotic mechanisms (Miura et al., 1995), whereas NO can be involved in both 
apoptotic and necrotic cell death (Liu et al., 2003; Bonfoco et al., 1995). 
Also AgNPs have been shown to induce apoptosis in various cell types (Lee et al., 
2011; Xue et al., 2016).  For Caco-2 cells, however, no apoptotic effect of AgNP-
exposure has been observed in either differentiated or undifferentiated state (Böhmert et 
al., 2015; Georgantzopoulou et al., 2016; Böhmert et al., 2012).  In contrast to AgNPs, 
AgNO3 was found to slightly induce several apoptosis-associated proteins, but most 
increases were not statistically significant (Georgantzopoulou et al., 2016). 
The induction of apoptosis does not explain the elevated LDH activity measured earlier 
(Chan et al., 2013), but necrosis does not feature the condensation of chromatin 
(Vanden Berghe et al., 2010) as was observed here.  However, other necrosis-related 
mechanisms might have been triggered, which could explain the observed combination 
of the LDH release and chromatin condensation / nuclear fragmentation.  The exposure 
to AgNPs and AgNO3 might have induced of a highly regulated type of necrosis termed 
necroptosis (Chan et al., 2013; Rayamajhi et al., 2013), which has been reported to 
occur in the intestinal epithelium (Negroni et al., 2015).  Necroptosis can be induced by 
TNF-α and seems to occur in case the apoptotic cascade is blocked (Günther et al., 
2011; Pasparakis and Vandenabeele, 2015).  However, necroptosis causes only 
moderate chromatin condensation and the nucleus remains largely intact (Pasparakis 
and Vandenabeele, 2015), which is in contrast to the results presented here.   
In the inflamed co-culture two other sub-types of programmed necrotic processes – 
pyronecrosis and pyroptosis – might be involved in the observed cytotoxicity 
(Pasparakis and Vandenabeele, 2015).  Pyroptosis shares several characteristics with 
apoptosis, e.g. nuclear condensation and DNA fragmentation, but also displays features 
associated with necrosis, like cell lysis, cell swelling, and LDH release (Labbé and 
Saleh, 2011).  The induction of pyroptosis is linked to the activation of caspase-1 
(Labbé and Saleh, 2011; Rayamajhi et al., 2013).  However, in some cell types, e.g. 
epithelial cells, the activation of caspase-1 does not trigger pyroptosis but rather initiates 
cell protective mechanisms (Yang et al., 2015).  In contrast to pyroptosis, pyronecrosis 
is characterised by the activation of a protein of the NOD-like receptor (NLRs) family – 
NLRP3 (Satoh et al., 2013).  The activation of NLRP3 in the intestinal epithelium is 
associated with protection against pathogens, whereas its reduced expression is linked 
to increased susceptibility to Crohn’s disease (Song-Zhao et al., 2014).  AgNPs were 
shown to activate NLRP3 in THP-1 cells (Simard et al., 2015).  Both pyroptosis and 
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pyronecrosis are associated with moderate chromatin condensation and might, therefore, 
not be involved in the here observed effects (Pasparakis and Vandenabeele, 2015). 
A more likely explanation is the occurrence of apoptosis-induced secondary necrosis, 
which occurs when the normal scavenging capacities of phagocytising cells are 
overwhelmed or impaired (Silva et al., 2008).  In contrast to primary necrosis, 
secondary necrosis features nuclear shrinkage and severe fragmentation of the nucleus, 
as well as cytoplasmic swelling (Silva, 2010).  As mentioned above, pro-inflammatory 
cytokines and NO can induce apoptosis in IECs, whereas the low level of LDH release 
could have been caused by TNF-α-mediated necrotic processes.  In the inflamed co-
culture, the exposure to stressors, e.g. AgNPs and AgNO3, could have resulted in 
additional induction of apoptotic processes.  Apart from its role in apoptosis and 
necrosis, TNF-α has been demonstrated to be essential for ‘apoptosis-induced-
apoptosis’.  Apoptosis-induced-apoptosis describes a process of non-autonomous 
apoptosis that can occur within a tissue  (Perez-Garijo et al., 2013).  Even though IECs 
are capable of engulfing apoptotic neighbouring cells their capacity might have been 
exceeded by this additional increase in apoptosis.  Eventually, the cells underwent 
secondary necrosis, which could explain the significant increase in LDH after exposure 
to AgNPs and AgNO3.  In contrast to this hypothesis, Böhmert et al. (2012) did not 
observe induction of apoptosis by AgNPs.  However, the already stressed state of the 
cells in the inflamed model could have increased their susceptibility.   
The occurrence of secondary necrosis could, furthermore, elucidate the increases in 
TEER discussed earlier (Sections 4.3.2.1 & 4.4.3.1).  Like primary necrosis, secondary 
necrosis is characterised by cell swelling, which can cause an increase in TEER.  A 
significant increase in TEER was only observed in Caco-2 monocultures and stable co-
cultures exposed to AgNO3 but not after exposure to 10 µg / mL AgNPs, even though 
the levels of LDH release were similar.  It is possible, that the cytotoxic mechanisms 
induced by 10 µg / mL AgNPs were different from those caused by AgNO3 or, simply, 
not sufficient to cause secondary necrosis. 
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4.5 Conclusions 
The cytotoxicity studies in THP-1 and UDCaco-2 monocultures confirmed that AgNO3 
exerts toxic effects at significantly lower concentrations than AgNPs.  Surprisingly, 
concentrations of both ionic and particulate Ag that were found to be non-toxic in 
monocultures of UDCaco-2 cells caused significant cytotoxicity in DCaco-2 cells, clearly 
disproving the corresponding hypothesis.  Confirming the initial hypothesis, the 
presented results showed distinct effects of AgNPs and AgNO3 depending on the health 
status of the in vitro model at the time of exposure.  Whereas lower concentrations of 
AgNPs did not cause any effects regardless of the condition, higher concentrations of 
AgNPs induced a significant increase in barrier integrity in the inflamed but not in the 
stable co-culture.  In contrast to this, the exposure to non-toxic concentrations of 
AgNO3 resulted in elevated TEER in both co-cultures and the Caco-2 monoculture.  In 
both co-culture models, AgNPs and AgNO3 caused a significant increase in cell death, 
which was likely caused by a combination of apoptosis, secondary necrosis, and 
apoptosis-induced-apoptosis.  The occurrence of secondary necrosis might be involved 
in the observed increase in TEER above the unexposed Caco-2 monoculture control.  
Like the general re-establishment of barrier integrity in the inflamed co-culture the 
cause for the TEER increase could not be conclusively explained.  The observed effects 
were significantly more pronounced in the inflamed model than in the stable co-culture.  
The exposure to AgNPs and AgNO3 did not induce a pro-inflammatory reaction in the 
stable co-culture and did not affect the cytokine release or NO synthesis in the inflamed 
co-culture.  
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5. Application of the co-culture model in homeostatic and inflamed 
state to study the effect of exposure to CuO NPs 
5.1 Introduction 
Due to their very favourable thermo-physical properties (Bondarenko et al., 2013), CuO 
NPs are used in the manufacture of electronics and technologies, e.g. semiconductors 
(Rahnama and Gharagozlou, 2012), electro chips, or conductivity-enhancing nano-
fluids (Chang et al., 2011).  Even though CuO NPs exert strong antimicrobial effects 
(Borkow et al., 2009; Ren et al., 2009), this function only accounts for around 4 % of 
the material’s applications (Bondarenko et al., 2013). 
In contrast to Ag, Cu is an essential trace element needed by the great majority of cell 
types (Bondarenko et al., 2013), where it is involved in electron transfer reactions, 
neurotransmission, and antioxidant defence mechanisms, e.g. CuZn superoxide 
dismutase (SOD) (Bo et al., 2008).  The average dietary intake of Cu for adults is 
estimated between 0.6-1.6 mg / d (Tapiero et al., 2003).  The absorption of Cu is 
inversely related to the dietary intake: the more Cu is ingested, the less is absorbed (van 
den Berghe and Klomp, 2009).  Reliable data on the daily exposure of particulate Cu 
through ingestion, inhalation, or skin contact are not available. 
 
5.1.1 Toxicity mechanism 
As a trace element, Cu is necessary for a number of vital processes, but an oversupply 
can have deleterious effects.  One example is the ability to replace other metal cofactors 
from their ligand, e.g. in receptors or enzymes (Tapiero et al., 2003).  Even though it is 
not their required material, most proteins favour Cu over the designated metallic 
cofactor (Foster et al., 2014).  These ‘mismetallations’ can render proteins 
transcriptionally and functionally inactive (Predki and Sarkar, 1994; Foster et al., 2014).  
To prevent Cu from replacing other metals, its intracellular concentration has to be 
closely controlled using specialised cellular uptake pathways and regulation 
mechanisms (Foster et al., 2014).  Since organisms have historically received the 
required Cu in ionic state as Cu
+
 or Cu
2+
 the regulating uptake mechanisms are likely 
specialised on ionic but not particulate Cu.  As other NMs, CuO NPs are expected to be 
taken up by the cell through endocytic mechanisms (Thit et al., 2013).  In this context, a 
‘Trojan Horse’-type toxicity process has been suggested, meaning the uptake of the 
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particles and subsequent induction of toxic effects through Cu ions generated by the 
lysosomal degradation of the particles.  The acidic environment of the lysosome favours 
the dissolution of CuO NPs, resulting in the generation of uncontrolled concentrations 
of Cu
+
 and Cu
2+
 within the cell (Studer et al., 2010; Bondarenko et al., 2013).   
If ionic and particulate Cu species are taken up through individual mechanisms, 
differences in the toxicity should be observed.  Supporting this, CuO NPs were found to 
be more cytotoxic than ionic Cu in a non-human kidney epithelial (A6) and a human 
lung epithelial cell line (A549) (Thit et al., 2013; Wang et al., 2012).  Karlsson et al. 
(2008) demonstrated in A549 cells that CuO NP-induced cyto- and genotoxicity were 
independent of the release of ionic Cu.  Furthermore, Wang and colleagues (2012) 
observed that the intracellular Cu levels in A549 cells increased more strongly after 
exposure to CuO NPs than equal mass concentrations of Cu
2+
, supporting the hypothesis 
of different uptake and control mechanisms.  Whereas the uptake of CuO NPs into the 
cells could be reduced by endocytosis inhibitors, the uptake of Cu
2+
 was unaffected 
(Wang et al., 2012).  
 
5.1.2 Cu in inflammatory conditions 
Various studies in humans and animals have investigated the levels of Cu in unimpaired 
health and in presence of ongoing inflammatory processes.  In children with IBD, the 
analysis of serum Cu concentrations at presentation at the hospital showed significantly 
increased levels in those diagnosed with Crohn’s disease but not Ulcerative Colitis 
(Ojuawo and Keith, 2002).  In adult IBD patients, the type of nutrition appeared to 
influence serum Cu levels.  In patients receiving an uncontrolled diet the serum 
concentrations were increased compared to healthy controls (Fernández-Banares et al., 
1990), whereas no significant differences were detected in patients on a controlled 
enteral or parenteral nutrition (Johtatsu et al., 2007; Kobayashi et al., 2012).  A study 
using rats showed that the inflammation-related increase in serum Cu levels is not 
exclusive to conditions of intestinal inflammation.  In a pulmonary inflammation model, 
elevated Cu levels were found in serum and liver tissue, which the authors suggested to 
indicate an increased Cu-demand in the organism (Milanino et al., 1986).  A study by 
DiSilvestro and Marten (1990) proposed the increased Cu-demand to be linked to the 
elevated activity of Cu-dependent antioxidant mechanisms like CuZn SOD.  The 
authors demonstrated that the enzyme’s activity in the liver and blood depended on the 
158 
availability of sufficient concentrations of dietary Cu by feeding rats a diet containing 
adequate, marginal, or insufficient levels of the trace element.  
 
5.1.3 Toxic effects in vitro 
In cell culture experiments, CuO NPs were found to be highly toxic, for instance in 
different airway epithelial cell lines (Fahmy and Cormier, 2009; Karlsson et al., 2008; 
Edelmann et al., 2014), keratinocytes (Alarifi et al., 2013), hepatocytes (Cuillel et al., 
2014), and cardiac endothelial cells (Sun et al., 2011).  Whereas cytotoxicity was 
generally observed, the sensitivity to CuO NPs-induced effects varied between cell 
types (Jing et al., 2015).   
Exposure to CuO NPs caused generation of ROS and depleted levels of intracellular 
antioxidants (Fahmy and Cormier, 2009; Karlsson et al., 2008).  Further effects include 
DNA damage (Karlsson et al., 2008), mitochondrial depolarisation (Wang et al., 2012), 
as well as induction of pro-inflammatory cytokines (Jing et al., 2015).  Many of the 
effects, including cytotoxicity, seem to be linked to the formation of ROS.  Co-exposure 
or pre-incubation of cells with antioxidants was able to increase cell viability, prevented 
the depletion of glutathione, and decreased the formation of ROS (Niska et al., 2015; 
Siddiqui et al., 2013; Jing et al., 2015).  Additionally, CuO NPs were found to cause cell 
death through the induction of autophagy in A549 cells (Sun et al., 2012).  Proteomic 
analysis of BEAS-2B cells exposed to very low concentrations of CuO NPs (0.01 µg / 
cm², 24h) revealed distorting effects on the actin cytoskeleton, as well as on protein 
ubiquitination (Edelmann et al., 2014).  
 
5.1.4 Toxicity in IECs and macrophages 
In IECs, Piret et al. (2012b) noted significant cytotoxic effects in response to the 
exposure to both CuO NPs and ionic Cu.  The exposure resulted in barrier destruction, 
which was reflected in strong TEER reduction and increased passage of LY (Piret et al., 
2012b).  As observed in other cell types, the exposure to particulate Cu was more 
detrimental than ionic Cu.  The toxicity of CuO NPs mainly depended on the specific 
surface area of the particles (Piret et al., 2012b).  Chen et al. (2015a) demonstrated the 
uptake of CuO NPs by Caco-2 cells through energy-dependent endocytic mechanisms.  
The groups’ quantification of Cu recovered from the BL side of the cell culture 
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suggested a transport and exocytosis of CuO NPs across the cell layer.  The transport 
rate of nano-sized CuO particles (60%) was significantly higher compared to equal Cu 
concentrations in ionic (40 %) and microparticulate state (11 %) (Chen et al., 2015a).  In 
contrast to ionic Cu and CuO MPs, no obvious saturation was observed for the uptake 
and transfer of CuO NPs (Chen et al., 2015a).  
In macrophages, the exposure to CuO NPs induced strong cytotoxic effects with an 
EC50 between 5 and 10 µg / mL (Lanone et al., 2009).  Khatri et al. (2013) observed an 
upregulation in the gene expression and protein levels of pro-inflammatory cytokines in 
THP-1 cells in response to CuO NPs.  Treatment with CuO NPs resulted in the 
formation of ROS, which seemed to be largely responsible for the observed 
cytotoxicity, as co-incubation with antioxidants increased cell viability significantly 
(Rotoli et al., 2012).  Contradicting results were reported regarding the cytotoxic effects 
of ionic and particulate Cu in macrophages.  Whereas Rotoli et al. (2012) did not 
observed significant differences in murine RAW264.7 macrophages, Triboulet and 
colleagues (2015) reported higher toxicity for the exposure to CuO NPs compared to Cu 
ions in murine J774A1 macrophages.   
 
5.1.5 Toxicity in vivo 
In contrast to other metal and metallo-oxide NMs, very few in vivo studies in mammals 
were conducted to investigate the effects of CuO NPs.  Therefore, also studies on Cu 
NPs will be considered, which might help to estimate the potential effects of CuO NPs. 
In rats, the inhalation of a single dose of 1 or 5 mg / kg bodyweight CuO NPs resulted 
in a dose-dependent cell damage and lasting infiltration of leukocytes detected in the 
broncho-alveolar lavage fluid at 1 and 7 days post-exposure (Rani et al., 2013).  The 
CuO-induced cell damage lead to increased levels of LDH in lung lavage fluid and 
histopathological changes in the lung tissue (Rani et al., 2013; Kim et al., 2011).  
Exposure chamber experiments in mice using Cu NPs (surface phase: CuO) revealed a 
higher rate of leukocyte infiltration, as well as cell damage after chronic exposure (2 
weeks, 5 days / week, 3.68 mg / m
3
 per treatment) compared to an acute single dose 
(6.23 mg / m
3
) (Pettibone et al., 2009).  Furthermore, the levels of pro-inflammatory 
cytokines and chemokines, e.g. TNF-α, IL-6, GM-CSF, MIP-1α, and MCP-1, were 
significantly increased in chronically exposed animals that were sacrificed one day after 
the last exposure.  Many cytokines returned to the control levels after a recovery period 
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of 3 weeks (Pettibone et al., 2009).  Interestingly, Kim and colleagues (2011) found that 
both sub-acute inhalation (2 weeks, 5 days / week, ~32 µg / mouse) and single-dose 
instillation (3-100 µg / mouse) exposure to Cu NPs significantly impaired the clearance 
of bacteria from the lung. 
After one-time intraperitoneal injection of 1 or 3 mg CuO NPs in mice, indications for a 
genotoxic effects were found in red blood cells.  Together with an increased occurrence 
of micronucleated reticulocytes, elevated markers of oxidative DNA damage were 
detected in the bone marrow and liver at 1 to 3 days post-exposure, respectively (Song 
et al., 2012).  Sub-chronic exposure of rats to intraperitoneally injected CuO NPs 
resulted in an accumulation in several organs, primarily in the kidneys and liver tissue.  
Furthermore, neurotoxic changes were noted in parts of the brain, as well as significant 
DNA fragmentation in the liver and spleen after sub-chronic exposure to 2 mg / rat / 
exposure (3 times / week, up to 6 weeks) (Privalova et al., 2014). 
The oral exposure route has scarcely been investigated to date, and no in vivo studies 
addressing CuO NPs were found.  An oral in vivo exposure study is currently conducted 
within the ‘Sustainable Nanotechnologies (SUN) Project’, but final results were not yet 
available.  However, few studies on Cu NPs were found.  Meng et al. (2007) exposed 
mice to a single dose of 70 mg / kg bodyweight Cu NPs by oral gavage.  Most 
interestingly, the authors described a striking morphological change in the stomach of 
Cu NP-exposed mice 24h after the gavage.  The organ swelled and displayed an 
unnatural cyan colour, which was exclusive to the exposure to nano-sized Cu and not 
observed after treatment with proportional concentrations of micro-sized or ionic Cu.  
Meng et al. (2007) argued that Cu NPs were retained in the stomach longer than Cu 
MPs, where the continuous dissolution of Cu in the acidic environment caused an acid-
base imbalance.  A strong deposition of Cu was found in the kidneys, accompanied by 
necrotic changes in the renal tubules (Meng et al., 2007).  Another study investigated 
the acute toxicity of Cu NPs in mice by administering single doses between 108 and 
1,080 mg / kg bodyweight via oral gavage (Chen et al., 2006).  After 48h, the group 
observed pathological changes in the liver, spleen, and kidneys at exposure 
concentrations ≥341 mg / kg bodyweight.  In a study using rats, the animals were 
exposed sub-chronically to 50-200 mg / kg bodyweight for 5 days via oral gavage.  The 
most overt hepatotoxic and nephrotoxic results were observed in the high-dose group 
(Lei et al., 2008). 
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5.1.6 Aims and hypotheses 
The assessment of CuO NP-exposure in the stable and inflamed co-culture was 
performed as part of Aim III – the application of the model to study the effects of orally 
ingested NMs.  The oral uptake of noticeable concentrations of CuO is rather unlikely.  
However, the material offered the interesting possibility to investigate an essential trace 
element, which might interact differently with cells than non-essential metals like Ag.  
Furthermore, the pH-sensitive nature of the material allowed us to assess the influence 
of artificial digestion on CuO-induced toxicity.  This study aimed to investigate the 
induction of cytotoxicity in relation to the health status of the co-culture, as well as 
potential inflammatory effects after the exposure to non-toxic concentrations of digested 
and undigested CuO NPs.  
The following hypotheses were tested: 
 Digested CuO NPs are less toxic than undigested CuO NPs.  
 CuO NP concentrations that are non-toxic in UDCaco-2 monocultures can be 
applied as non-toxic concentration in DCaco-2 cells. 
 A one-time exposure of the stable co-culture with non-toxic concentrations of 
digested and undigested CuO NPs will affect at least one of the investigated 
endpoints. 
 The exposure to non-toxic concentrations of undigested and digested CuO NPs 
will induce the same effects in the stable co-culture. 
 A one-time exposure of the inflamed co-culture with non-toxic concentrations of 
undigested and digested CuO NPs will affect at least one of the investigated 
endpoints. 
 The exposure to non-toxic concentrations of undigested and digested CuO NPs 
will induce the same effects in the inflamed co-culture. 
 The effects induced in the stable co-culture will be different from the effects in 
the inflamed co-culture.  
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5.2 Materials & Methods 
5.2.1 CuO NPs 
The CuO NPs were received from a commercial source (PlasmaChem GmbH, Berlin, 
Germany).  The primary particle size is between 15-20 nm with a specific surface area 
of 47 m² / g (Gosens et al. 2016).  The particles were used by the partners of the 
Sustainable Nanotechnologies (SUN) project and kindly made available by Prof. Vicki 
Stone from Heriot-Watt University (Edinburgh, UK).  The particles were received as 
brown-blackish powder and freshly dispersed before each experiment: 
A particle suspension of 1 mg / mL CuO NPs was prepared in H2O containing 2 % FBS.  
For experimental digestions, the particles were re-suspended at a higher concentration 
of 10 mg / mL in 2 % FBS / H2O.  After vortexing the suspension for 30 seconds, the 
vial was sonicated using a waterbath sonicator for 16 min.  Subsequently, the 
suspension was kept on ice until further use.  Just before use, the vial was briefly 
vortexed again to re-disperse sedimented particles.  
 
5.2.2 Artificial digestion of CuO NPs 
To account for the environmental changes throughout the GI-passage, the CuO NPs 
were subject to a very simple artificial digestion.  An artificial gastric fluid was 
prepared in a bijou vial by adding 0.2 % w/v NaCl and 0.7 % v/v HCl to 8 mL distilled 
H2O.  The pH was measured and adjusted to ~1.5-1.7 using HCl (0.4 M) (an 
explanation of why the pH was reduced below the physiological pH of the gastric 
environment will be given in Section 5.3.1.).  Of this, 4 mL were transferred to a second 
bijou vial and served as digestive fluid control.  To the other vial, 1 mL of the 10 mg / 
mL CuO NPs suspension was added and incubated at standard culture conditions for 2h.  
After 2h, the pH was measured and adjusted in both vials to ~6.8 using NaOH (1 M).  
The vials were then incubated again for 1.5h at standard culture conditions.  After the 
incubation time, the suspension was used directly for the exposure of the cultures or to 
prepare a dilution range in CCM.  
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5.2.3 Characterisation of CuO NPs 
Both undigested and digested CuO NPs were analysed using CLS.  The analysis was 
performed on the pristine particles in dispersant and the artificial digestive fluid, as well 
as after dilution in CCM (100 µg / mL) and incubation at standard culture conditions for 
4, 24, and 48h. 
For the analysis, the CPS instrument was prepared and operated as described before 
(Section 4.2.3.2).  Due to expected large size of the particles the rotational speed was 
reduced from 22,000 to 12,000 rpm.   
 
5.2.4 Cell cultures 
For the experiments, monocultures of Caco-2 and THP-1 cells, as well as stable and 
inflamed co-cultures were used.  The culture and maintenance of the cells, as well as the 
preparation of the co-culture models were done as described before (Sections 2.1.2 & 
4.2.3).  
 
5.2.5 Alamar Blue assay 
The Alamar Blue assay was used to estimate the cytotoxic effects induced by CuO NPs.  
For the exposure, THP-1 cells and Caco-2 cells were grown and treated as described 
earlier (Section 4.2.4) and the assay run as described in Section 4.2.6.  Undigested and 
digested CuO NPs were prepared freshly according to the protocols above.  A range of 
7 concentrations (from 1.6 to 100 µg / mL) was prepared as 1:2 dilutions in fresh CCM 
and the cells exposed for 24 or 48h.  In each experiment a negative control, as well as a 
dispersant or digestion control were included.   
 
5.2.6 IN Cell Analyzer: Count of DAPI-stained nuclei  
A second measurement of cytotoxicity in Caco-2 cells was provided by quantification 
of DAPI-stained nuclei (IN Cell Analyzer) using the cell cultures of the Alamar Blue 
assay.  The cells were washed 2x with 200 µL PBS and fixed with 3.7 % formaldehyde 
for 13 min at RT.  The cells were permeabilised and stained as described in Section 
2.1.6 and imaged and analysed as before (Section 4.2.8).  The imaging and image 
analysis was kindly performed by Patricia Urbán. 
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TEER measurements (Section 2.1.4), measurements of cytokine release using ELISA 
(Section 2.1.8), and the Griess reaction (Section 3.2.4) were performed as described 
before.  
 
5.3 Results 
5.3.1 Characterisation 
After suspending the CuO NPs in dispersant the occurrence of two fractions was 
noticeable by the naked eye: one fraction remained in a relatively stable dispersion, 
while a second fraction of presumably larger particles sedimented quickly.  Due to this 
rapid sedimentation the use of DLS was not applicable and it was decided to limit the 
characterisation to CLS. 
The CLS analysis revealed a considerable heterogeneity between individual dispersions 
(Figure 5.1A), which were all prepared according to the described protocol.  Whereas in 
some dispersions (Figure 5.1A, black and red line), a population of nano-sized CuO 
particles with an average diameter of 90 nm could be detected, particles in this size 
range were entirely absent in others (green line).  Likewise, the average diameter of the 
major particle population was either between 1.2-1.4 µm (red and green line) or greatly 
exceeded a size of 2 µm.  After an incubation time of 24h in dispersant at 4°C and 
without re-suspending the sample before measurement, nearly 100 % of the CuO 
particles were sedimented to the bottom of the vial (not shown) and no signal was 
recovered by CLS (Figure 5.1A, striped line).   
After addition to MEM-based CCM (Figure 5.1B, black line), the signal intensity 
measured by CLS strongly decreased.  The maximum peak remained at >1 µm particle 
diameter.  A second very small peak was visible at ~70 nm. 
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Figure 5.1 Hydrodynamic diameter of CuO NPs (100 µg / mL) in dispersant and CCM measured by 
CLS  
(A) Measurements of 3 independent dispersions of CuO NPs in dispersant (Dispersion 1-3) and after 24h 
storage at 4°C; (B) CuO NPs in dispersant and after 0, 4, 24, and 48h  incubation in MEM-based CCM 
(CCM T0-T48) at 37°C, 5 % CO2. 
 
After incubation in gastric fluid, the dark brown particle suspension turned transparent.  
At this stage, no particulate matter could be observed by the naked eye and / or CLS 
(data not shown).  Interestingly, when the pH was adjusted to a physiologically more 
relevant value of ~2.2 the CuO particles were not fully dissolved after 2h incubation.  
When measuring the pH it was found to have increased from 2.2 to >5.   
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After incubation in acidic conditions, the pH was increased to roughly 6.8 using NaOH 
and a light blue, particulate fallout formed (Figure 5.2A).  When allowing the 
suspension to rest for 2-3 minutes, the blue particles sedimented quickly to the bottom 
of the bijou vial (Figure 5.2B).  The particles could be re-suspended easily and, as the 
repeated CLS analysis of a digested CuO batch confirmed, did not change over several 
days of storage at 4°C (data not shown).  
 
A 
 
B 
 
Figure 5.2 CuO NPs after increasing the pH from acidic (pH 1.7) to near-neutral (pH 6.8) 
(A) vortexed digested CuO NPs, (B) sedimented digested CuO NPs after 10 min  
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After the artificial digestion, the blue fallout could be detected by CLS using the same 
protocol as for the analysis of the CuO NPs (Figure 5.3, dotted line).  Compared to the 
undigested CuO NPs in dispersant the peak intensity was clearly decreased.  Whereas 
before the digestion two differently sized populations were detectable, only one peak 
was measured after the digestion at around 750 nm.  Immediately after the addition to 
MEM-based CCM, the peak intensity decreased and the average particle diameter 
slightly increased to ~810 nm (Figure 5.3, black line).  When the artificially digested 
CuO NPs were incubated in CCM at standard culture conditions for 48h, no particulate 
matter could be detected anymore between 0.01 and 2 µm. 
 
 
Figure 5.3 Hydrodynamic diameter of artificially digested CuO NPs (100 µg / mL) measured by 
CLS  
CuO NPs were measured before digestion (CuO in Dispersant), after digestion in dispersant (CuO 
digested), after digestion and addition to CCM after incubation at 37°C, 5 % CO2 (Digested CCM T0-
T48)  
 
5.3.2 Cytotoxicity in Caco-2 and THP-1 monoculture 
To ensure the use of non-toxic exposure concentrations in the co-culture experiments, 
the cytotoxicity of digested and undigested CuO NPs was investigated in monocultures 
of confluent UDCaco-2 cells and 24h PMA-differentiated THP-1 cells.  The toxicity was 
quantified via the measurement of metabolic activity with the Alamar Blue assay.  In 
Caco-2 cells the quantification of DAPI-stained nuclei using the IN Cell Analyzer was 
performed additionally. 
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5.3.2.1 Quantification of metabolic activity 
In monocultures of UDCaco-2 cells, the exposure to undigested CuO NPs of up to 12.5 
µg / mL did not reduce metabolic activity noticeably after 24 and 48h (Figure 5.4A).  At 
concentrations higher than 25 µg / mL a dose-dependent decrease in metabolic activity 
was detected, which was more pronounced after 48h compared to 24h of exposure.  The 
exposure to 100 µg / mL resulted in 100 % reduction in metabolic activity after 24h and 
48h.  No adverse effect was observed in the dispersant control corresponding to the 
highest CuO exposure concentration at either time point.  
The exposure effects of undigested and digested CuO NPs were largely comparable.  Up 
to a concentration of 12.5 µg / mL no reduction in metabolic activity was detected 
(Figure 5.4B).  At concentrations higher than 12.5 µg / mL, a dose dependent decrease 
in cell viability occurred.  After 48h, the metabolic activity was significantly lower 
(p≤0.001) in cells exposed to 25 µg / mL digested CuO NPs (40 % of the control) 
compared to the same concentration of undigested CuO NPs (28 %).  The observed 
reduction in cell viability is not linked to the components of the digestive fluid, since 
the digestion control (DC) did not induce significant effects over 48h (Figure 5.4B).
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Figure 5.4 Metabolic activity of UDCaco-2 cells after 24 and 48h exposure to CuO NPs  
The Alamar Blue assay was performed after exposure to (A) undigested CuO NPs or (B) digested CuO 
NPs; Disp.= Dispersant control, DC= Digestion control (Average of N≥3 ± StDev, *p≤0.05 compared to 
corresponding negative control; 
#
p≤0.05 compared to corresponding concentration of undigested CuO 
NPs) 
 
In PMA-differentiated THP-1 cells, undigested CuO NPs at concentrations of up to 6.25 
µg / mL did not affect the metabolic activity significantly (Figure 5.5A).  
Concentrations of undigested CuO NPs equal to or higher than 12.5 µg / mL induced 
significant cytotoxicity (Figure 5.5A).  After 24h, the metabolic activity was reduced to 
74 ± 14 %, whereas it was slightly higher after 48h with 82 ± 21 %.  Again, the CuO-
associated cytotoxicity was induced in a dose- and time-dependent manner for 
concentrations equal to or higher than 12.5 µg / mL.  
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Interestingly, digested CuO NPs were less toxic than undigested CuO NPs in PMA-
differentiated THP-1 cells.  Only at concentrations ≥25 µg / mL a statistically 
significant reduction in cell viability was detected (Figure 5.5B).  After 48h, lower 
concentrations of digested CuO NPs between 1.6 and 12.5 µg / mL caused a non-
significant increase in metabolic activity by 11-16 % compared to the control.  A similar 
non-significant increase in metabolic rate was observed after the exposure to the 
digestion control (112 and 119 % compared to the negative control after 24h and 48h, 
respectively). 
 A 
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Figure 5.5 Metabolic activity of PMA-differentiated THP-1 cells after 24 or 48h exposure to CuO 
NPs  
The Alamar Blue assay was performed after exposure to (A) undigested CuO NPs or (B) digested CuO 
NPs; Disp.= Dispersant control, DC= Digestion control (undigested CuO NPs: Average of N=3 ± StDev; 
Digested CuO NPs: Average of N=2 ± StDev, *p≤0.05 compared to corresponding negative control, 
#
p≤0.05 compared to corresponding concentration of undigested CuO NPs) 
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5.3.2.2 Quantification of DAPI-stained nuclei of Caco-2 cells using HCA 
For Caco-2 cells, the CuO NP-induced cytotoxicity was additionally quantified by HCA 
of DAPI-stained nuclei.  After exposing the cells to undigested CuO NPs for up to 48h, 
no significant reduction in the number of nuclei was detected for concentrations equal to 
or below 12.5 µg / mL (Figure 5.6A).  The exposure to 25 µg / mL induced moderate 
but significant cytotoxic effects, reducing the total number of nuclei by 25 and 14 % 
after 24h and 48h, respectively.  At an exposure concentration of 50 µg / mL, the 
cytotoxicity drastically increased.  Compared to the control, the number of nuclei was 
reduced by 95 % after 24h and >99 % after 48h of exposure.  No reduction in cell 
number was detected in cells exposed to the dispersant control. 
Also the exposure to digested CuO NPs induced significant cytotoxicity at 
concentrations equal to or higher than 25 µg / mL (Figure 5.6B).  In contrast to the 
undigested particles, 25 µg / mL digested CuO NPs induced a drastic decrease in the 
number of nuclei after 24 and 48h (55 and 93 %, respectively).  The exposure to the 
digestion control did not result in noticeable adverse effects. 
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Figure 5.6 Number of DAPI-stained Caco-2 nuclei after 24 and 48h exposure to CuO NPs  
Nuclei were stained and counted (In Cell Analyzer) after exposure to (A) undigested or (B) digested CuO 
NPs; Disp.= Dispersant control, DC= Digestive control (DC 48h: Average of N=2, rest: Average of N≥3 
± StDev; *p≤0.05 compared to corresponding negative control, #p≤0.05 compared to corresponding 
concentration of undigested CuO NPs) 
 
 
5.3.3 Co-culture exposure to CuO NPs 
Based on the cytotoxicity results, a concentration of 12.5 µg / mL digested and 
undigested CuO NPs was chosen for the co-culture experiments.  The stable and 
inflamed co-cultures were established as described before (Section 4.2.4) and 
maintained for 24h before the exposure.  After 24h of co-culture, 12.5 µg / mL digested 
CuO NPs, undigested CuO NPs, or the equivalent volume of the digestive fluid as 
digestion control were added to the AP compartment.   
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5.3.3.1 Caco-2 barrier integrity  
The first TEER measurement was taken just before the start of the co-culture (T0), as 
well as after 4, 18, 24, 28, and 48h.  The exposure to digested and undigested CuO NPs 
or the digestion control started after 24h of (co-)culture and continued for another 24h.  
Hence, the time points T28 and T48 correspond to 4h and 24h of exposure (Table 4.2). 
For all three culture models an unexposed control was included in each experiment.  
The Caco-2 barrier integrity in stable and inflamed co-cultures was comparable to 
earlier results.  Both conditions met all earlier defined requirements (Sections 2.2.3.1 & 
2.2.4.1).  To enhance the clearness of the graphs (Figure 5.7A-C) the StDev of the 
control conditions were not included.  For all time points the StDev was within a range 
of 5.1-7.9 %, 5.2-9.0 %, and 5.8-11.9 % for the monoculture, stable, and inflamed co-
culture, respectively.  
In the Caco-2 monoculture (Figure 5.7A), no statistically significant differences were 
measured between the control and the cultures designated for the exposure conditions 
before the start of the co-culture, except for the designated digestion control at T0 
(p=0.012) (Figure 5.7A, green line).  Since no significant differences were observed at 
the subsequent pre-exposure time points (T4, T18, and T24) this should not affect the 
credibility of the results.  Any differences in TEER observed at T28 and T48 can in all 
probability be linked to the exposure to undigested CuO NPs, digested CuO NPs, or the 
digestion control.  After 4h of exposure (T28), digested CuO NPs (red line) and the 
digestion control (green line) induced a slight but not significant increase in TEER by 2 
and 4 %, respectively.  No changes were observed in response to undigested CuO NPs 
(blue line). At T48, the TEER of the digestion control was identical to the unexposed 
control.  Treatment with both undigested and digested CuO NPs induced a reduction in 
TEER compared to the control by 13 ± 16 and 8 ± 5 %, respectively.  For undigested 
CuO NPs this reduction was statistically significant (p=0.002).  
In the stable co-culture (Figure 5.7B), no significant differences in TEER were noted 
between the barriers before the exposure T24.  From T24 to T28, a slight but not 
significant reduction in TEER was noted in co-cultures exposed to undigested (blue 
line) and digested (red line) CuO NPs.  No change was observed in stable co-cultures 
treated with the digestion control.  At T48, the TEER of digestion control-exposed stable 
co-cultures was equal to the corresponding control and the Caco-2 monoculture control 
(100.2 ± 2.6 %).  The TEER of stable co-cultures exposed to undigested CuO NPs was 
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significantly reduced (p≤0.001) to 80 ± 8.9 % of the monoculture control.  In contrast, 
the TEER of co-cultures exposed to digested CuO NPs was slightly but not significantly 
(p=0.216) reduced (94 ± 8.6 %). 
In the inflamed co-culture (Figure 5.7C), the TEER of the unexposed inflamed control 
(dotted line) was significantly reduced (p≤0.001) over the first 28h compared to the 
Caco-2 monoculture control (Figure 5.7 A, dotted line).  After 48h, the TEER of the 
inflamed co-culture control was re-established to 97.6 ± 11.9 % of the monoculture 
control.  Before the exposure to CuO NPs (red line), digested CuO NPs (blue line), or 
the digestion control (green line) the TEER of the designated inflamed co-cultures were 
not significantly different from the inflamed co-culture control (Figure 5.7C, dotted 
line).  After 4h of exposure, no significant changes in TEER were observed.  At T48, the 
barrier integrity of digestion control-exposed inflamed co-cultures was fully recovered 
with a TEER of 95.9 ± 12.6 % of the monoculture control.  In contrast, the TEER of 
cultures treated with undigested and digested CuO NPs remained reduced compared to 
the Caco-2 monoculture control by 14.4 % ± 18.6 and 22.3 % ± 17.7, respectively.  For 
cultures exposed to digested CuO NPs the TEER reduction was statistically significant 
compared to both the Caco-2 monoculture (p=0.002) and inflamed co-culture control 
(p=0.016). 
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Figure 5.7 Barrier integrity measured as TEER over 48h (A) Caco-2 monoculture, (B) stable, and 
(C) inflamed co-culture with and without exposure (24h ) to 12.5 µg / mL CuO NPs, 12.5 µg / mL 
digested CuO NPs, or the digestion control  
Black line marks the start of the exposure (Average of N≥3 ± StDev, *p≤0.05 compared to monoculture 
control; 
+
p≤0.05 compared to stable co-culture control; #p≤0.05 compared to inflamed co-culture 
control)  
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5.3.3.2 Cytokine release 
The release of IL-1β, IL-8, and TNF-α was quantified in BL supernatants of Caco-2 
monocultures, stable, and inflamed co-cultures after 24h exposure to undigested CuO 
NPs, digested CuO NPs, or the digestion control (Figure 5.8A-C). 
In the Caco-2 monoculture (Figure 5.8A), all three cytokines were released at very low 
concentrations.  In both the control and the three exposure conditions, IL-1β and TNF-α 
remained at concentrations below the detection limit (Table 2.2).  The release of IL-8 
was generally higher compared to IL-1β and TNF-α.  However, large variations 
between the independent runs resulted in high a StDev.  In unexposed controls, 47 ± 35 
pg / mL IL-8 were detected.  Whereas the concentration of IL-8 remained similar after 
treatment with the digestive fluids (53 ± 33 pg / mL), it slightly but not significantly 
increased in response to undigested and digested CuO NPs to 65 ± 78 and 104 ± 142 pg 
/ mL, respectively.  
Also in the stable co-culture the release of IL-1β remained at concentrations close to the 
detection limit of the assay (Figure 5.8B).  In contrast to the Caco-2 monoculture, low 
concentrations of TNF-α could be detected in the stable co-culture control (23 ± 45 pg / 
mL).  However, the release of TNF-α was subject to considerable variations between the 
independent runs causing a large StDev in the control and all exposure conditions.  
Even though the TNF-α concentration was slightly increased after the exposure to 
undigested CuO NPs (34 ± 54 pg / mL), digested CuO NPs (61 ± 117 pg / mL), and the 
digestion control (109 ± 165 pg / mL), the effect was not found to be statistically 
significant compared to the stable co-culture control.  The release of IL-8 was clearly 
increased in the stable co-culture control (1,051 ± 545 pg / mL) compared to the 
monoculture.  After 24h exposure to undigested CuO NPs, the level of IL-8 remained 
similar to the untreated control (1,092 ± 441 pg / mL).  Slightly higher but not 
significantly increased amounts were detected after exposure to digested CuO particles 
(1,376 ± 680) and the digestion control (1,473 ± 769 pg / mL). 
In the unexposed inflamed co-culture (Figure 5.8C, Control), all three cytokines were 
detected at significantly increased (p≤0.001) concentrations (IL-1β: 359 ± 362 pg / mL; 
IL-8: 12,120 ± 4,031 pg / mL; TNF-α: 826 ± 421 pg / mL) compared to the Caco-2 
monoculture and stable co-culture control.  In the different exposure conditions, the 
release of IL-1β, IL-8, and TNF-α remained similar to the inflamed co-culture control 
(Figure 5.8C).  No statistically significant differences were observed. 
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Figure 5.8 Release of IL-1β, IL-8, and TNF-α in (A) Caco-2 monoculture, (B) stable co-culture, and 
(C) inflamed co-culture with and without exposure to 12.5 µg / mL CuO NPs, 12.5 µg / mL digested 
CuO NPs, or the equivalent volume of the digestion control (DC)  
(Average of N=3 ± StDev; *p≤0.05 compared to corresponding monoculture control, #p≤0.05 compared 
to corresponding stable co-culture control) 
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5.3.3.3 Quantification of NO2ˉ 
The formation NO in response to the exposure to CuO NPs or the digestion control was 
indirectly determined by measurement of NO2ˉ.  Here, the inflamed co-culture control 
also acted as positive control for the formation of NO.  If no increased concentrations of 
NO2ˉ were detected in the inflamed co-culture control, the run was not considered 
further for the analysis.   
After 48h of Caco-2 monoculture (Figure 5.9A), the levels of NO2ˉ in both AP and BL 
compartment were very low (1.8 and 1.3 µM, respectively).  Neither the exposure to 
CuO NPs nor the digestion control induced a noticeable change in the release of NO2ˉ.  
In the stable co-culture condition the concentration of NO2ˉ was not significantly 
different from the monoculture in both AP and BL compartment (Figure 5.9B).  Also 
after the exposure to digested and undigested CuO NPs, as well as the digestion control 
the levels remained close to the detection limit of the assay.  In the inflamed co-culture, 
the release of NO2ˉ increased significantly 3.8-fold in the AP and 4.5-fold in the BL 
compartment compared to the monoculture control to 6.9 and 5.9 µM, respectively 
(Figure 5.9C).  Also in the inflamed model the exposure to digested and undigested 
CuO NPs and the digestion control did not results in significantly changes. 
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Figure 5.9 Quantification of NO2ˉ after 48h (A) Caco-2 monoculture, (B) stable, or (C) inflamed co-
culture with and without 24h exposure to 12.5 µg / mL CuO NPs, 12.5 µg / mL digested CuO NPs, 
or an equivalent volume of the digestion fluids as control (DC)  
(Caco-2 monoculture and inflamed co-culture: Average of N=2 ± StDev; Stable co-culture: Average of 
n=3 from one experiment; *p≤0.05 compared to Caco-2 monoculture control) 
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5.4 Discussion 
In the present study, the stable and inflamed co-culture models were used to study the 
effects of CuO NPs.  The main findings can be summarised in the following points: 
 The CuO NPs rapidly dissolved in CCM so that the cells were likely exposed to 
increasing concentrations of ionic Cu instead of particulate CuO. 
 THP-1 cells were more sensitive to the exposure to undigested CuO NPs than 
Caco-2 cells, but less vulnerable to digested CuO NPs, as indicated by changes 
in metabolic activity. 
 The exposure to undigested CuO NPs significantly reduced the Caco-2 barrier 
integrity in the monoculture and stable co-culture.  In the inflamed co-culture, 
the exposure to digested CuO NPs significantly inhibited the re-establishment of 
barrier integrity. 
 The exposure to undigested and digested CuO NPs did not affect the release of 
IL-1β, TNF-α, and IL-8 or the generation of NO in any of the three culture 
models. 
 
5.4.1 CuO NPs characterisation 
The characterisation of the CuO NPs with CLS confirmed the presence of a substantial 
amount of micron-sized CuO particles, agglomerates, or aggregates next to a second 
fraction of nanoparticulate CuO.  The observed rapid sedimentation was, therefore, not 
surprising.  For a short period of time, the cellular dose of the particles can be expected 
to be equal to the exposure concentration.  When incubated in CCM at standard culture 
conditions the particles sedimented rapidly but also dissolved over time.  From the CLS 
curves it can be assumed that the dissolution occurred mainly throughout the first 4h 
and reached equilibrium at longer incubation times.  Therefore, treated cells were likely 
exposed to nano- and micron-sized CuO particles, but also to an increasing 
concentration of ionic Cu. 
As discussed previously (Section 4.4.1), the particle size and stability greatly influence 
the cellular dose, i.e. the concentration of sedimented NMs the cells are eventually 
exposed to in contrast to the total exposure concentration (Hinderliter et al., 2010).  
Apart from the media density and viscosity, the particle size and density are important 
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characteristics to determine a particle’s deposition, as they define its diffusion and 
sedimentation behaviour (Hinderliter et al., 2010). 
In line with the here presented results, a similar dissolution behaviour of CuO NPs was 
described by Misra and colleagues (2014).  The group observed that ~80 % of both 
spherical and rod-shaped CuO NPs rapidly dissolved over the first 4h of incubation in 
CCM without further changes over the subsequent 20h (Misra et al., 2014).  
Interestingly, we observed an increase in peak intensity in the CLS measurements 
between 4 and 24h of incubation, which cannot be clearly explained.  It is possible that 
a precipitation of solubilised Cu ions occurred, as has been observed for AgNPs (van 
der Zande et al., 2012).  Otherwise, the lower peak intensity after 4h compared to 24 
and 48h of incubation might have been caused by insufficient re-suspension of 
sedimented particles before the CLS sample was taken.  Taking into account the general 
heterogeneity of the particle stock suspension, the differences in peak intensity could 
reflect variations in the subsequently prepared samples.  
Due to the rapid sedimentation rate, the exposed cells likely encounter intact CuO NPs 
or particle aggregates before they dissolve.  Since cells are able to engulf particles of up 
to 5 µm by macropinocytosis (Odzak et al., 2014) an uptake of these large CuO particles 
or complexes is generally possible (Lim and Gleeson, 2011).  Since the average size of 
the particles varied considerably between different stock suspensions the average 
particle size and specific surface area that cells were getting in contact with probably 
differed between the experiments.   
After the artificial digestion of the particles, probably no or little particulate CuO 
remained in the stock suspension.  Indeed, both in vivo and in vitro, the dissolution of 
Cu and CuO NPs has been shown to be strongly influenced by the pH of the 
environment (Meng et al., 2007; Odzak et al., 2014).  Interestingly, we noted a pH-
increasing effect of CuO NPs in artificial gastric fluid at physiologically relevant pH.  A 
similar effect was observed earlier by Meng et al. who demonstrated nicely how nano-
Cu but not micro-Cu particles consumed significant amounts of H
+ 
in strongly acidic 
environment (pH<2) and, thereby, induced an increase in pH to above 5.  As a basic 
oxide, CuO dissolves in mineral acids.  In HCl, the dissolution results in the formation 
of copper chloride (CuCl2) and H2O (Equation 5.1).  As a consequence of the 
continuous oxidation of the particles, H
+
 is consumed.  This explains why in our 
conditions the initial pH of ~2.2 increased over the incubation time with CuO NPs.  
Therefore, we decided to decrease the pH of the gastric phase further, even though it 
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does not perfectly represent a physiological condition.  We assumed that in a realistic 
exposure condition in vivo the organism would likely react with an increased synthesis 
of gastric fluid to compensate for the H
+
 scavenging.  In a study conducted in mice, 
however, Meng et al. (2007) found severe swelling and green discoloration of the 
gastric tissue after exposure to Cu NPs.  The group suggested that nano but not micro-
sized Cu particles are retained in the stomach and continue to react in the acidic 
environment generating considerable amount of Cu ions.   
When the pH was subsequently increased to ~6.8 to reflect the conditions in the small 
intestine, the Cu ions reacted with NaOH to form copper (II) hydroxide (Cu(OH)2) 
(Equation 5.2).  Hence, cells exposed to digested CuO NPs probably encountered only 
very low concentrations of solid particles if any at all.  Instead, the cells were likely 
exposed to Cu compounds like CuCl2 and Cu(OH)2.   
 
CuO(S) + 2HCl  CuCl2 + H2O (5.1) 
CuCl2 + 2NaOH  Cu(OH)2 + 2NaCl (5.2) 
 
In retrospective, a more elaborate digestive process or at least use of NaHCO3 instead of 
NaOH should have been favoured, as it is more representative of the physiological 
processes within the GI-tract (Säfsten, 1993).  In presence of NaHCO3, CuCl2 would 
have likely reacted to Cu carbonate (CuCO3) instead of Cu(OH)2.  The implication of 
these differences for the downstream effects of exposure to digested CuO NPs is not 
clear.  Cu
2+
 is generally regarded as the main form to cause toxicity, whereas CuCO3 
appears to be less or non-toxic.  The potential of Cu(OH)2 is less clear but has also been 
shown to exert a certain level of cytotoxicity.  At a pH of 6.5-7 the Cu complexes might 
dissolve over time to ionic Cu
2+
 regardless of the composition (Grosell, 2012). 
It remains debateable, whether the particulate fallout formed after addition of NaOH 
acts on the cells like particulate or ionic Cu.  Since the calculation by the instrument’s 
internal software is based on the molecular weight and density of CuO the average size 
of the particles as measured by CLS is probably distorted.  The molecular weight of 
Cu(OH)2 is slightly higher with 97.5 compared to 79.5 g / mol. 
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5.4.2 Cytotoxic effects of undigested and digested CuO NPs in cell 
monocultures 
Undigested CuO NPs induced a dose–dependent decrease in cell viability in both 
UDCaco-2 and PMA-differentiated THP-1 cells.  The more detailed cytotoxicity 
assessment, however, revealed considerable differences between Caco-2 and THP-1 
cells, as well as between undigested and digested CuO NPs.  In contrast to Caco-2 cells, 
the viability of PMA-differentiated THP-1 cells was already significantly reduced at 
exposure concentrations of 12.5 µg / mL undigested CuO NPs.  Similar observations 
were made by other groups, for both CuO NPs and other NMs.  In an interlaboratory 
study investigating the toxicity of 24 NMs, Lanone et al. (2009) reported significant 
differences in the sensitivity between an epithelial cell line (A549) and monocytes 
(THP-1).  Whereas rather low concentrations of just 3 µg / mL were sufficient to reduce 
THP-1 viability by 50 %, 26.5 µg / mL CuO NPs were necessary to induce the same 
effect in A549 cells (Lanone et al., 2009).  In contrast, Soto and colleagues (2007) 
observed a slightly higher sensitivity to the exposure to NMs in A549 cells compared to 
human macrophages.  What seems like a contradiction at first might be related to the 
proliferation rate of the cells.  It was suggested that the cytotoxic effect of NMs also 
depends on the metabolic activity of the cells, with slower proliferation times increasing 
the susceptibility (Chang et al., 2007).  In contrast to Soto et al., Lanone and colleagues 
and this project used PMA-differentiated THP-1 cells.  One of the effects of PMA 
exposure is the drastically reduced or even inhibited proliferation of the cells.  Instead, 
the UDCaco-2 cells are likely in a phase of rapid growth and a high proliferation rate 
(Singh et al., 1996), which might explain the reduced vulnerability compared to the 
macrophages. 
Another potential reason for the higher cytotoxicity of CuO NPs in the macrophages is 
the cells’ phagocytic activity, which is increased in response to PMA-differentiation 
(Tsuchiya et al., 1982).  Furthermore, the uptake of particles by PMA-differentiated 
THP-1 cells has been shown to be almost exclusive to macropinocytosis, a mechanism 
which is essentially required for the uptake of very large particles (Lunov et al., 2011) 
as used here.   
Several groups have studied the influence of artificial digestion on exposure effects of 
NMs, for instance induction of cytotoxicity.  The impact of digestion seems to heavily 
depend on the type of investigated NM.  Both Böhmert et al. (2014) and Gerloff et al. 
(2013) did not find a significant influence of digestion of the toxic potentials of either 
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AgNPs or SiO2 NPs in Caco-2 cell cultures.  A study using PEG-coated CdSe quantum 
dots on Caco-2 cells showed a drastically increased cytotoxicity after incubating the 
particles in acidic pH (Wang et al., 2008a).  As mentioned earlier (Section 5.1.1), 
different groups noted a lower level of cytotoxicity induced by ionic Cu compared to 
CuO particles (Thit et al., 2013; Piret et al., 2012b).  The artificial digestion caused the 
complete dissolution of the CuO NPs and the cells were most likely exposed to ionic Cu 
compounds instead of particulate CuO.  Based on the assumption that cells have better 
regulated uptake mechanisms for ionic than particulate Cu we expected to see a less 
potent induction of cytotoxicity by digested compared to undigested CuO NPs.  This 
was, however, only the case for THP-1 cells.  In Caco-2 cells, digested CuO NPs were 
slightly more toxic after 48h of exposure than undigested CuO NPs.  In contrast to other 
groups, we investigated the cytotoxicity in confluent UDCaco-2 cells.  As was discussed 
before (Section 4.4.3.2), the differentiation of the cells might lead to the induction or 
resting of pathways or proteins, e.g. receptors, which might be essential for the uptake 
of ionic Cu.  Whereas the uptake of Cu ions is strictly regulated in differentiated 
enterocytes it might be controlled less rigidly before and throughout the differentiation.   
 
5.4.3 The effect of CuO NPs exposure in the (co-)culture models 
The monoculture and both co-culture conditions were used to study the cytotoxic and 
pro-inflammatory potential of non-toxic concentrations of CuO NPs, as well as the 
impact of the health status on the exposure effects.  However, quantifying cytotoxic 
effects in the context of the health status was challenging, as neither the Alamar Blue 
nor the LDH assay could be applied.  Hence, the analysis of a representative number of 
cells of the Caco-2 cell layer using the IN Cell Analyzer was the only feasible 
alternative.  Due to the complexity of the image acquisition and analysis, these results 
could not be generated on time.  Therefore, no information on the potentially increased 
susceptibility of differentiated compared to UDCaco-2 cells and inflamed compared to 
stable co-cultures are available.   
In the experiments presented here, CuO NPs did not induce a cytokine release or NO 
generation in the Caco-2 monoculture and the stable co-culture.  In contrast to this, Piret 
et al. (2012b) found a clear upregulation of IL-8 synthesis in monocultures of DCaco-2 
cells.  However, Piret and colleagues applied much higher exposure concentrations of 
25 µg / mL which in our cell cultures reduce the viability significantly.  Furthermore, in 
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the study by Piret et al. (2012b) the noticeable induction of IL-8 release required an 
exposure time of at least 48h.  It is possible that an exposure period of 24h was not 
sufficient to observe changes in the cells’ cytokine profile.  In other cell lines, e.g. the 
lung epithelial cell line A549, a 24h treatment has been reported to be sufficient to 
induce IL-8 at even lower concentrations of around 10 µg / mL (Cho et al., 2011).  At 
high concentrations of 100 µg / mL, an exposure time as short as 3h caused a significant 
release of pro-inflammatory cytokine in lung epithelial cells (Moschini et al., 2013). 
Another important point to consider is the translocation rate of apically added CuO NPs 
or Cu ions across the Caco-2 barrier.  In this study it is not clear what concentrations of 
CuO particles and Cu ions passed the Caco-2 barrier to directly interact with the THP-1 
cells in the BL compartment.  Moreover, as shown by the CLS results, the average 
particle size can vary considerably between different batches of stock dispersion.  It can 
be assumed that the dissolution of the particles in the CCM differs depending on the 
initial ratio of MPs to NPs in the suspension.  In this context, it is difficult to estimate 
the composition of the supernatant including the ratio of ionic to nano- to micro-sized 
Cu throughout the exposure period.  This information is, however, crucial since large 
variations in Cu uptake are likely between particulate and ionic Cu, as well as between 
nano- and micro-sized CuO.  According to in vitro experiments in Caco-2 cells and in 
vivo research in chicken the absorption rate is highest for CuO NPs (60 and 51 % 
respectively) and lowest for CuO microparticles (MPs) (12 and 14 %, respectively) 
(Chen et al., 2015a).  The transfer rate of ionic Cu has been measured to be ~40 % 
(Chen et al., 2015a; Bauerly et al., 2004). 
Additionally, the effect of CuO exposure seems to vary considerably between cell types 
and even within the same cell type of different origin.  When the same particles and 
exposure concentrations were used, CuO particles induced the generation of IL-8 in 
alveolar epithelial cells, but not in bronchial epithelial cells (Cho et al., 2013a).  
Whereas CuO NPs could induce the release of IL-1β in alveolar macrophages, no 
increase in either TNF-α or IL-1β was observed in both differentiated PBMCs and 
PMA-differentiated THP-1 cells (Cho et al., 2013a).  Even though this study found 
digested and undigested CuO NPs to exert strong cytotoxic effects in THP-1 cultures it 
is possible that the cells generally do not react to the exposure with the release of pro-
inflammatory cytokines. 
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Instead of inducing an inflammation in the co-culture it is possible that CuO affected 
the system differently if the exposure occurs during an ongoing inflammatory condition.  
As mentioned in the introduction, studies suggest that ongoing inflammatory processes 
lead to a dysregulation of the otherwise well-controlled uptake of Cu ions (Fernández-
Banares et al., 1990; DiSilvestro and Marten, 1990).  However, no worsening or 
amelioration of the ongoing inflammation was observed in this project.  In contrast, 
Triboulet et al. (2013) observed a reduction in RNS as well as the release of IL-6 but 
not TNF-α in LPS-stimulated murine macrophages after 26h exposure to different 
concentrations (5 and 20 µg / mL) of CuO NPs.  Based on the earlier mentioned 
differences between different cell types and cell lines it is possible that this effect does 
not occur in THP-1 but only J774 cells. 
Even though no effects were noted in the cytokine release and induction of nitrous 
stress the exposure to CuO NPs had an impact on the barrier integrity in all three 
conditions.  In the Caco-2 monoculture and stable co-culture the exposure to undigested 
CuO NPs induced a significant reduction in TEER indicating a disruption of the barrier 
function.  Whether this barrier disruption was based on an effect on the TJ network or 
the Caco-2 cell viability cannot be answered.  Based on the cytotoxicity data generated 
in UDCaco-2 cells the exposure concentrations should not have induced cytotoxicity.  It 
might, however, confirm the discussed susceptibility of cells in relation to their 
metabolic activity (Section 5.4.2).  Whereas UDCaco-2 cells were in rapid growth phase 
after 3 days of culture their proliferation was likely strongly reduced or halted after a 
culture period of 13 days (Singh et al., 1996).  If a reduced proliferation rate renders the 
cells more susceptible it is possible that 12.5 µg / mL CuO NPs negatively affected 
DCaco-2 cells, even though no effect was noted in UDCaco-2 cells.  Similar results were 
obtained by Thit et al. (2013) after exposing kidney cells (aquatic toad Xenopus laevis) 
to CuO particles.  The group reported increased vulnerability of differentiated compared 
to dividing cells to both ionic Cu and CuO NPs.  Interestingly, in the experiments 
presented here the effect on the barrier integrity of DCaco-2 cells was limited to 
undigested CuO particles in both the monoculture and stable co-culture.  This was in 
line with the findings of other groups showing that ionic Cu induces less severe effects 
than Cu or CuO particles (Piret et al., 2012a; Wang et al., 2012).   
In contrast, the opposite effect was observed in the inflamed co-culture.  Here, the 
exposure to digested CuO NPs interfered more strongly with the re-establishment of the 
barrier integrity than undigested CuO NPs.  So far, the results were discussed assuming 
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that the uptake of ionic Cu is well controlled and regulated and, therefore, causes less 
damage than particulate CuO.  As research showed, patients suffering from chronic 
inflammation of the intestine display significantly higher serum Cu levels than healthy 
controls (Fernández-Banares et al., 1990; Ojuawo and Keith, 2002).  This suggests that 
the uptake of dietary Cu and the systemic balance of the trace element are distorted in 
inflamed conditions.  It is possible that we observed a similar effect in the inflamed co-
culture.  Whereas the undigested CuO NPs affected the barrier to a similar extent as in 
the monoculture and stable co-culture, the Cu ions of the digested CuO NPs could 
possibly exert a stronger effect due to an increased / distorted uptake in stressed Caco-2 
cells.  Even though the exposure did not influence the release of pro-inflammatory 
cytokines and NO, digested CuO NPs might interfere with the re-establishment of 
barrier integrity in intestinal inflammation.  A decreased integrity of the intestinal wall 
impairs the gate function of the intestinal barrier (Suzuki et al., 2011; Al-Sadi and Ma, 
2007; Gerova et al., 2011), which in turn might result in the increase translocation of 
potentially harmful antigens.  Therefore, the interference of CuO NPs with the barrier 
re-establishment in vivo might cause a prolongation or even worsening of an existing 
medical condition. 
  
5.5 Conclusions 
The aim of this study was to apply the developed stable and inflamed co-cultures to 
study the cytotoxic and inflammatory effects of non-toxic concentrations of undigested 
and digested CuO NPs.  The results generated in cell monocultures showed that the 
cytotoxic potential of digested CuO NPs is not generally lower compared to undigested 
CuO NPs but depends on the studied cell type, which clearly disproved the chapter’s 
first hypothesis.  Due to the lack of available methods to study the cell viability in 
transwells the CuO-induced cytotoxicity could not be addressed sufficiently in the 
transwell cultures.  An indirect assumption regarding the CuO-induced toxicity could be 
made based on the CuO-mediated reduction in TEER.  This indication is, however, very 
vague since a reduction in TEER does not necessarily reflect a reduction in cell 
viability.  Whether non-toxic CuO NP-concentrations remain non-toxic in DCaco-2 cells 
could not be answered.  Interestingly, digested and undigested CuO NPs affected the 
exposed co-cultures differently.  On the one hand, this disproved the hypotheses that the 
digestion will not affect the effects in the stable or inflamed co-culture.  On the other 
hand, these results confirmed the hypothesis that digested and undigested CuO NPs will 
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induce different effects the stable compared to the inflamed co-culture.  This was clearly 
proven as undigested but not digested CuO NPs negatively affected the barrier integrity 
in the stable co-culture, whereas effects in the inflamed co-culture were only significant 
in response to digested CuO NPs.  No pro- or anti-inflammatory effects were noted in 
either co-culture model. 
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6 Application of the co-culture models to study the barrier crossing 
of radio-labelled [
195
Au]AuNPs 
6.1 Introduction 
For many years, nanotoxicological research has focused on studying the effects of NMs 
with the investigation of fixed endpoints, like cytotoxicity, genotoxicity, or induction of 
inflammation.  Therefrom, a considerable amount of knowledge has been generated 
regarding the toxicity mechanisms of NMs in biological systems.  However, the 
understanding of the biokinetics of NMs (i.e. absorption, systemic bioavailability, tissue 
distribution, accumulation / excretion) has been insufficiently covered to date.  
Understanding the uptake and distribution kinetics of NMs in biological systems is 
crucial to determine the concentrations effectively crossing biological barriers, e.g. the 
intestine (Lee et al., 2014).  The effective uptake and subsequent distribution are 
important pieces of information for a thorough risk assessment of NMs (Bouwmeester 
et al., 2009).   
Also with regard to the developing field of nanomedicine knowledge on the biokinetics 
of NMs is of utmost importance.  Firstly, oral administration of drugs still is the 
preferred and often only feasible route of drug administration, e.g. in case of insufficient 
health care infrastructure (Sastry Venkateswara et al., 2000).  Furthermore, several 
developments in the medical field like cancer research and cell-based therapies depend 
on the availability of reliable and safe real-time in vivo detection/imaging solutions to 
determine systemic availability and tissue distribution of nano-sized objects (Taylor et 
al., 2012).  However, the tracing, and quantification of unlabelled NMs is problematic 
and often unprecise (Holzwarth et al., 2014).  Therefore, the labelling of NMs has 
received increasing interest over the last years, with radioactive isotopes having 
emerged as one of the most sensitive methods to quantify and visualise the location of 
NMs in vivo and in vitro (Holzwarth et al., 2014). 
 
6.1.1 Application of radio-labelled NMs to study intestinal availability 
The labelling of NMs with radionuclides can be effected by different means.  It can 
either be performed on a material before the synthesis of the desired nano-object (Yang 
et al., 2013) or follow post-synthesis on the final object (Holzwarth et al., 2014).  For 
post-synthesis labelling, the radio-label can be introduced into the structure of the NM 
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(e.g. by proton irradiation of NPs that causes transmutation in a small fraction of their 
atoms into radionuclides) or attached onto its surface (Abbas et al., 2009; Gibson et al., 
2011; Holzwarth et al., 2014).  In contrast to surface-labelling, which is an important 
determinant for the behaviour of NMs in biological systems, the introduction of radio-
isotopes in the internal structure seems to hardly, if at all, alter the surface chemistry of 
NMs (Lee et al., 2014; Abbas et al., 2009; Holzwarth et al., 2014).  Several research 
groups have successfully labelled various types of NMs, e.g. ZnO, SiO2, and polymers, 
and subsequently applied for kinetic studies and nanomedical applications, or a 
combination of both.  Radio-labelled polylactic acid NPs were used to demonstrate the 
impact of polyethylene glycol surface coverage on mucus penetration and absorption of 
NMs (Ensign et al., 2012).  Both Lee et al. (2012) and Bimbo et al. (2010) used 
18
F-
labelling to study the bio-compatibility and -distribution of ZnO and SiO2 NPs in rats.  
The application of SiO2 NPs was further developed as potential drug delivery system to 
increase the oral bioavailability of drugs (Sarparanta et al., 2012).  However, not all 
NMs are suitable for oral exposure applications due to colloidal instability, dissolution, 
and hence, release of ions (Bergin and Witzmann, 2013).  For example, CdSe quantum 
dots (QD) did not induce a cytotoxic effect in vitro when dispersed in CCM unless they 
were subject to an artificial gastric digestion, which drastically increased their toxic 
potential (Wang et al., 2008).   
 
6.1.2 Use of AuNPs for radio-tracer studies 
Even though several materials have been investigated and used for radio-labelling and   
-tracing studies, Au has received special attention because of its biocompatibility, easy 
handling of surface modification, and high colloidal stability under physiological 
conditions (de Barros et al., 2012; Chanana et al., 2013).  AuNPs are generally reported 
to be non-cytotoxic even at high exposure concentrations of 500-1000 µM (Freese et al., 
2012; Lin et al., 2011), but potentially induce the release of pro-inflammatory 
cytokines.  In mesenchymal stem cells, for instance, the exposure to AuNPs caused an 
increased release of IL-8 and IL-6 (Mahl et al., 2010).  In macrophages the reported 
effects are more diverse.  Some groups noted more detrimental effects of AuNP-
exposure with a reduction in cell viability and upregulation of pro-inflammatory 
cytokines like IL-6 and TNF-α (Yen et al., 2009).  Others observed a similarly high 
resilience to AuNPs as in epithelial and endothelial cells and no indications for pro-
inflammatory processes (Shukla et al., 2005; Bancos et al., 2015).  All studies using 
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macrophages uniformly described an uptake of AuNPs, though the uptake efficiency 
seemed to heavily depend on the particle characteristics like geometry, surface 
modification, and protein corona (Arnida et al., 2011). 
 
6.1.3 Aims and hypotheses 
Several studies have investigated the intestinal uptake of AuNPs in vivo (Schleh et al., 
2012; Hillyer and Albrecht, 2001) and in vitro (Lin et al., 2011).  To our knowledge, the 
effect of an inflammation-like process on the uptake / translocation of AuNPs has not 
been addressed to date.  With radio-actively labelled [
195
Au]AuNPs we aimed to study 
the paracellular translocation across the Caco-2 epithelial barrier and the potential 
uptake by the THP-1 cells in the BL compartment in relation to the health status of the 
co-culture at the time of exposure, as well as the particle size.  
The investigation was based on the following hypotheses: 
 In the Caco-2 monoculture and stable co-culture the translocation of 
[
195
Au]AuNPs to the BL compartment is minimal to absent. 
 In the inflamed co-culture the loosened TJ network allows for a significantly 
increased translocation of [
195
Au]AuNPs to the BL side compared to exposed 
Caco-2 monocultures and stable co-cultures.   
 The rate of translocation is higher for smaller [195Au]AuNPs. 
 [195Au]AuNPs passing into the BL compartment are taken up by THP-1 cells.  
 
6.2 Materials & Methods 
6.2.1 Au irradiation  
The irradiation was kindly performed by Neil Gibson and Uwe Holzwarth from the 
Radiotracers CG (NBS Unit, JRC, Italy).   
The radionuclide 
195
Au was produced by irradiating Au foil (99.99 %, 0.25 mm thick, 
25x25 mm, Sigma Aldrich) with protons of 29.8 MeV energy.  During the proton 
irradiation the foil was immersed in a cooling water flow to ensure simultaneous 
cooling from the front (oriented towards the incoming proton beam) and the rear side.  
The collimated proton beam had a circular shape with a diameter of 10 mm.  Hence, 
only a circular central part of the foil with a diameter of 10 mm was irradiated and 
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contained the desired radionuclide.  Only this irradiated part – hereinafter 195Au or ‘hot’ 
Au – was used for the subsequent synthesis.   
The activity )(tA  of a radionuclide after proton irradiation of a target for a duration t  
can be calculated as 
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where VN denotes the number density of target atoms in the irradiated volume and Φ  
the flux of protons through the irradiated volume per second.  The irradiation conditions 
were selected to exceed an activity concentration of 1 MBq / mg of Au in the irradiated 
area.  A total proton dose of 400 A.h was applied. 
 
6.2.2 Quantitative γ-ray spectrometry 
Quantitative γ-ray spectrometry was applied to quantify the 195Au activity in the 
different experimental fractions and to determine the mass of AuNPs from the activity 
concentration of the irradiated Au foils used for the synthesis of the NPs back to end of 
proton bombardment as time reference.  Quantitative γ-ray spectrometry was performed 
with ultrahigh-purity germanium (HPGe) detectors from CANBERRA (USA) and 
EG&G Ortec (USA) calibrated in energy and efficiency with certified standard 
calibration sources (uncertainty: 1-1.5 %) for each standard geometry (DAMRI and 
CERCA, France; ENEA, Italy; the Czech Metrological Institute, Czech Republic).   
Standardised geometrical conditions were defined for measuring the activity of the 
irradiation capsule, Au foils, [
195
Au]-HAuCl4 x H2O solution (0.01 M), as-synthesised 
[
195
Au]AuNPs (5 nm) and [
195
Au]Au core-shell NPs (30 nm), washing liquids and all 
samples from the intestinal barrier model exposed to the NPs for each time point.  The 
γ-ray spectra were analysed using the spectrometry analysis software packages of 
Canberra (Genie 2000 software) and EG&G Ortec (Gamma Vision Software).  In order 
to correct for radioactive decay during the experiments all activity values were 
calculated back to end of bombardment as reference time t=0 or back to the end of 
synthesis of the radiolabelled AuNPs. 
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6.2.3 [195Au]AuNPs synthesis 
The particles were synthesised by Isaac Ojea Jiménez and Elena Bellido of the 
Radiotracers CG (NBS unit, JRC, Italy). 
 
6.2.3.1 Preparation of the radioactive precursor - 195Au-labelled gold(III) chloride 
hydrate  
The precursor for the NP synthesis [
195
Au]-HAuCl4·x H2O was prepared by the 
dissolution of hot Au foil in a stoichiometric appropriate volume of freshly prepared 
aqua regia and subsequent evaporation of the liquid at boiling temperature.  All 
solutions were freshly prepared and glassware was cleaned before use with aqua regia 
and MilliQ water.   
 
6.2.3.2 Synthesis of 5 nm [195Au]AuNPs 
After dissolving 63.8 mg Au contained in dried HAuCl4 in MilliQ H2O and subsequent 
filtration (0.22 µm pore size), 76% of the starting activity were recovered in the filtered 
solution.  Hence, the NP-synthesis started from 48.5 mg Au in 10 mL aqueous solution, 
which corresponds to a concentration of 25 mM. 
Of this 25 mM Au(III)-salt solution 1 mL was added to 100 mL of 0.25 mM sodium 
citrate solution under permanent stirring.  The synthesis of particles was initiated by 
adding 1 mL of 0.1 M chilled sodium borohydride (NaBH4) solution under immediate 
stirring, which resulted in a dark red solution.  Stirring was continued for 20 min at RT.  
A sample was taken for DLS analysis and -ray spectrometry.  The remaining 
[
195
Au]AuNPs suspension was stored at 4°C protected from light.  For the batch used in 
these experiments an initial activity concentration of 286  18 kBq / mg was calculated. 
 
6.2.3.3 Synthesis of 30 nm core-shell [195Au]AuNPs 
Citrate-stabilized 30 nm [
195
Au]Au core-shell NPs were synthesized by seeding growth 
from non-radioactive Au seeds.  Small non-radioactive AuNPs (12 nm by TEM, data 
not shown) were used as seeds for growing a [
195
Au]Au-labelled shell.  The process 
results in the synthesis of cold Au core hot Au shell NPs (Figure 6.1).  In a typical 
194 
synthesis, trisodium citrate dihydrate solution (5.6 mL, 0.1 M) and sodium hydroxide 
solution (0.8 mL, 0.2 M) were added to MilliQ H2O (184 mL) while stirring and heated 
up to 65°C in a silicone oil bath.  Then the 12 nm cold Au seeds (5.2 mL, 0.5 mM) were 
added to the solution under continued stirring.  Finally, a solution of [
195
Au]-HAuCl4·x 
H2O (4.4 mL, 0.01 M) was added to the mixture and the reaction was allowed to 
continue under stirring at 65°C for 48h.  Subsequently, the reaction solution was cooled 
to RT. 
For example the following activity was calculated for one batch: the synthesis resulted 
in a total mass of 9.18 mg [
195
Au]Au-NPs with a total activity of 4.07 MBq.  Therefore, 
an activity concentration of 444  28 kBq / mg was obtained. 
 
 
Figure 6.1 Structural composition of 30 nm core-shell AuNPs 
 
6.2.3.4 Determination of the radiochemical yield after NP synthesis 
The radiochemical yield was determined from the liquid phase after filtration using 10 
kDa Amicon centrifugal filters (Merck).  The centrifugation was carried out at 2,415 xg 
for a total of 45 minutes at 4°C.  The centrifugation recovered a fraction of 
195
Au
+ 
ions 
with a total activity of 0.030 ± 0.013 Bq / mL.  Based on the total activity of irradiated 
Au foil the recovered ion-associated activity accounted for less than 0.01 % of the 
material used for the synthesis.  Hence, a reaction yield of 99.9 % was achieved. 
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6.2.3.5 Evaluation of 195Au release from [195Au]AuNPs in CCM 
To evaluate the integrity of the two sizes of [
195
Au]AuNPs throughout the in vitro 
experiments, leaching tests were performed in MilliQ H2O and CCM at standard culture 
conditions.  35 mL of the nanoparticle suspensions (100 μM) in CCM and MilliQ water 
were kept in Falcon tubes under standard culture conditions.  At different time points (0, 
6, 24, and 96h), the tube contents were mixed by inverting the tubes.  Three aliquots of 
2.5 mL each were collected from which the [
195
Au]AuNPs were removed by filtration 
(10 kDa Amicon filters at 3,460 xg for 20 min).   Finally, the presence of 
195
Au 
radioisotopes was determined in the filtrate by γ-ray spectrometry. 
 
6.2.3.6 Preparation of NP suspensions for biological experiments 
For cell exposure experiments, the original NP suspension was concentrated 20x from 
0.25 mM to 5 mM (stock) using 10 kDa Amicon centrifugal filters.  The particle 
suspension was centrifuged at 2,415 xg at 4°C in several stages of up to 50 min each 
until the desired volume was obtained.  
To prepare the working stock concentration (100 µM), 1 mL of the 5 mM stock 
suspension was diluted 1:50 in fresh pre-warmed MEM-based CCM.  To obtain a 
homogenous distribution, the NPs suspension in CCM was vortexed for 30 sec and used 
within 30 min.  
 
6.2.4 Characterisation of [195Au]AuNPs 
The characterisation of 5 and 30 nm AuNPs was kindly performed by Patricia Urbán, 
Carine Drewes (IBS CG, NBS Unit, JRC, Italy), Isaac Ojea Jiménez, and Uwe 
Holzwarth.  The radio-labelled [
195
Au]AuNPs of both sizes were characterised by DLS 
and TEM as described earlier (Sections 4.2.2.1 & 4.2.2.4).  The particles were analysed 
in dispersant, as well as at different time points after incubation in CCM.  A cold batch 
of small AuNPs was investigated using CLS (Section 4.2.3.2) and UV-Vis (Section 
4.2.3.3).  Since the visual inspection of the samples collected after incubation with cells 
indicated a potential for aggregation/agglomeration, the batch of cold 5 nm AuNPs was 
used to study the particle size distribution after incubation with Caco-2 monocultures.  
For this, Caco-2 cells were seeded onto transwell filter inserts and maintained as 
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described in Section 6.2.5.1.  At day 21, the cells were apically exposed to 100 µM of 5 
nm [
195
Au]AuNPs.  After 0, 4, 24, and 48h the AP supernatants containing 
[
195
Au]AuNPs were collected and analysed using CLS and TEM.  
 
6.2.5 Exposure experiments 
6.2.5.1 Cell culture and co-culture set-up 
The cell culture, IFN-γ-priming of Caco-2 cells, PMA-differentiation and activation of 
THP-1 cells was done by Angela Kämpfer.  The co-culture establishment and exposure, 
as well as subsequent sample collection and TEER measurements were performed by 
Agnieszka Kinsner-Ovaskainen (IBS CG, NBS Unit, JRC, Italy) under oversight and 
instruction of Angela Kämpfer. 
Caco-2 and THP-1 cells were cultured and maintained as described before (Section 
2.1.2).  For co-culture experiments, the Caco-2 cells were seeded onto 6-well PET-
transwell filter inserts with a pore size of 1 µm (Falcon, 353102) at a density of 1.8x10
5
 
cells / cm².  The THP-1 cells were differentiated using PMA (100 nM, 24h).  Before the 
start of the co-culture, the THP-1 cells were seeded onto transwell-suitable 6-well plates 
at a density of 6.7x10
5
 cells / well in 3 mL RPMI-based CCM without ME.  Compared 
to the 12-well based co-cultures the THP-1 cell density increased 3.7 fold, whereas the 
BL volume doubled.  Therefore, the exposure concentrations for both LPS and IFN-γ 
were increased to 20 ng / mL.  The stable and inflamed co-cultures were started as 
described earlier (Section 4.2.4).  For all conditions and time points, cell cultures were 
prepared in triplicates. 
 
6.2.5.2 Exposure to [195Au]AuNPs and sample collection 
The AP and BL medium was discarded from the wells.  For the Caco-2 monocultures, 
the BL medium was replenished with fresh RPMI-based CCM.  For the co-cultures, the 
designated transwell filters were directly transferred to the corresponding well plates 
containing unstimulated or stimulated THP-1 cells.  Subsequently, 2 mL of the 
[
195
Au]AuNPs suspension in CCM (100 µM, Section 6.2.3.6) were transferred to the AP 
compartment.  In each experiment, an unexposed Caco-2 monoculture was included, 
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which served as the negative control for the analysis of barrier integrity as measured by 
TEER.   
The sedimentation behaviour of the particles and their kinetics of passage through cell-
free filter inserts were evaluated separately.  The cell-free filter inserts were treated with 
[
195
Au]AuNPs using the same protocol as for the cell cultures.   
All exposed cultures were incubated for 24 or 48h at 37°C, 5 % CO2.  After 24 or 48h of 
incubation, each Caco-2 monoculture and cell-free transwell generated 4 individual 
samples:  
1. A: AP supernatant 
2. B: BL supernatant 
3. C: Wash of the AP compartment / transwell filter (‘filter wash’) 
4. D: Transwell filter insert  
The stable and inflamed co-cultures generated a 5
th
 sample:  
5. E: Accutase-detached THP-1 cells. 
The AP and BL supernatants were collected in 15 mL Falcon tubes.  The AP 
compartment and filter were washed once with 2 mL PBS, which was collected in 15 
mL Falcons.  After washing the filter inserts were collected in zip-lock bags.  To the BL 
compartments of the stable and inflamed co-culture conditions 1 mL Accutase was 
added to detach the THP-1 cells.  After 10 min incubation, the cells were collected with 
2 mL PBS in a separate 15 mL Falcon tubes and activity measured as described in 
Section 6.2.2.  
 
6.2.5.3 Monitoring barrier integrity 
Before the start of the co-cultures and after 18, 24, and 48h of exposure the barrier 
integrity of the Caco-2 monocultures and co-cultures was measured as TEER as 
described in Section 2.1.4.  The TEER was monitored to confirm the compliance of the 
co-cultures with the earlier defined criteria, as well as to study potential cytotoxic 
effects of [
195
Au]AuNPs.   
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6.3 Results 
6.3.1 Characterisation of [195Au]AuNPs 
6.3.1.1 Characterisation of 5 nm [195Au]AuNPs 
The characterisation results for 5nm [
195
Au]AuNPs in dispersant and CCM are 
summarised in Table 6.1. 
 
Table 6.1 Summary of TEM, CLS and DLS measurements of 5 nm AuNPs performed in water and 
MEM-based CCM 
 
* no meaningful results could be generated; PDI: poly-dispersity index; HHW: half-height width of the 
measured size distribution 
 
The 5 nm [
195
Au]AuNPs were found to be homogenously dispersed with an average 
diameter of 4.5 ± 0.7 nm according to TEM analysis (Figure 6.2).  No change in 
colloidal stability was noted after incubating the particles in fresh CCM for a minimum 
of 48h (Figure 6.3). 
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A 
 
B 
Figure 6.2 TEM imaging of 5 nm [
195
Au]AuNPs and quantitative analysis  
(A) Representative image of AuNPs suspension in dispersant acquired by TEM, (B) particle size 
distribution of AuNPs in dispersant based on the quantitative analysis of TEM images (The graph was 
kindly provided by Isaac Ojea Jiménez) 
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Figure 6.3 TEM image of 5 nm [
195
Au]AuNPs after 48h+ incubation in fresh CCM at 37°C, 5 % 
CO2 
The significance of results generated by DLS was limited (Figure 6.4).  In dispersant, 
various batches of [
195
Au]AuNPs showed a hydrodynamic diameter at around 6 nm.  
The results obtained for Batch 4 (Figure 6.4A, yellow line) were clearly different from 
the other 4 batches tested, with an increase in hydrodynamic diameter to roughly 10 nm.  
Therefore, the batch was discarded.  After incubation in CCM for 0, 6, 24, or 48h the 
size distribution changed considerably (Figure 6.4B).  After 6h incubation, the DLS-
derived graph showed 3 peaks at 10 nm, 200 nm, and > 5 µm.  The size distribution 
developed two further peaks after 24h incubation at ~40 and 300 nm.  Between 24 and 
48h of incubation the AuNPs size did not change significantly anymore.   
 
A 
 
B 
 
Figure 6.4 Hydrodynamic diameter of 5 nm [
195
Au]AuNPs measured by DLS  
(A) Various batches of AuNPs in dispersant, (B) AuNPs after incubation in MEM-based cell culture 
medium at 37°C, 5 % CO2 (The graphs were kindly provided by Uwe Holzwarth.) 
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More reliable results could be obtained using CLS (Figure 6.5).  The hydrodynamic 
diameter of 5 nm [
195
Au]AuNPs dispersed in CCM measured by CLS was slightly 
higher than in TEM with 5.5 nm (Figure 6.5).  After incubation in fresh CCM the 
hydrodynamic diameter increased to 6.3 and 6.5 nm after 1 and 24h, respectively.  After 
48h, an increase to around 32 nm was noted.   
 
 
Figure 6.5 Hydrodynamic diameter of 5 nm AuNPs incubated in fresh complete MEM-based CCM 
measured by CLS 
Measured by CLS after 0, 1, 24, and 48h (T0-T48) incubation in CCM at 37°C, 5 % CO2 
 
The spectroscopic analysis of 5 nm AuNPs using UV-Vis showed a maximum 
absorbance at around 520 nm after the addition to fresh CCM (Figure 6.6, black line).  
After 1h incubation in CCM, the maximum absorbance remained at 520 nm and the 
peak intensity reduced minimally.  After 24 and 48h (Figure 6.6, blue and red line, 
respectively) a slight right-shift to roughly 528 nm was observed. 
Summing up, the 5 nm [
195
Au]AuNPs were homogenously dispersed in both water and 
fresh CCM.  The presence of serum proteins in CCM did not affect the AuNPs size 
distribution significantly over 24h of incubation.  After extended incubation times some 
agglomeration or aggregation might occur.  
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Figure 6.6 UV-Vis spectra of 5 nm AuNPs after incubation in fresh MEM-based CCM  
Measurements were taken after 0, 1, 24, and 48h (T0-T48) incubation at 37°C, 5 % CO2 (The graph was 
kindly provided by Carine Drewes.) 
 
6.3.1.2 Characterisation of 30 nm [195Au]AuNPs 
The characterisation results for 30 nm [
195
Au]AuNPs are summarised in Table 6.2. 
 
Table 6.2 Summary of TEM and DLS measurements of 30 nm [
195
Au]AuNPs performed in water 
and CCM 
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The TEM analysis of the 30 nm core-shell [
195
Au]AuNPs in dispersant showed a 
homogenous distribution of single particles with an infrequent occurrence of 
agglomerates (Figure 6.7A).  A small fraction of smaller particles (15-20 nm) was 
observed.  The quantitative analysis of the TEM images resulted in an average particle 
diameter of 31.8 ± 6.5 nm. 
 
 
A 
 
B 
 
Figure 6.7 TEM imaging of 30 nm [
195
Au]AuNPs and quantitative analysis  
(A) Representative image of AuNPs in dispersant acquired by TEM, (B) Particle size distribution of 
AuNPs in dispersant based on the quantitative analysis of TEM images (The graph was kindly provided 
by Isaac Ojea Jiménez.) 
 
The hydrodynamic diameter measured with DLS was clearly larger in both dispersant 
and fresh CCM.  In dispersant, the Z-average was 54.4 ± 5.7 nm with the primary peak 
at 73 ± 9.4 nm (Figure 6.8A).  In most batches a small fraction of very large particles 
was detected in the range of >5 µm.  This second peak disappeared after incubating the 
particles in fresh CCM (Figure 6.8B).  In CCM, another peak appeared at 10 nm, which 
was probably caused by the large amount of serum proteins.  Hence, the Z-average 
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decreased slightly to 48.8 ± 3.2 nm, even though the main peak shifted to 80 ± 8 nm.  
The PDI remained similar with 0.358 and 0.367 in dispersant and CCM, respectively.  
 
A 
 
B 
 
Figure 6.8 Hydrodynamic diameter of 30 nm [
195
Au]AuNPs in dispersant and CCM measured by 
DLS 
(A) 30 nm AuNPs in dispersant; (B) 30 nm AuNPs after incubation in CCM at 37°C, 5 % CO2 (The 
graphs were kindly provided by Uwe Holzwarth.) 
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6.3.2 
195
Au release from [
195
Au]AuNPs in CCM 
During in vitro experiment to study NP-translocation it was important to guarantee that 
the measured activity of 
195
Au-radioisotopes can be related to the presence of AuNPs 
and not free 
195
Au released into the medium due to a partial dissolution of the NPs.  
Free 
195
Au might easily pass thorough the cell barriers and mistakenly be considered as 
the signature of NP-translocation.  In our experiments we did not detect any activity of 
195
Au radioisotopes in the filtered solutions of AuNPs incubated both in MilliQ H2O and 
in CCM for up to 48 hours (not shown).  Thus, the release of free 
195
Au was below the 
detection limit, which indicated that no significant disintegration of 5 nm and 30 nm 
[
195
Au]AuNPs occurred under the experimental conditions. 
 
6.3.3 Passage of [195Au]AuNPs across cell-free filters 
The passage of [
195
Au]AuNPs across cell-free filter inserts was investigated for two 
reasons.  Firstly, to ensure that the NPs can cross the 1 µm filter and translocate to BL 
compartment of the transwell.  Secondly, studying the passage of the NPs across cell-
free filters gave a general indication of their sedimentation behaviour, which is an 
important parameter to estimate the cellular exposure concentration. 
To study the passage of [
195
Au]AuNPs, 2 mL of the working stock suspension in CCM 
(100 µM) was added to the AP compartment of a cell-free transwell insert and placed 
onto a transwell-suitable 6-well plate containing 3 mL RPMI-based CCM.  The plates 
were incubated a standard culture conditions and the samples taken as described in 
Section 6.2.5.2. 
 
6.3.3.1 Passage of 5 nm [195Au]AuNPs across cell-free transwell filters 
After 24h incubation, 70.5 % of the total activity was measured in the AP supernatants 
(sample A) (Figure 6.9).  Of the remaining 29.5 %, 28 % were recovered in the BL 
supernatants (sample B).  The other 1.5 % were distributed over the filter (C) and the 
filter insert (D).  After 48h incubation, 37.5 % of the total activity was measured in the 
BL compartment, whereas 61 % remained on the AP side.  The activity recovered in the 
filter wash increased slightly to 0.83 %.  The activity retained in the filter insert 
decreased to 0.64 %.   
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Figure 6.9 Sedimentation and passage of 5 nm [
195
Au]AuNPs across cell-free transwell filter inserts 
over 24 and 48h  
[
195
Au]-associated activity in the AP (A) and BL (B) compartment, the filter wash (C) and the filter insert 
(D) after incubation at 37°C, 5 % CO2 (Average of n=3 of one experiment ± StDev) 
 
6.3.3.2 Passage of 30 nm [195Au]AuNPs across cell-free transwell filters 
After 24h incubation, 55 % of the total activity was detected in the AP supernatants 
(sample A) (Figure 6.10).  One third of the total activity was recovered from the BL 
side (sample B).  The remaining 10 % were allocated over the filter wash and the filter 
insert with 4.2 and 6.4 %, respectively.  After 48h incubation, the activity measurements 
of the AP and BL compartment were almost identical with 46 % each.  The activities 
recovered from the filter wash and filter samples decreased slightly to 2.9 and 4.6 %, 
respectively. 
 
Figure 6.10 Sedimentation and passage of 30 nm [
195
Au ]AuNPs across cell-free transwell filter 
inserts over 24 and 48h  
[
195
Au]-associated activity in the AP (A) and BL (B) compartment, the filter wash (C) and the filter insert 
(D) after incubation at 37°C, 5 % CO2 (24h: Average of N=2 ± StDev, 48h: Average of n=3 of one 
experiment ± StDev) 
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6.3.4 The effect of [195Au]AuNPs exposure on the barrier integrity 
Throughout the exposure to 5 and 30 nm [
195
Au]AuNPs the TEER was measured in all 
culture models at the start of the exposure (T0), as well as after 18, 24, and 48h.   
Before exposure to 5 nm [
195
Au]AuNPs (Figure 6.11A, T0), the TEER of the designated 
exposure filters for the monoculture (blue line) and stable co-culture conditions (red 
line) were not statistically different from the control barrier (striped line).  The IFN-γ-
primed barriers for the inflamed co-culture had a significantly increased (p=0.003) 
TEER compared to the control.   
In exposed Caco-2 monocultures no significant changes in TEER were observed over 
the exposure time of 48h.  Also in the stable co-cultures the exposure to 5 nm 
[
195
Au]AuNPs did not cause changes in the TEER over the first 24h.  After 48h, the 
TEER was significantly increased (p=0.013) to 115 ± 13 %.   
The TEER of the inflamed co-culture (green line) was strongly reduced compared to the 
untreated monoculture control over the first 24h of exposure (Figure 6.11A).  The 
reduction was only statistically significant (p≤0.001) at T24 with 66 ± 13 % compared to 
the unexposed monoculture control.  Subsequently, the barrier integrity was re-
established and no significant difference was measured at T48.   
Before the exposure to 30 nm [
195
Au]AuNPs (Figure 6.11B, T0), no statistically 
significant difference in TEER were measured between the Caco-2 barriers.  The TEER 
of the exposed Caco-2 monoculture (blue line) and stable co-culture (red line) were not 
significantly different from the unexposed control at T18 and T24.  At T48, the TEER of 
the exposed monoculture and stable co-culture were significantly increased compared to 
the unexposed monoculture control to 120 ± 7.8 % (p≤0.001) and 112 ± 10 % 
(p=0.006), respectively.   
The TEER of the inflamed co-culture (green line) was significantly decreased (p≤0.001) 
at T18 and T24 compared to the unexposed monoculture control to 72 ± 4 and 74 ± 7 %, 
respectively.  At T48, the barrier integrity of the inflamed co-culture was completely re-
established to 100 ± 4.4 % compared to the unexposed monoculture control.   
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Figure 6.11 Barrier integrity measured as TEER in Caco-2 monoculture, stable, and inflamed co-
cultures after exposure to [
195
Au]AuNPs 
(A) over 48h exposure to 5 nm [
195
Au]AuNPs; (B) over 48h exposure to 30 nm [
195
Au]AuNPs (5 nm: 
Average of N=2 ± StDev; 30 nm: Average of N=3 ± StDev, T18: N=2 ± StDev; *p≤0.05 compared to 
corresponding unexposed Caco-2 monoculture (control)) 
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6.3.5 Colloidal stability of 5nm [195Au]AuNPs suspension in presence of 
Caco-2 cells 
After 24h incubation with cells no effect on the colloidal stability of the particle 
suspension was noted (Figure 6.12A).  Two interesting observations were made, 
however, after an increased incubation time of 48h.  Firstly, significant differences in 
the colour of the CCM were visible between the Caco-2 monoculture and the inflamed 
co-culture.  As this was also observed in unexposed cultures (not shown) the colour 
differences cannot be attributed to the presence of the [
195
Au]AuNPs.  Secondly, 
sedimented dark material accumulated at the bottom of the vials after sample collection.   
When comparing the particle suspension after 48h incubation in a cell-free environment 
to samples taken from exposed cell cultures a clear difference in the suspension stability 
is visible (Figure 6.12B).  Whereas dark particulate material sedimented to the bottom 
of the vial in the cell culture sample no sedimentation occurred in cell-free transwells.  
 
A 
 
B 
 
Figure 6.12 Colloidal stability of 5nm [
195
Au]AuNPs in presence and absence of cells  
(A) Particle suspensions of the AP compartment after 24h incubation and 48h incubation at 37°C, 5 % 
CO2 in the Caco-2 monoculture (24h: 1.1A; 48h: 4.1A) and inflamed co-culture (24h: 2.1.A; 48h:3.1A); 
(B) particle suspensions of the AP compartment after 48h incubation at 37°C, 5 % CO2 in cell-free 
environment (left vial) or in the inflamed co-culture (right vial) 
 
To further investigate the impact of cells on the colloidal stability of the particles a 
batch of cold 5nm AuNPs was analysed using CLS and TEM after incubation with 
Caco-2 monocultures.  Interestingly, the exposure of Caco-2 monocultures resulted in a 
significantly larger hydrodynamic diameter (Figure 6.13) starting from 4h of incubation 
compared to fresh CCM (Figure 6.5B).  After 48h, the average hydrodynamic diameter 
was increased 5-fold to 27.7 nm. 
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Table 6.3 Hydrodynamic diameter of 5 nm [
195
Au]AuNPs measured by CLS after incubation with 
Caco-2 monocultures 
 Cell-exposure in CCM 
 4h 24h 48h 
CLS Size (nm) 9.8 20.7 27.7 
 
 
Figure 6.13 Hydrodynamic diameter of 5nm AuNPs in presence of cells measured by CLS 
Measured in H2O and after 0, 4, 24, and 48h (T0-T48) incubation with Caco-2 monocultures in MEM-
based CCM at 37°C, 5% CO2 
 
The analysis with TEM confirmed the occurrence of considerable agglomeration or 
aggregation in presence of Caco-2 cells (Figure 6.14A-D).  Whereas the particles were 
homogenously distributed directly after addition to the cell cultures (Figure 6.14A) 
small agglomerates of around 10 particles were visible after 4h of incubation (B).  The 
size of the agglomerates steadily increased which resulted in the formation of large 
clusters after 24 (C) and 48h of incubation (D). 
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Figure 6.14 TEM images of 5 nm AuNPs incubated with Caco-2 monocultures  
Samples of 5nm AuNPs (100 µM) were prepared after (A) 0h, (B) 4h, (C) 24h, (D) 48h incubation with 
Caco-2 monocultures at 37°C, 5% CO2 
 
6.3.6 Measurement of radioactivity in the collected transwell samples 
6.3.6.1 Exposure to 5 nm [195Au]AuNPs 
The results for Caco-2 monocultures and both co-culture models exposed to 5 nm 
[
195
Au]AuNPs are summarised in Figure 6.15. 
After 24h exposure to [
195
Au]AuNPs (Figure 6.15a) more than 97 % of the total activity 
remained in the AP supernatants (A) in all three culture models.  Virtually no activity 
could be measured in the BL supernatants (B) (0.039 ± 0.055 %, 0.007 ± 0.004, and 
0.044 ± 0.047 % for the monoculture, stable co-culture, and inflamed co-culture, 
respectively).  Between the individual replicates large variations in activity were 
observed ranging from <1 to ~30 Bq for 5 nm [
195
Au]AuNPs (not shown).  The 
remaining 2.2-2.3 % of activity were recovered in almost equal parts in the filter wash 
(C) and filter inserts (D).  No statistically significant differences were observed between 
the cultures. 
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In the Caco-2 monoculture (Figure 6.15b, white bars), the [
195
Au]AuNPs-associated 
activity in the AP compartment was slightly but significantly reduced compared to the 
activity recovered after 24h to 96.8 (p=0.015) after 48h incubation.  The decrease in AP 
activity did not result in an increase in BL activity.  The activity in the filter wash (C) 
and the filter insert (D) remained similar to the results after 24h with 1.8 ± 0.45 and 1.3 
± 0.19 %, respectively. 
Also in the stable co-culture (Figure 6.15b, striped bars), the AP activity reduced 
significantly after 48h compared to 24h of incubation (p=0.022) to 95.7 %. As in the 
monoculture, no increase in BL activity was measured.  The filter wash recovered 
slightly higher results with 2.4 ± 0.83 %.  The activity measured in the filter of the 
stable co-cultures after 48h was significantly increased compared to the monoculture 
(p=0.003) but not compared to the stable co-culture filter results after 24h exposure. 
In the inflamed co-culture (Figure 6.15b, black bars), the AP activity was significantly 
lower (p≤0.001) after 48h compared to the corresponding 24h results with 92.8 %.  The 
AP activity of the inflamed co-culture was significantly lower (p≤0.001) compared to 
the 48h results of the monoculture and stable co-culture.  Also in the inflamed co-
culture, no increase in BL activity was noted after 48h.  Most interestingly, the activity 
detected in the filter wash and filter was significantly increased (p≤0.003) compared to 
corresponding 24h results, as well as compared to the monoculture and stable co-culture 
after 48h.  Together, the activity in samples C and D accounted for roughly 7 % of the 
total activity (3.2 ± .053 % in the filter wash, 3.9 ± .071 % in the filter). 
Neither in the inflamed nor in the stable co-culture 
195
Au-related activity was recovered 
in the THP-1 cells after 24 or 48h exposure. 
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Figure 6.15 Distribution of 
195
Au-associated activity in Caco-2 monocultures, stable, and inflamed 
co-cultures after exposure to 100 µM 5nm [
195
Au]AuNPs 
The 
195
Au-associated activity was measured in AP (A) and BL (B) supernatants, the filter wash (C), the 
filter insert (D), and if applicable the THP-1 cells (E) in Caco-2 monocultures, stable, and inflamed co-
cultures (CC) after (a) 24h exposure and (b) 48h exposure (Average of N=2 ± StDev, *p≤0.05 compared 
to corresponding monoculture, 
#
p≤0.05 compared to corresponding stable co-culture; +p≤0.05 compared 
to corresponding 24h sample) 
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6.3.6.2 Exposure to 30 nm [195Au]AuNPs 
After 24h exposure to 30 nm [
195
Au]AuNPs (Figure 16a), ~96.5-96.6 % of the activity 
was measured in the AP supernatants of all three culture models.  Of the remaining 4 %, 
1.3-1.5 % was detected in the filter wash (C) and 2 % in the filter insert (D).  Virtually 
no activity was measured in the BL supernatants of all culture models or the THP-1 
cells of the stable and inflamed co-cultures.  The differences between the culture models 
were not statistically significant for any of the 5 samples.  
After 48h exposure (Figure 6.16b), the activity of AP supernatants remained at 96 % in 
the Caco-2 monoculture (white bars).  The activity in the filter wash significantly 
(p=0.046) increased compared to the corresponding 24h results to 1.8 %.  No change in 
activity was measured in the BL supernatants and the filter insert.  
In the stable co-culture (Figure 6.16b, striped bars), the activity in AP supernatants 
decreased significantly (p=0.019) between 24 and 48h of exposure to 95.6 %.  However, 
no statistically significant increase in activity was measured in samples B-E after 48h.  
Also in the inflamed co-culture (Figure 6.16b, black bars), the activity in AP 
supernatants decreased significantly (p=0.003) to 95 % after 48 compared to 24h of 
exposure.  In accordance, the activity in the filter wash and filter insert increased 
significantly after 48h to 1.9 and 3.0 %, respectively.  
No activity was detected in samples B and E in any of the culture models.  
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Figure 6.16 Distribution of measured 
195
Au-associated activity in Caco-2 monocultures, stable, and 
inflamed co-cultures after exposure to 100 µM 30 nm [
195
Au]AuNPs 
The 
195
Au-assoicated activity was measured in the AP (A) and BL (B) supernatants, the filter wash (C), 
the filter insert (D), and if applicable the THP-1 cells (E) in Caco-2 monocultures, stable, and inflamed 
co-cultures (CC) after (a) 24h and (b) 48h exposure (Average of N=3 ± StDev; 
+
p≤0.05 compared to 
corresponding 24h sample) 
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6.4 Discussion 
With the use of radio-labelled [
195
Au]AuNPs this study aimed to investigate the barrier 
passage of NMs across a Caco-2 cell layer, and to detect a potential increase in particle 
translocation during an ongoing inflammation-like process.  The results discussed 
hereinafter, can be summarised in the following points: 
 The environment greatly influenced the characteristics of the [195Au]AuNPs.  In 
contrast to fresh CCM, the presence of cells caused significant agglomeration or 
aggregation of the 5 nm particles, which most likely accelerated the particles’ 
sedimentation.  
 In fresh CCM, 30 nm [195Au]AuNPs sedimented faster across cell-free filters 
than 5nm [
195
Au]AuNPs. 
 The 48h exposure to 30 nm [195Au]AuNPs caused a significant increase in 
TEER in the Caco-2 monoculture and stable co-culture, whereas the exposure to 
5 nm [
195
Au]AuNPs significantly increased the TEER in the stable co-culture 
only.  
 No barrier integrity-related effects were observed for either size of 
[
195
Au]AuNPs in the inflamed model. 
 For 5 nm [195Au]AuNPs an increased accumulation of 195Au-associated activity 
was found in the filter insert of the inflamed co-culture. 
 The induction of an artificial inflammation-like process did not cause an 
increased translocation of [
195
Au]AuNPs over 48h.  
 
6.4.1 Characterisation and stability of ([195Au])AuNPs 
The characterisation of 5 and 30 nm [
195
Au]AuNPs in dispersant showed a homogenous 
and narrow size distribution.  Whereas the hydrodynamic diameter of the larger 30 nm 
particles increased significantly in fresh CCM, the 5 nm [
195
Au]AuNPs were very stable 
over an incubation period of 24h, but increased to a size of 30 nm after 48h.  This 
increase in hydrodynamic diameter was not reflected in the TEM analysis of 5nm 
particles.  The 5 nm [
195
Au]AuNPs behaved differently in fresh CCM compared to 
CCM in the presence of cells.  In cell-free CCM no agglomerates, aggregates, or 
deposition of 5 nm [
195
Au]AuNPs were visible by the naked eye after 48h incubation.  
In cell exposure experiments on the other hand, a clear deposition at the bottom of the 
AP compartment was noted after 48h.  Whereas the deposition suggested the presence 
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of very large particle complexes only a 6-fold increase in hydrodynamic diameter from 
5 to ~30 nm was measured.  TEM imaging of 5nm AuNPs incubated with Caco-2 cells, 
however, confirmed a gradual formation of large agglomerates. 
The effect of salts and proteins on the stability of NMs has received increasing attention 
over the last years.  Several groups demonstrated a significant impact of the dispersant 
composition on the characteristics of NMs.  Ji et al. (2010) systematically analysed how 
the combination of the basic culture medium together with the type and concentration of 
protein influences the colloidal stability of TiO2 NPs.  The group demonstrated a 
striking impact of the dispersant but not the agglomeration state on the sedimentation 
behaviour of the particles.  Whereas the agglomeration behaviour of TiO2 NPs was 
largely unaffected by the type and concentrations of protein the sedimentation varied 
between 7 and 94 % (Ji et al., 2010).  In case of AuNPs the addition of proteins to CCM 
was shown to prevent rather than cause agglomeration independent of the type of 
protein used (Mahl et al., 2010; Luby et al., 2015).  Probably also in our case such a 
stabilising effect took place when dispersing the 30 nm [
195
Au]AuNPs stock suspension 
in CCM.  Whereas a small fraction of very large structures in the micrometre range was 
detected in dispersant the signal disappeared immediately after diluting the stock in 
CCM.  The availability of large quantities of proteins in the CCM and, therefore, 
formation of a protein corona around the particles possibly led to a dissociation of 
formerly present agglomerates.   
The composition of the protein corona seems to play an important role in determining 
the colloidal stability of NPs in CCM (Ji et al., 2010; Halamoda-Kenzaoui et al., 2015).  
It has to be noted that the protein corona is not only influenced by the type of protein 
added to the CCM but also by compounds released by the cells (Albanese et al., 2014).  
This might explain the different stability we observed for 5 nm AuNPs in fresh CCM 
compared to the stability in cell exposure experiments.  As Tenzer et al. (2013) showed 
elegantly, the protein corona composition depends less on the size or surface charge of 
NPs, but is influenced by the type of material (e.g. Au, Ag, SiO2,…).  Hence, even 
though it was not explicitly studied within this project an effect of the presence of cells 
on the stability of the 30 nm [
195
Au]AuNPs is likely to occur in a comparable fashion to 
our observations for 5 nm [
195
Au]AuNPs. 
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6.4.2 Sedimentation and passage of [195Au]AuNPs across cell-free filters 
Disregarding the colloidal stability, both 5 and 30 nm [
195
Au]AuNPs sedimented and 
passed into the BL compartment at significant concentrations, as indicated by the results 
obtained in cell-free filter inserts.  The passage of 30 nm particles was higher compared 
to 5 nm particles, indicating that the sedimentation of the smaller particles was slower.   
Indeed, the transport of NPs in the in vitro conditions is mainly driven by diffusion and 
gravitational sedimentation (Hinderliter et al., 2010; Teeguarden et al., 2007).  The 
diffusion rate is a function of the surrounding liquid properties (temperature, medium 
viscosity) and of the NP diameter, while the gravitational velocity depends on the mass 
density of the NPs and the medium.  Therefore, the NP diameter and mass density have 
a major impact on the transport of NPs.  The velocity of sedimentation is proportional to 
the square of the NP diameter (Hinderliter et al., 2010), which explains the faster 
passage of larger 30 nm [
195
Au]AuNPs across cell-free filters.   
 
6.4.3 Effect of [195Au]AuNPs exposure on the barrier integrity in the culture 
models 
The exposure to 5 and 30 nm [
195
Au]AuNPs did not induce a reduction in barrier 
integrity in the Caco-2 monoculture and stable co-culture.  Furthermore, the exposure 
did not affect the barrier disruption or the re-establishment of barrier integrity in the 
inflamed co-culture.  Interestingly, both sizes of [
195
Au]AuNPs increased the TEER of 
the monoculture and stable co-culture after 48h of exposure but not in the inflamed co-
culture.   
These results suggest that [
195
Au]AuNPs did not negatively affect the TJ network or the 
Caco-2 cell viability.  This is in line with the majority of published findings of other 
groups.  To date, most studies agree that AuNPs do not exert cytotoxic effects unless 
functionalised with cationic surface charge or administered at very high concentrations 
(500-1000 µM) (Boisselier and Astruc, 2009; Freese et al., 2012).  Even highly sensitive 
cytotoxicity assays, like the study of colony forming efficiency, did not show adverse 
effects of 5 and 30 nm AuNPs in Caco-2 cells (Bajak et al., 2015).  As mentioned 
earlier, results of in vitro experiments using macrophages are in disagreement.  Whereas 
some groups observed significant cytotoxicity at rather low concentrations (10 µg / mL) 
and induction of pro-inflammatory cytokines (Yen et al., 2009), others did not note any 
adverse effects (Shukla et al., 2005; Bancos et al., 2015).  Since it is unlikely that 
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AuNPs cross the intact Caco-2 barrier at sufficiently high numbers to reach potentially 
cytotoxic concentrations, no adverse effects on the THP-1 cells were expected.   
Some studies challenge the generally assumed harmlessness of AuNPs.  Lin et al. 
(2011) reported a significant reduction in TEER in Caco-2 cells after 3h exposure to 45 
µg / mL AuNPs.  All AuNPs tested by Lin and colleagues were modified with various 
polymer chains to provide negative, neutral, or positive surface charges.  A clear 
reduction in barrier integrity was noted for all tested AuNPs independent of their size 
and surface charge, and was accompanied by an increase in the translocation of 
mannitol (Lin et al., 2011).  A study using 13 nm PEG-coated AuNPs in mice resulted 
in the induction of apoptosis in the liver, as well as elevation of inflammatory mediators 
(Cho et al., 2009).  
The [
195
Au]AuNPs in our study were not further functionalised or surface modified.  
The surface properties of NPs can greatly influence the composition of the protein 
corona (Safi et al., 2011).  It is, therefore, possible that the surface modifications 
unbeneficially influenced the protein corona and, hence, the biological identity of the 
AuNPs, whereas the pristine surface in our project enabled the formation of a more 
favourable protein corona composition. 
 
6.4.4 [195Au]AuNPs translocation in the different culture models 
In the Caco-2 monoculture, virtually no 
195
Au-associated activity was measured in the 
BL supernatants, indicating that no significant translocation of 5 or 30 nm 
[
195
Au]AuNPs across the IEC barrier occurred.  Even after a prolonged exposure period 
of 48h more than 95 % of the activity remained in the AP supernatant.  Furthermore, no 
statistically significant differences were found between the Caco-2 monoculture and 
stable co-culture, supporting the statement that the presence of unstimulated THP-1 
cells does not negatively affect the Caco-2 barrier.  Interestingly, in the inflamed co-
culture exposed to 5 nm [
195
Au]AuNPs the measured activity in the AP supernatants 
was significantly reduced compared to both the monoculture and stable co-culture after 
48h.  In parallel, an increased activity was measured in the filter wash and the transwell 
inserts.  A similar trend was observed for 30 nm [
195
Au]AuNPs, but these results failed 
to be statistically significant.  However, no increase in the translocation of 
[
195
Au]AuNPs to the BL side of the transwell was detected for both particle sizes.  
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Neither the BL supernatant samples nor the separately investigated THP-1 macrophages 
revealed an increased 
195
Au-associated activity after 48h of exposure. 
These results suggest that the [
195
Au]AuNPs were deposited and potentially taken up by 
the Caco-2 cells at a higher rate in the inflamed model compared to the monoculture or 
stable co-culture.  They, furthermore, indicate that the effect was more pronounced for 
the smaller 5 nm particles compared to 30 nm [
195
Au]AuNPs, even though the 
sedimentation studies in fresh CCM showed a higher sedimentation rate for 30 nm than 
5 nm [
195
Au]AuNPs.  Here the discussed effect of cells on the colloidal stability might 
be of importance.  In presence of cells, 5 nm AuNPs formed large agglomerates, which 
did not occur in fresh CCM.  Most likely, the sedimentation of these large agglomerates 
was accelerated compared to single 5 nm particles.  In contrast, the presence of cells 
might have had the opposite effect on the 30 nm [
195
Au]AuNPs.  Instead of accelerating 
the sedimentation, it might have rather led to an increased colloidal stability, slowing 
down sedimentation.   
Even though an increased 
195
Au-associated activity was measured in the filters the exact 
location of the [
195
Au]AuNPs could not be determined.  The particles might be attached 
to the apical side of the cells, located within the cells after uptake, or between the 
basolateral cell membrane and the filter after exocytosis.  In all exposure conditions and 
culture models, however, the translocation to the BL compartment and uptake by THP-1 
cells was negligible or absent. 
Based on the current literature, an increased accumulation of [
195
Au]AuNPs in IECs of 
the inflamed compared to the stable model is not surprising.  A localisation of NMs at 
inflamed lesions has already been reported in vivo and in vitro.  Biodegradable 
polystyrene NPs and SiO2 NPs were primarily detected at inflamed sites in rodent colitis 
models (Lamprecht et al., 2001; Moulari et al., 2008).  Moulari et al. (2008) clearly 
demonstrated an increased accumulation of SiO2 NPs at inflamed tissues compared to 
healthy and non-inflamed areas.  The deposition of NPs at inflamed lesions might 
depend on specific characteristics like the particle size as was shown for polystyrene 
NPs in a triple co-culture model of the intestine.  Whereas 50 nm particles adhered 
significantly more to the Caco-2 cell layer of inflamed co-cultures compared to the 
control cells no differences were measured for larger particles between 100-500 nm 
(Leonard et al., 2010).  In contrast to this, Schmidt et al. (2013) found a statistically 
increased accumulation of micro- but not nano-sized PLGA particles, as well as an 
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elevated translocation from the mucosal to the serosal side of nano- but not micro-sized 
particles.   
The translocation of NPs at inflamed areas of the intestine has been suggested to be 
related to the increased synthesis of mucus at these sites (Lamprecht et al., 2001).  The 
elevated synthesis of mucus has also been demonstrated in Caco-2 cells after the 
induction of an inflammation-like response using IL-1β (Leonard et al., 2010).  The 
formation of a mucus layer has not been studied within this project; however, based on 
other groups’ findings it is possible that the THP-1-mediated inflammation-like process 
caused a similar effect here.  Concerning the interaction of NMs with mucus, the 
particles’ surface charge and hydrophilicity appear to be crucial determinants.  Mucus 
carries an overall negative charge and is characterised by the presence of numerous 
hydrophobic domains (Lai et al., 2009).  The 5 and 30 nm [
195
Au]AuNPs used here had 
a strong negative surface charge in dispersant (-46 and -44 mV respectively), which 
increased closer to neutral charge in fresh CCM (-11 and -10 mV, respectively).  An 
increased formation of mucus on the Caco-2 cells and subsequent entrapment of 
particles could explain the increased recovery on the filter in the inflamed condition, but 
also the increased activity measured in the wash.  It has been shown that particles with 
an overall negative charge penetrate mucus more easily than positively charged 
particles, which became entrapped and immobilised within (Crater and Carrier, 2010; 
Wang et al., 2008b).  In line with this, several groups reported increased cellular 
penetration and barrier crossing of negatively and neutrally charged compared to 
positively charged NPs.  Schleh and colleagues (2012) observed a significantly 
increased intestinal uptake of carboxylated compared to amine-modified AuNPs in 
orally exposed rats.  Also Jo and colleagues (2015) reported an uptake of slightly 
negatively charged AuNPs (5-15 nm diameter) in orally exposed rats.  Whereas the 
translocation rate in vivo was below 2 % a surprisingly high barrier crossing rate of up 
to 20 % was observed in vitro for neutrally charged AuNPs and 10 % for negatively 
charged particles in Caco-2 cells (Lin et al., 2011; Lin et al., 2012).  The increased 
barrier crossing might have been caused by the strong reduction in barrier integrity (30-
50 %) in response to the exposure (Lin et al., 2011).  Even though we measured a 
similar reduction in TEER in the inflamed co-culture model we could not detect an 
increased translocation of either 5 or 30 nm [
195
Au]AuNPs to the BL compartment.  One 
might assume that the reduction in barrier integrity observed by Lin et al. was caused by 
cytotoxicity rather than an effect on the TJs as in the inflamed model of this project.  
However, the rapid recovery of barrier integrity after elimination of AuNPs, as well as a 
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separately conducted cytotoxicity assay strongly suggested that no cell death occurred 
(Lin et al., 2011).  This supports the idea that NPs might pass an epithelial barrier 
through disrupted TJs.  However, Leonard et al. (2010) did not find a co-localisation of 
NPs with ZO-1, suggesting that they were not transported in the paracellular space but 
penetrated the Caco-2 cells directly.   
 
6.5 Conclusions 
Neither 5 nm nor 30 nm [
195
Au]AuNPs crossed the Caco-2 barrier at significant 
numbers in the Caco-2 monoculture confirming the corresponding hypothesis.  
However, also in the inflamed co-culture no increased translocation of either size 
[
195
Au]AuNPs was noted, which disproved our initial hypothesis.  Hence, the loosening 
of the TJs and reduction in barrier integrity by 40-50 % after induction of an 
inflammation-like response was not sufficient to cause a paracellular passage of the 
particles.  No increased levels of 
195
Au-associated activity were detected in the BL 
supernatants or the separately investigated THP-1 cells.  The ongoing inflammatory 
process did, however, result in an elevated retention of 5 nm [
195
Au]AuNPs on the filter 
insert.  The results, furthermore, underlined the importance of a thorough 
characterisation of NMs not only in fresh CCM but also in presence of cells, as even 
smallest variations in the dispersant’s composition can greatly influence the colloidal 
stability of the particle suspension. 
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7. Discussion of the project 
7.1 Reconciliation of the project’s aims and the findings 
The following paragraphs will reflect on the aims and general hypotheses of the project 
laid out in Section 1.5 and discuss whether they can be accepted or rejected.  A 
summary of the specific hypotheses is listed in tabular form and attached in the Annex 
(Table S1). 
The goal of the project was the establishment of an in vitro cell line-based co-culture 
model of the human intestine using Caco-2 and THP-1 cells for nanosafety research.  
The establishment was divided into the development of a co-culture mimicking the 
homeostatic (‘stable’) intestine (Aim I), and its advancement to resemble the intestine in 
diseased (‘inflamed’) state after exposure to a pathophysiological stressor (Aim II).   
Altogether, the overarching goal of developing this 3D co-culture model with its two 
conditions was achieved, as presented and discussed in Chapter 2.  Throughout the 
process, however, several challenges were encountered.  As has been shown before 
(Daigneault et al, 2010; Aldo et al, 2013), the characterisation of the THP-1 cell line in 
monoculture once again demonstrated how critical the (PMA)-differentiation protocol 
and the type of stimuli are for the subsequent (cytokine) response of the cells.  When the 
adequate PMA-differentiation protocol was established, the two cell lines could exist in 
a co-culture model without negatively affecting each other.  This conclusion was based 
on the findings that no statistically significant differences in the barrier integrity, 
viability, release of pro-inflammatory cytokines (except IL-1β and IL-8), and generation 
of NO were detected in the stable co-culture compared to the Caco-2 monoculture.  
Even though the release of IL-1β and IL-8 was higher in the stable co-culture than the 
monoculture it did not exceed the levels found in THP-1 monocultures.  It can, 
therefore, be argued that the levels are attributable to the typical release by THP-1 cells 
and do not indicate an activation of the macrophages.  Hence, the first hypothesis the 
project was based on (‘Caco-2 and THP-1 cells can cohabit in a paracrine co-culture 
system to mimic the intestine in homeostatic state.’) was confirmed.   
The second step of inducing an inflammation-like response with LPS as 
pathophysiological stressor turned out to be unworkable without changing some details 
of the co-culture set-up and cell treatment.  Whereas the cohabitation of Caco-2 and 
THP-1 cells was necessary for the establishment of the stable co-culture it greatly 
complicated the development of the diseased model.  It is highly likely that the 
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macrophage-mediated pro-inflammatory response to LPS was suppressed by the Caco-2 
cells.  The ‘immuno-shaping’ role of IECs in the homeostatic intestine has become 
increasingly clear over the past years (Miron and Cristea, 2012) and was demonstrated 
to occur in vitro in presence of PBMCs (Parlesak et al., 2004).  On the one hand, this 
confirmed the applicability of the stable model as representative of the healthy intestine.  
On the other hand, it made further changes to the co-culture protocol necessary to 
achieve an inflammation-like response.  To overcome the downregulation of the 
inflammatory response in THP-1 cells, the Caco-2 barriers were primed with IFN-γ and 
the THP-1 cells were pre-stimulated with LPS and IFN-γ in advance of the co-culture.  
Therefore, the second general hypothesis of the project (‘An inflammation-like response 
displaying hallmarks of intestinal inflammation can be induced in the homeostatic co-
culture through the stimulation of the THP-1 cells.’) was partially but not fully 
accepted.  The induction of an inflammation-like response required more than the 
stimulation of THP-1 cells with LPS.  Treatment of the Caco-2 cells (IFN-γ-priming) 
did not cause inflammation-like effects by itself but only in combination with pre-
stimulated THP-1 cells (Section 2.2.4.2).   
Co-cultures treated according to the adapted protocol (Step 4) displayed several 
hallmarks of intestinal inflammation, e.g. a significant reduction in TEER, increased 
cytotoxicity in the IEC barrier, high levels of pro-inflammatory cytokines and 
generation of NO.  Nevertheless, the reduction in TEER, which can indicate both a 
destruction of the barrier through cell death or a loosening of the TJs, did not result in 
an increased translocation of LY.  However, the permeability of the barrier to LY is not 
necessarily a proof for TJ integrity but instead requires careful evaluation.  Even though 
few groups reported an increased LY translocation in response to cytokine-induced 
barrier disruption, the dye seems to be rather suitable to assess barrier destruction 
caused by cytotoxic effects rather than the integrity of TJs (Section 3.4.3).  Hence, the 
choice for LY to study the initial Caco-2 barrier development was adequate, but a 
different molecule, e.g. dextran, should have been applied to investigate the TJ integrity 
throughout the inflamed co-culture. 
Another issue was encountered when studying the possibility to activate the stable co-
culture with EDTA and LPS.  The exposure to EDTA and LPS confirmed that 
significant release of pro-inflammatory cytokines can be triggered in the stable co-
culture (Section 3.4.2).  For IL-1β and TNF-α, two essential cytokines for the induction 
and maintenance of inflammation, the release remained very low, albeit significantly 
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higher compared to the control.  The additional control experiment including IFN-γ in 
the apical exposure, however, resulted in a significantly increased cytokine response 
compared to EDTA/LPS exposure alone.  This confirmed the importance of IFN-γ for 
the synthesis of IL-1β and TNF-α, which has also been demonstrated in vivo 
(Shinozawa et al., 2002).  These results imply that the ability of the stable co-culture to 
react to a pro-inflammatory stimulus in the absence of IFN-γ is limited.  This, 
furthermore, leads to obvious questions regarding the applicability of the stable co-
culture to study the pro-inflammatory potential of NMs.  A possible solution to enhance 
the model’s validity could be the introduction of IFN-γ into the set-up of the stable co-
culture.  Segura et al. (2002) reported a priming effect of IFN-γ on THP-1 cells, which 
caused only minimally increased background levels of pro-inflammatory cytokines.  
Upon stimulation with LPS, Segura et al. (2002) observed a higher cytokine response in 
primed vs. non-primed THP-1 cells.  Taking into account the mentioned diversity in 
THP-1 responses to differentiation stimuli and stressors (Section 2.3.1.2) it cannot be 
guaranteed that the priming would cause the same effects here.  This consideration is 
supported by the observation of Sanceau et al. (1991), who did not note a priming effect 
of IFN-γ but only a synergistic effect of IFN-γ and TNF-α. 
Based on the results of the inflamed co-culture presented in Chapters 2 and 3 we 
concluded that the IEC barrier is not permanently destroyed and the inflammation-
mediated barrier disruption resolved itself.  The decisive factors for these statements 
were the increase in TEER at the end of the co-culture (Section 2.2.4.2), as well as the 
immunocytochemical staining of the corresponding barriers showing no gaps in the 
Caco-2 cell layer (Section 3.3.1.5).  In this context, the increased levels of LDH were 
interpreted as result of necrotic cell death within the first 24h of co-culture, when the 
TEER is clearly reduced.  Taking into account the observations in Chapter 4, however, 
the conclusion of a self-resolving inflammatory response might have been hasty.  The 
reduction in TEER is most likely attributable to the known synergistic effect of IFN-γ 
and TNF-α on the TJ proteins claudin 2 and 4 (Capaldo et al., 2014).  In contrast to 
other groups (Bruewer et al., 2003; Wang et al., 2005; Susewind et al., 2016), the 
barrier integrity in the inflamed model of this study was restored after 48h without any 
additional interference, e.g. medium change or addition of Ab.  The initial criterion for 
the inflamed co-culture of inducing a self-resolving inflammation-like process was not 
achieved.  Instead, TNF-α and IL-1β remained constant over 48h.  Furthermore, the 
turning point for the barrier re-establishment was between 18 and 24h of co-culture.  At 
this time point, the levels of both IFN-γ and TNF-α were remarkably high (Section 
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4.3.3.3).  The next possible explanation was based on the paracrine nature of the model, 
which allowed a dynamic co-culture of and communication between the IECs and 
macrophages.  It is possible that the inflammation like response also induced anti-
inflammatory, barrier-protecting mechanisms to counteract the barrier disruption which 
were not measured. 
Another possible explanation is that the increase in TEER can be traced back to cellular 
swelling.  Since no increase in TEER was observed in the Caco-2 monoculture and 
stable co-culture control the swelling might have been caused by the occurrence of 
secondary necrosis resulting from cytokine-induced apoptosis (Silva, 2010).  It may also 
explain the strong increases in barrier integrity in the inflamed co-culture after exposure 
to AgNO3 and AgNPs, as well as in the Caco-2 monoculture and stable culture in 
response to AgNO3 (Sections 4.3.3.1 & 4.4.3).  This explanation, however, challenges 
the initial interpretation of the ‘re-establishment’ of TEER, which we initially attributed 
to the restoration of the TJ network.  Instead, the increase in TEER might have 
originated from a reduction in intercellular space caused by cellular swelling as part of 
necrotic cell death.  
The third aim of the project was to use the developed co-culture models to study the 
effects of NMs in relation to the health status at the time of exposure.  The main 
hypothesis was that different effects of AgNPs can be observed in the two different co-
culture conditions.  When studying CuO NPs, several hypotheses aimed to show 
differences in the exposure effects between digested and undigested CuO NPs.  We 
hypothesised that, overall, the exposure to digested CuO would cause less pronounced 
effects in the co-culture conditions compared to the undigested particles.  
Even though no pro- or anti-inflammatory effects were noted for AgNPs several 
interesting observations were made on the cytotoxic potential of both AgNPs and 
AgNO3 (Section 4.3.2).  The results clearly showed an increased sensitivity to ionic Ag 
in DCaco-2 compared to UDCaco-2 cells underlining the importance of the differentiation 
status for the outcomes.  Furthermore, the model revealed a dramatically enhanced 
susceptibility of the inflamed co-culture to Ag species compared to the stable set-up.   
The results obtained from the co-culture exposure to CuO NPs were, overall, less 
dramatic.  Again, no effect on the cytokine release of NO generation was observed in 
any of the culture models.  Interestingly, digested and undigested CuO NPs had distinct 
effects on the barrier integrity in the stable and inflamed co-culture conditions.  
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Whereas only the exposure to undigested CuO NPs significantly reduced the TEER of 
the stable co-culture, significant effects in the inflamed co-culture were limited to the 
exposure to digested CuO NPs.  Hence as before, the two models were able to show 
distinct effects of NMs in relation to the health status of the co-culture.  In contrast to 
the study of Ag-species no clearly increased susceptibility of the inflamed co-culture 
was noted in case of CuO NPs.  The use of CuO NPs also rendered a limitation of the 
model visible regarding the detection of NM-induced cytotoxicity.  As we observed 
earlier, assays quantifying the metabolic activity are not suitable to sensitively assess 
cell viability in the transwell cultures.  Therefore, the LDH assay was used for AgNPs 
and AgNO3 exposure experiments.  Cu ions however, interfere with LDH and make it 
unavailable for the detection of enzymatic activity in the LDH assay.  Hence, in case 
NMs interfere with cytotoxicity assays the cell viability has to be assessed using cell 
count methods, e.g. based on nuclear counts.  Automated systems like the IN Cell 
Analyzer are highly suitable for these situations, but their operation is rather resource-
intensive.  Cell counts could also be performed manually.  But especially regarding low 
cytotoxic effects, the error and bias introduced with the human factor might lead to 
over- or underestimations of results.   
These results confirmed the hypothesis that an ongoing inflammation potentially alters 
the effects of NMs in the intestine.  This certainly stresses the need to include the health 
conditions at the time of exposure into the safety assessment of NMs.  However, other 
co-cultures mimicking the homeostatic and inflamed intestine failed to show similar 
outcomes (Susewind et al., 2016).  This might be related to the significantly different 
co-culture structure and pro-inflammatory stressor (IL-1β) (Section 3.4.1.1).  Without 
additional in vivo confirmation and validation the results generated here cannot be 
extrapolated to the potential effects of exposed human patients suffering from 
inflammatory conditions of the intestine.  
The fourth aim of the project was to use the co-culture system to assess the paracellular 
passage of different sizes of radio-labelled AuNPs.  The objective was to quantify and 
compare the translocation of [
195
Au]AuNP-associated activity from the AP to the BL 
compartment between the stable and inflamed co-culture models.  The experiments 
were based on the reports of other groups that AuNPs can translocate across the Caco-2 
barrier, with a higher translocation rate for smaller particles (Lin et al., 2011).  It was 
hypothesised that the barrier disruption in the inflamed co-culture would cause an 
increased paracellular passage compared to the Caco-2 monoculture and the stable co-
228 
culture.  However, the experiments did not show any significant translocation of 
particles independent of the particle size and cell culture health status at the time of 
exposure.  Taking into account that induction of inflammation mainly causes a 
loosening of the TJ network rather than a disintegration of the Caco-2 barrier these 
results were, in retrospect, not particularly surprising.  In a homeostatic state, the TJ are 
virtually impermeable to molecules larger than 15 Å (van Meer and Simons, 1986).  
Hence, a paracellular transport in the stable co-culture would have been an indication 
for cytotoxic effects induced by either the particles or by the co-culture conditions.  It 
could have been possible that the cytokine-induced disruption of the TJs induced a 
widening of the paracellular space, which might allow for the translocation of larger 
structures.  However, even if the size selectivity of the TJs was disrupted the passage of 
AuNPs would have most likely been prevented by their negative charge, as was 
observed with LY.   
Nevertheless, an interesting observation was made concerning the increased 
sedimentation and accumulation of [
195
Au]AuNPs in the inflamed co-culture, which was 
in line with in vivo and other in vitro studies (Sections 1.5.2 & 6.4.4).  Identifying these 
significantly different effects between the inflamed and stable co-culture that coincide 
with results obtained in human patients and animal models further strengthened the 
model’s closeness to reality and applicability. 
Studying the effects of different types of NMs in the two co-culture models showed that 
also the third hypothesis (‘The two co-culture conditions are suitable to study the effects 
of NMs in relation to the health status at the time of exposure.’) could only partially be 
supported.  On the one hand, significant differences regarding the effects of NMs were 
observed between the homeostatic and inflamed co-cultures for which the assessment of 
barrier integrity by means of TEER turned out to be the most sensitive and reliable 
method.  On the other hand, several limitations of both the model and applied methods 
became visible, which narrow the applicability of the co-culture conditions.  These 
include for instance the uncertain usefulness of the stable co-culture to study the pro-
inflammatory potential of NMs and the quantification of cytotoxicity.  
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7.2 Theoretical outlook 
A number of gaps remain and potential improvements of the model are possible. 
The overall goal of the project was to challenge the current status quo of in vitro 
research of the intestine with the development of a reliable, reproducible, and versatile 
co-culture model based on human cell lines.  The representation of the immune system 
using a monocytic cell line improves the model’s applicability and closeness to a 
biological system.  Nevertheless, it remains but a sketch of the complex construct that is 
the intestine.   
Even though the project generated many inputs for additional research it left several 
questions unanswered.  For example, it remains inconclusive how the barrier integrity 
of the inflamed model was restored.  This knowledge is important to determine whether 
the inflammatory process is resolving or on-going.  To elucidate this, the Caco-2 
barriers should be subject to additional analyses regarding apoptotic and necrotic cell 
death markers over the course of the co-culture.  The cells’ morphology could be 
investigated using flow cytometry or TEM to detect cell shrinkage, 
compartmentalisation, and chromatin condensation for apoptosis, or cell swelling and 
membrane rupture for necrotic cell death.  Furthermore, the activation of the caspase 
cascade could be monitored, as well as the expression of apoptosis-related cell surface 
markers like phosphatidylserine using annexin V (Krysko et al., 2008).  In this context, 
also the paracellular permeability in the co-culture conditions should be addressed again 
using other markers than LY.  Furthermore, the induction of anti-inflammatory or 
barrier-protective processes, e.g. the release of IL-10 (Madsen et al., 1997), should 
receive more attention.  In parallel, studying the dynamics of the Caco-2 barrier 
integrity requires a more thorough analysis of the changes in expression of TJ proteins.   
Another major question mark is the applicability of the stable co-culture to study the 
pro-inflammatory potentials of NMs (Section 3.4.2).  Before continuing to use the 
model for such purposes a more thorough testing has to be executed.  This includes the 
assessment of another stressor that does not depend on EDTA to disrupt the IEC barrier, 
for instance pathogenic Shiga-toxin.  In contrast to Staphylococcal enterotoxin, Shiga-
toxin can induce a barrier disruption in Caco-2 cells after AP exposure (Kwak et al., 
2012; Schüller et al., 2004).  Since Shiga-toxin alone is only inducing a moderate 
cytokine response in THP-1 cells a combined exposure with LPS would be useful 
(Harrison et al., 2005).  Since the introduction of a new stressor requires a thorough, 
230 
time-intensive characterisation of its effects in monocultures of both cell lines this step 
was not introduced anymore in this project.   
The introduction of additional cell types could certainly enhance the model’s relevance.  
For instance the incorporation of neutrophils and DCs could open up possibilities to 
study the first lines of inflammatory processes, as well as recruitment of leukocytes and 
initiation of healing mechanisms.  To do so it might be interesting to combine this 
paracrine co-culture with the collagen-embedded approach chosen by Susewind et al. 
(2015) and Leonard et al. (2010).  To induce a physiologically relevant inflammation-
like response the stimulation of leukocytes with LPS appears to bear greater potential 
than the stimulation of IECs with IL-1β (Section 3.4.1.1).  It is questionable, whether 
the direct stimulation of immune cells would be feasible in case they are embedded in a 
collagen matrix beneath the IEC barrier.  Furthermore, culturing leukocytes over an 
increased period of time, as done in the studies of Susewind et al. (2015) and Leonard et 
al. (2010), the cells’ responsiveness to stressor would likely be reduced or inhibited as 
was observed here (Section 2.2.4.2).  Therefore, the model should not be fully adapted 
to this approach but integrated.  The model might then be suitable to study the effect of 
the activation of macrophages in the BL compartment on the embedded immune cells 
and how this might affect the interaction with enterocytes.  Embedding immune cells 
under the IEC barrier allows assessing the migration of leukocytes to the AP side of the 
cells and a potentially distinct reaction to the exposure to NMs.  In the here presented 
co-culture the NMs have to cross the IEC barrier to interact with the macrophages, 
whereas they might encounter leukocytes directly on the AP side of the barrier in vivo.   
Another possibility would be the introduction of other non-enterocytic epithelial cell 
types.  Especially in the context of nanosafety and nanomedical studies the lack of both 
mucus-producing goblet cells and M-cells is unfortunate.  Long underestimated, the 
mucus layer covering the mucosa presents a major barrier and designing mucus-
penetrating NMs remains a challenge (Barua and Mitragotri, 2014).  M-cells, on the 
other hand, seem to be greatly involved in the uptake of NMs from the lumen (des 
Rieux et al., 2005).  Their targeting has, therefore, been the goal to increase the 
efficiency of orally delivered vaccines (Garinot et al., 2007).  The introduction of one, 
or better both cell types, would further increase the model’s application range and 
potential to extrapolate results to an in vivo situation.  However, even without these 
adaptions the model can generate useful information, especially regarding the 
231 
potentially increased susceptibility of the inflamed compared to the homeostatic 
intestine to the exposure to NMs.   
 
7.3 Final conclusions 
Altogether, three of four aims of the project, i.e. the development of the co-culture 
model in homeostatic state, its advancement to an inflamed state, and the application of 
both conditions to study the effect of NMs could be achieved.  As the model is based on 
cell lines of human origin it is easily established in other laboratories and more 
applicable to studies on human exposure than models using cells from other mammalian 
species.  It further sets itself apart from available models as it can mimic the intestine in 
homeostatic and controlled inflamed state.  For the inflamed state, a pathophysiological 
mechanism was used that is has been shown to be involved in IBD.  Hence, a highly 
realistic inflammation-like process was simulated, which is unique in the available in 
vitro intestinal models.  
With the application of the model highly interesting results were obtained on the impact 
of the health status on NMs-induced effects that indicated a significantly increased 
susceptibility of the epithelial barrier under inflamed conditions.  Especially in the 
context of rising prevalence and incidences of IBD these results underline the 
importance to consider the health status as part of the safety assessment of NMs.  The 
fourth aim of studying the paracellular passage of NMs was not fulfilled.  This can be 
traced back to unrealistic expectations concerning the disruption of the TJ network, as 
well as an overestimation of the barrier damage caused throughout the inflammation-
like processes.  Nevertheless, the use of radio-labelled NMs revealed an interesting, 
size- and time-dependent accumulation of AuNPs in the inflamed co-cultures, which 
further supported the model’s applicability and closeness to reality. 
The here presented model offers a promising basis for the safety assessment of NMs, as 
well as for further developments, adjustments, and applications beyond nanosafety 
research. 
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